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SUMMARY 
 
Currently, the in vitro production (IVP) of porcine embryos suffers from low 
efficiency and reduced blastocyst quality. Poor outcomes from in vitro matured 
oocytes and in vitro fertilised embryos have limited the use of assisted 
reproductive technologies (ARTs) within commercial porcine herds, reducing the 
potential for global genetic improvement programs. It is believed that this reduced 
developmental competency compared to in vivo embryos is attributable to altered 
metabolism resulting from in vitro culture. 
 
Improper or incomplete metabolic support from the culture media leads to 
production of inferior embryos. Much of the prior research centres on metabolism 
of carbohydrates by oocytes and embryos, with the formulation of media based on 
this knowledge. However, oocytes and embryos also contain endogenous lipid 
substrates, and there is a lack of understanding as to how and when these stores 
are utilised. Lipids are a dense form of energy storage, and there is evidence of 
their metabolism by oocytes and embryos for energy generation. Porcine oocytes 
and embryos have higher intracellular lipid content than other domestic livestock 
species, and this makes them an excellent model for studying aspects of lipid 
metabolism in vitro. 
 
The aim of this study was to examine the impact of lipid metabolism on the 
acquisition of developmental competence during porcine IVP, and how this is 
affected by the presence or absence of exogenous carbohydrates. Stimulation or 
inhibition of the β-oxidation pathway was used to discern the importance of fatty 
acid oxidation to oocyte maturation and embryo development during in vitro 
maturation (IVM), in vitro fertilisation (IVF) and in vitro embryo culture (IVC). 
 
During IVM, it was identified that porcine oocytes are capable of using different 
substrates to compensate for deficiencies in others. While pyruvate and glucose 
are preferentially utilised to support maturation, upregulation of β-oxidation can 
compensate for a low glucose concentration and an absence of pyruvate to 
support nuclear maturation. Although there was no discernible decrease in lipid 
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content associated with this, lipids provide such a dense energy reserve that any 
usage may have been beyond the limit of detection. Inhibition of β-oxidation in the 
absence of carbohydrates had a greater effect on nuclear maturation compared to 
inhibition in complete media. This indicates that lipid metabolism plays a minor 
role during oocyte maturation in the presence of carbohydrates and is likely to be 
more important when other substrates are deficient. 
 
Energy generation prior to fertilisation is an important factor in the developmental 
outcomes of subsequent embryos. Upregulation of β-oxidation for the duration of 
IVF increased cleavage rates, but doses above 6mM L-carnitine led to decreased 
blastocyst development. This effect may be attributable to the antioxidant activity 
of L-carnitine, with low levels of reactive oxygen species (ROS) being required at 
fertilisation for normal sperm function and sperm-oocyte interactions. Oocyte 
incubation in media supplemented with 3mM L-carnitine for an hour prior to 
insemination increased cleavage and improved cryosurvival of Day 7 embryos 
after vitrification. While ATP content of oocytes did not increase over this period, it 
is unclear if lipid content was reduced. Previous studies have shown that L-
carnitine treatment of oocytes and embryos decreased lipid content, thereby 
increasing cryotolerance. It would therefore appear that there is a limited role for 
β-oxidation during the IVF period itself, although upregulation immediately prior to 
fertilisation may have beneficial effects on metabolic processes and may provide 
antioxidant protection leading to improved development in early cleavage stage 
embryos. 
  
During embryo culture, there was a greater effect of upregulating lipid metabolism 
seen in the absence of carbohydrate substrates than in complete media. 
However, this could not support embryo development to the same extent as 
carbohydrate substrates. Changing nutrient requirements of embryos has led to 
the development of sequential media, leading to the production of better quality 
IVP embryos. Upregulation of β-oxidation for the first three days of culture in a 
single media system increased embryo quality to the same extent as a sequential 
carbohydrate media system, implying there is some level of plasticity to embryo 
metabolism allowing for adaptability to different substrates. Inclusion of L-carnitine 
for either a three day period or the duration of culture increased cryosurvival, 
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suggesting decreased lipid content due to increased β-oxidation activity. Similarly 
for oocyte maturation, β-oxidation appears to be able to compensate for 
carbohydrate deficiencies during embryo culture to some extent, and oxidation of 
lipids has a greater role in promoting embryo quality over increasing production 
rates. 
 
The findings reported in this thesis represent a contribution to the understanding 
of lipid metabolism during the in vitro production of porcine embryos. These 
results provide evidence to support a level of adaptability of porcine oocytes and 
embryos to different substrates available during maturation and culture. There is a 
preference shown for carbohydrates substrates, with the ability to utilise lipids to 
compensate for certain deficiencies. This would justify the inclusion of co-factors 
of lipid metabolism such as L-carnitine in culture media, to ensure that any 
deficiencies in other substrates might be corrected for and to promote higher 
embryo quality. Upregulation of β-oxidation also increased the cryosurvival of 
porcine embryos following vitrification, with this being a major development in the 
global movement of superior genetics for herd improvement programs. These 
findings will also have implications for improving in vitro culture of oocytes and 
embryos of other species, most notably advancements in human ARTs where 
research is predominantly limited to work in animal models. The understanding of 
how lipids are metabolised alongside exogenous carbohydrates will contribute to 
improving media formulations for better metabolic support in vitro, further to 
improving embryo production and quality. 
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CHAPTER 1. LITERATURE REVIEW 
 
1.1. Introduction 
 
In vitro production of porcine embryos is currently limited to research applications 
in oocyte and embryo studies and the production of transgenic pigs for 
xenotransplantation. This is because the system is not effective or efficient 
enough to permit the application of ARTs, including embryo transfer, cloning and 
vitrification on a commercial scale. These ARTs are invaluable tools for facilitating 
genetic improvement and breeding programs of pig herds globally, and the ability 
to use them would be of great benefit to the industry. Quality differences between 
in vitro and in vivo derived embryos stem in part from poor metabolic support 
during in vitro culture, due to an incomplete understanding of the metabolic 
requirements of oocytes and embryos. 
 
Porcine oocytes and embryos contain a large complement of lipid, the majority of 
which is stored as lipid droplets within the cytoplasm. There is evidence that lipids 
play an important metabolic role during oocyte maturation and embryo 
development in numerous species, including mice (Dunning et al. 2010a; Dunning 
et al. 2010b), cattle (Sutton-McDowall et al. 2012), and pigs (Somfai et al. 2011; 
Wu et al. 2011; You et al. 2012). However, the level of contribution to energy 
generation within the cell and the reasons for such high levels of intracellular lipid 
in porcine oocytes and embryos are still poorly understood.  
 
The majority of research into oocyte and embryo metabolism has focussed on 
carbohydrate usage. Because of this, many current media formulations used 
during in vitro oocyte maturation and embryo culture are based predominantly on 
carbohydrate requirements, leading to potential inefficiencies as the metabolic 
requirements of the cells are only partially met. Comparatively little is known 
regarding lipid metabolism, as this is a recently emerging area of research 
(Romek et al. 2009; Romek et al. 2011b,  a; Somfai et al. 2011; McKeegan and 
Sturmey 2012; You et al. 2012). 
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Specific metabolic processes and preferential substrate utilisation by oocytes and 
embryos appears to be species-specific. Understanding metabolic processes 
utilised by the oocyte and embryo for energy production will provide insight into 
substrate utilisation, critical to improving culture media conditions. By tailoring 
media to the needs of the cells, IVP protocols may be optimised to more closely 
match in vivo development and produce higher quality embryos, allowing this 
technology to be utilised in a commercial setting. 
 
1.2. Embryo IVP 
 
1.2.1. Significance of the technology 
 
Further development of protocols for IVP of porcine embryos would be beneficial 
in providing the opportunity for the application of a wider range of ARTs to pig 
production. Genetic improvement programs are enhanced by the ability to create, 
store and transport embryos globally, allowing improvements in economically 
important traits. Embryo transfer programs using in vitro produced embryos 
facilitate gene flow between herds, as well as the ability to vitrify embryos for 
indefinite storage of desirable gene lines. 
 
Porcine IVP also benefits human biomedical research. Pigs are particularly 
valuable models because of the similarities to human physiology, and the readily 
available nature of abattoir-sourced material. Development of ART treatments for 
infertile human couples relies largely upon animal models due to legislative 
restrictions on working with human tissue and limited availability of material. 
Further, animal cloning and production of transgenic animals is a growing 
research area with transgenic pigs used as models of human diseases (Kragh et 
al. 2009; Luo et al. 2011) and for research into xenotransplantation (Luo et al. 
2012; Zinovieva et al. 2014). This research is creating potential options for 
treatments of certain diseases, such as islet cell transplantation in patients with 
diabetes mellitus (Nagaraju et al. 2013), demonstrating the value of developing 
porcine IVP technologies. 
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1.2.2. Limitations of the technology 
 
These biotechnologies depend largely upon large quantities of good quality 
porcine embryos. Despite extensive and ongoing research into refining IVP 
protocols, these applications are currently limited due to inefficiencies inherent in 
IVP porcine embryos. Current porcine IVP systems still suffer from inefficient 
oocyte maturation and fertilisation, poor developmental capacity of in vitro 
produced embryos, and suboptimal IVC conditions (Abeydeera 2002; Grupen 
2014). 
  
Standard IVP systems include in vitro maturation, in vitro fertilisation and in vitro 
culture. During each in vitro stage, factors such as oxygen tension, temperature, 
humidity and composition of culture media all differ from conditions to which the 
oocytes and embryos are exposed in vivo, compromising the quality of the 
resulting embryos. The low efficiency of IVP in pigs, especially compared to that of 
other livestock species and of in vivo embryos, is a major limitation of this 
technology. 
 
In vitro produced embryos have been shown to have altered metabolic processes 
compared with in vivo embryos, with differences seen in substrate utilisation and 
activity levels of metabolic pathways (Swain et al. 2002). Energy generation within 
the cell is a complex and important process required for proper growth and 
development, and this is likely a major contributor to the poorer quality of in vitro 
produced embryos. Further, improper or asynchronous cytoplasmic and nuclear 
maturation during IVM and a consequential high incidence of polyspermy following 
IVF, as well as sub-optimal embryo culture conditions, are also suspected to be 
major contributors to the low efficiency of IVP systems for porcine embryos. 
Porcine oocytes and embryos have high endogenous lipid reserves, stored 
predominantly as triglycerides within the cytoplasm, compared with other species. 
Negative effects of this increased lipid content include reduced cryotolerance 
(Dobrinsky and Johnson 1994; Abe et al. 2002; Sudano et al. 2011), making 
successful vitrification of these cells difficult. 
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1.2.3. In vitro maturation 
 
In vitro maturation is a critical component of IVP systems, involving the harvesting 
of immature cumulus oocyte complexes from antral follicles and maturing them 
within the lab environment. Oocyte quality plays a major part in determining the 
yield and quality of resulting embryos (Krisher 2004), and therefore proper 
maturational support is a critical component of any IVP system. Oocyte quality is 
influenced by the nuclear and mitochondrial genome, as well as the surrounding 
environment supporting the oocyte, including factors such as in vitro culture 
media, temperature, humidity and oxygen tension. Because oocyte quality has 
such a marked effect on the quality of resulting embryos, ensuring optimal 
conditions throughout maturation is vitally important. 
 
The cumulus oocyte complex (COC) refers to the oocyte itself as well as the 
surrounding cumulus cells (CCs). These are differentiated from follicular 
granulosa cells and act as support cells for the oocyte during growth and 
development. Interaction between CCs and oocytes is primarily through small 
transzonal projections from the cumulus cells which penetrate the zona pellucida 
of the oocyte to provide direct contact with the surface of the oolemma, forming 
gap junctional communication (Albertini et al. 2001). Oocytes also communicate 
with the cumulus cells via paracrine signalling, allowing oocyte-directed 
stimulation of processes within the cumulus cells. Bi-directional communication 
between the oocyte and the cumulus cells is critical for acquisition of oocyte 
developmental competence (Gilchrist et al. 2008). 
 
Oocytes go through two periods of meiotic arrest. The first period of arrest is at 
the germinal vesicle (GV) stage following oogenesis within the immature follicle. In 
vivo, resumption of meiosis following arrest at the GV stage is triggered by the 
pre-ovulatory LH surge and gonadotrophin stimulation. This process occurs 
spontaneously in IVM systems following aspiration of the COC (Gilchrist and 
Thompson 2007). Following resumption of meiosis after the first arrest, the 
oocytes undergo germinal vesicle breakdown (GVBD), leading to arrangement of 
the chromatids on the spindle at metaphase I (MI) stage. Following MI, oocytes 
undergo anaphase and telophase to reach the stage of metaphase II (MII). This is 
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the second period of meiotic arrest, and can only be maintained for a few hours 
until cell quality irreversibly declines and cell death occurs. Sperm related factors 
trigger calcium oscillations within the oocyte, increasing calcium concentrations 
within the cell to reinitiate development and allow fertilisation to occur (Carroll 
2001). Higher rates of in vitro nuclear maturation, pronuclear formation and 
blastocyst development are attained in oocytes derived from large follicles 
compared to those derived from small follicles (Yoon et al. 2000; Marchal et al. 
2002). Oocytes obtained from adult pigs had higher developmental competence 
than those from gilts (Grupen et al. 2003; Bagg et al. 2007). 
 
Concurrent with nuclear maturation, the oocyte undergoes cytoplasmic 
maturation. Cytoplasmic maturation involves rearrangement of the cytoplasmic 
structures, such as the endoplasmic reticulum and mitochondria, as well as 
accumulation of factors such as nutrients, substrates, mRNAs and de novo 
purines required for DNA synthesis and completion of maturation. The synthesis 
of gluthathione (GSH) plays a vital role in successful cytoplasmic maturation, with 
evidence for a role in maintenance of meiotic spindle morphology to ensure 
normal fertilisation (Zuelke et al. 1997). Sperm head decondensation, male 
pronuclear formation and development to the blastocyst stage are all quality 
markers of cytoplasmic maturation, and are positively correlated with GSH levels 
(Yoshida 1993; Abeydeera et al. 1998a). In vivo matured oocytes typically have 
higher levels of GSH than in vitro matured oocytes (Brad et al. 2003a), possibly 
contributing to quality differences. 
 
The optimisation and synchronisation of nuclear and cytoplasmic maturation are 
major factors required for successful oocyte maturation. It is vital to ensure these 
factors are accounted for to ensure the mature oocyte has attained developmental 
competency prior to fertilisation. 
 
1.2.4. In vitro fertilisation 
 
Fertilisation marks the uniting of a mature MII oocyte with a spermatozoon to form 
a diploid zygote. There are numerous events necessary for normal, successful 
fertilisation; these include sperm penetration, sperm-oocyte fusion, oocyte 
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activation, expulsion of the second polar body, male and female pronuclear 
development and syngamy. Fertilisation media, sperm:oocyte ratio and co-
incubation time all influence sperm penetration and fertilisation rates in vitro (Gil et 
al. 2010). The proportion of monospermic fertilisation in vitro from the total 
oocytes inseminated in pigs is around 30-50% (Abeydeera et al. 1998a; Kikuchi et 
al. 1999; Funahashi et al. 2000; Suzuki et al. 2000; Gil et al. 2003; Gil et al. 2004). 
 
At fertilisation, spermatozoa undergo a series of reactions in order to bind to, and 
then penetrate, the oocyte. Acrosome-intact spermatozoa firstly bind in a species-
specific manner to the zona pellucida of the oocyte, before undergoing the 
acrosome reaction to allow penetration of the zona pellucida and access to the 
perivitelline space. Following this, spermatozoa must bind to the plasma 
membrane of the oocyte. Oocyte activation is induced by fusion of the gamete 
membranes and entry into the ooplasm of a sperm cytoplasmic factor, 
phospholipase C-ζ (Fujimoto et al 2004), which causes an increase in intracellular 
calcium levels within 1-3 min (Lawrence et al. 1997; Carroll 2001). In mammalian 
oocytes, following the initial increase in calcium levels, transient fluctuations in 
calcium levels occur over the next several hours (Schultz and Kopf 1995; Carroll 
2001; Whitaker and Larman 2001). It is likely that these oscillations play a role in 
regulating cell cycle transitions within the oocyte and embryo, with reciprocal 
regulation of calcium transients by mitotic kinases (Emerson et al. 2000; Carroll 
2001; Whitaker and Larman 2001). 
 
This elevation in intracellular calcium concentration induces alterations in the 
surface of the oocyte via exocytosis of cortical granules. This alteration prevents 
the penetration and binding of multiple spermatozoa, thus preventing polyspermy 
and ensuring formation of a normal diploid zygote. There is an increased 
adenosine triphosphate (ATP) requirement at this time to support calcium 
oscillations and exocytosis. Calcium increase also triggers completion of the 
second meiotic division, with the second polar body being extruded. Following 
completion of meiosis, the zygote contains two haploid pronuclei, one maternally- 
and one paternally-derived. The two pronuclei migrate to the centre of the zygote, 
where both nuclear envelopes break down and the condensed chromosomes of 
each align on a common spindle. Mitotic divisions begin to give rise to a two cell 
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embryo, each cell containing the diploid genome. These cells continue to undergo 
a series of mitotic cell divisions during embryo development. 
 
1.2.5. In vitro culture 
 
Following fertilisation, cell divisions within the embryo are associated with 
changing metabolic requirements to support new cell processes. Cleavage stages 
in the embryo include early cell divisions, from the two-cell stage through to the 
compacted morula, comprised of 8 to 16 cells. Within normal healthy embryos, 
cleavage divisions are uniform, producing blastomeres of approximately equal 
size; uneven cleavage or cell fragmentation is an indication of poor quality 
(Giorgetti et al. 1995). Compaction begins at the 8- to 16-cell stage, with an 
increase in cell-to-cell adherence through formation of tight junctions to form a 
morula. 
 
From the morula, the cells located in the outer part of the embryo flatten out and 
form tight junctions with neighbouring cells to form the trophectoderm layer which 
eventually becomes placental tissue (Rossant and Croy 1985). The remainder of 
the cells are destined to become the inner cell mass, giving rise to the embryo 
proper (Rossant and Croy 1985). Fluid between the cells of the morula is 
increased to form a cavity which is then maintained through the action of the 
membrane sodium/potassium pump. This increases the internal salt concentration 
of the embryo, attracting water via osmosis. The fluid is concentrated into a 
centralised compartment known as the blastocoel, surrounded by the now tightly 
adhered trophectoderm cells. As fluid in the blastocoel increases, the number of 
cells also increases, leading to progressive growth in size of the blastocyst. 
Associated with this growth is a thinning of the zona pellucida, until the blastocyst 
hatches from the zona pellucida. In vivo, the hatched blastocyst would then 
implant within the uterus; in vitro culture systems cannot support development 
past this point. 
 
As the embryo develops, the maternal genome inactivates as the embryonic 
genome assumes control of embryogenesis (Hsu et al. 2012). Embryonic genes 
become transcriptionally active at the late 4-cell stage in porcine embryos, with 
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the total levels of transcription increasing as the embryo develops. Subsequent 
cell divisions and protein synthesis are driven by the embryonic genome, and this 
can include changes in metabolic processes at this time (Hsu et al. 2012; Ostrup 
et al. 2013). 
 
Compared with in vivo embryos, IVP porcine embryos typically have lower 
average cell numbers (Bryla et al. 2009), higher proportion of DNA fragmentation 
(Pomar et al. 2005; Bryla et al. 2009) and a greater number of blastocysts 
showing chromosomal aberrations (McCauley et al. 2003). Overall efficiency of 
IVP technology is still low, resulting in low embryo and pregnancy rates compared 
with in vivo systems and to results commonly achieved in other species. Rates for 
blastocyst development in porcine IVP systems are typically around 20% (Nguyen 
et al. 2015; Sakurai et al. 2015), with pregnancy and farrowing rates reported at 
30-40% and 17-25% respectively (Yoshioka et al. 2012; Sakurai et al. 2015). 
Comparatively, blastocyst rates of around 50% are commonly seen in bovine IVP 
systems (Rizos et al. 2002; Sun et al. 2015), and both bovine and ovine systems 
have reported pregnancy rates of approximately 55% following transfer of IVP 
embryos (Papadopoulos et al. 2002; Machatkova et al. 2008). 
 
This is partially attributable to a lack of understanding regarding the metabolic 
requirements of embryos, resulting in poor metabolic support during in vitro 
culture. 
 
1.3. Energy requirements of oocytes and embryos 
 
1.3.1. ATP synthesis and requirement throughout IVP 
 
Metabolism refers to the chemical processes occurring within a living organism in 
order to maintain life. Included within these processes are the metabolic reactions 
occurring to produce energy within the cell, in the form of ATP. The ability to 
generate energy is important for all cells, as a requirement for growth, repair and 
production. Each stage of growth and development is energetically expensive for 
the cell, with ATP required for protein synthesis, homeostatic regulation and 
cellular functions throughout maturation, fertilisation and embryo development. 
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ATP is often used as a marker of cell viability, as it is present in all metabolically 
active cells and its concentration rapidly decreases following cell death. ATP 
production is self-regulated based on the ADP/ATP ratio within the cell, and 
therefore increased ATP synthesis reflects an increase in cell energy 
requirements.  
 
The ATP accumulated during the oocyte maturation period is likely to be important 
during fertilisation events and embryo culture (Krisher et al. 2007). Higher rates of 
development and implantation are seen in human embryos derived from in vivo 
matured oocytes with an ATP content ≥2pM/oocyte (Van Blerkom et al. 1995). 
More bovine oocytes with high morphological quality had ATP levels between 2-3 
pM/oocyte and increased blastocyst rates following IVF, compared with 
morphologically poorer quality oocytes which typically had lower ATP levels 
(Stojkovic et al. 2001). However, in porcine oocytes, ATP content did not differ 
between in vivo and in vitro matured oocytes (0.71-1.03pM/oocyte; Brad et al. 
2003a) despite it being common to see developmental differences between these 
cohorts of oocytes. A later study found that while ATP content of porcine oocytes 
was shown to increase over the course of maturation (1.21pM/oocyte when 
immature to 3.08pM/oocyte at MII), the addition of 25% follicular fluid to 
maturation media did not affect final ATP content in mature oocytes (3.08 vs 
3.60pM/oocyte; Brevini et al. 2005). Follicular fluid is known to improve 
developmental competence of oocytes (Algriany et al. 2004; Tatemoto et al. 2004; 
Ito et al. 2008) and this suggests that ATP content may not directly reflect porcine 
oocyte quality. Differences in ATP content between studies may reflect the 
sensitivity of porcine oocytes to media conditions and components, as well as the 
use of dbcAMP in one study (Brevini et al. 2005) but not the other (Brad et al. 
2003a).  
 
There is an increase in energy requirement at the blastocyst stage, corresponding 
to increased protein synthesis (Thompson 1997) and increased Na+ / K+ ATPase 
activity to create the blastocoel (Watson 1992). ATP content of Day 6 porcine 
embryos was higher when media contained glucose (0.635 vs 0.273pM/embryo; 
Mito et al. 2012), indicating a reliance on glucose substrates for energy production 
during embryo development. With ATP generation being a requirement for cell 
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growth and repair, it is vital that the metabolic pathways responsible for energy 
generation are properly supported with the required substrates. 
 
1.3.2. Metabolic pathways for energy generation 
 
The majority of energy production within mammalian cells is via aerobic 
respiration. The complete breakdown of products through this pathway involves 
glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation. The 
pentose phosphate pathway (PPP) produces intermediaries important for cell 
functions, although does not directly produce ATP. Lipogenesis and lipolysis are 
related to storage and utilisation of fatty acids. During maturation, oocytes have 
been shown to metabolise substrates via glycolysis, the TCA cycle in conjunction 
with oxidative phosphorylation, and the PPP, all to varying degrees (Durkin et al. 
2001). In vivo matured porcine oocytes show unusually high levels of PPP activity 
(Durkin et al. 2001), indicating that this pathway may be of particular importance in 
this species. During culture, pre-implantation porcine embryos predominantly 
utilise the PPP, glycolysis and the TCA cycle (Flood and Wiebold 1988; Swain et 
al. 2002), although activity of these pathways is higher in in vivo-derived embryos 
than those produced in vitro (Swain et al. 2002). There is evidence supporting a 
role for lipolysis during both oocyte maturation and embryo development, although 
this is an area requiring further investigation. 
 
1.3.2.1. Glycolysis (Figure 1.1) 
 
Occurring in the cytoplasm, glycolysis is responsible for the formation of pyruvate 
from glucose via anabolic catabolism. The glycolytic pathway itself results in the 
production of 4 molecules of ATP and 2 of NADH but utilises 2 ATP molecules in 
the process, resulting in a net gain of 2 ATP and 2 NADH per glucose molecule 
entering the pathway. The pyruvate produced from glycolysis is utilised by the 
TCA cycle or the PPP. 
 
Glycolysis is regulated by inhibition or activation of enzymes involved in certain 
steps of the pathway, thus increasing or decreasing flux through the pathway. The 
three regulatory enzymes of glycolysis are hexokinase, phosphofructokinase 
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(PFK), and pyruvate kinase. The reactions catalysed by these enzymes are 
effectively irreversible, serving as points of control for glycolytic flux. A high 
ATP:ADP ratio will serve to inhibit both PFK and pyruvate kinase activity, allowing 
for decreased glycolytic activity when energy is abundant. 
 
1.3.2.2. The tricarboxylic acid cycle (Figure 1.2) 
 
Also known as the citric acid cycle or the Krebs cycle, the tricarboxylic acid (TCA) 
cycle is an aerobic process which metabolises pyruvate to produce acetyl-CoA, 
NADH and FADH2. The TCA cycle is closely linked to oxidative phosphorylation, 
where these products are fully metabolised to produce ATP. Further, many of the 
intermediaries produced through the TCA cycle are also utilised as precursors for 
other biomolecules, including for synthesis of amino acids and purine nucleotides 
required for growth and DNA synthesis. The TCA cycle is regulated via substrate 
availability, product inhibition, and feedback inhibition. 
 
Several different metabolic pathways feed intermediaries into the TCA cycle, with 
the end goal of producing ATP. These include glycolysis, providing pyruvate; the 
β-oxidation cycle, providing acetyl-CoA, and propionyl Co-A for conversion to 
succinyl-CoA; and protein catabolism, whereby the carbon backbone of amino 
acids can be converted to acetyl-CoA for use in the TCA cycle. 
 
Oxidative phosphorylation is a metabolic pathway occurring in the mitochondria, 
which utilises redox reactions to release energy in the form of ATP. Oxidative 
phosphorylation incorporates both the electron transport chain and chemiosmosis. 
The electron transport chain involves NADH and FADH2, formed through other 
metabolic processes, acting as electron donors to oxygen, creating H2O and 
liberating a large amount of free energy. Oxidative phosphorylation is a highly 
efficient means of producing ATP. It releases between 30-36 molecules of ATP 
from the complete hydrolysis of one molecule of glucose to CO2 and water; 
compared with only 2 ATP molecules produced via glycolysis alone.  
 
1.3.2.3. Pentose phosphate pathway (Figure 1.3) 
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While the pentose phosphate pathway itself does not directly generate ATP, it is 
an important metabolic pathway for the generation of NADPH and pentoses. This 
pathway acts as an alternative to glycolysis, playing a primarily anabolic role. The 
primary products of this pathway are reducing equivalents (NADPH), ribose-5-
phosphate (R5P), and erythrose-4-phosphate (E4P). NADPH is used in reductive 
biosynthetic reactions within cells, for example fatty acid synthesis, as well as 
serving to reduce glutathione via glutathione reductase to reduce accumulation of 
H2O2 and prevent oxidative stress. R5P and E4P are required for the synthesis of 
nucleotides and nucleic acids and synthesis of aromatic amino acids, respectively; 
these are all requirements for cell growth and DNA synthesis. 
 
The PPP is regulated by activity of the glucose-6-phosphate dehydrogenase 
enzyme. Activity of this enzyme is stimulated by increasing concentrations of 
NADP+, which is formed from the use of NADPH in reductive biosynthetic 
pathways. The PPP then reduces NADP+ to restore NADPH levels. 
 
1.3.2.4. Lipogenesis and lipolysis 
 
Lipogenesis is the process by which triglycerides are formed from acetyl-CoA, 
incorporating both the processes of fatty acid synthesis and triglyceride synthesis. 
The majority of acetyl-CoA within the cell results from pyruvate breakdown. In 
times of nutritional deficit, this acetyl-CoA will then feed into the TCA cycle to 
produce cellular energy. When there is sufficient energy available, the excess 
acetyl-CoA not required immediately for energy production is instead directed 
toward fatty acid synthesis, thus storing excess energy substrates as fatty acids 
for use when required. 
 
The converse reaction, lipolysis, is the breakdown of lipids. The first step involves 
the hydrolysis of triglycerides by hormone sensitive lipase (HSL) to produce free 
fatty acids, which are subsequently metabolised to form a fatty acyl-CoA. 
Carnitine palmitoyl transferase 1 (CPT1) catalyses the exchange of the CoA for 
carnitine, forming fatty acyl-carnitine, which is capable of passing through the 
mitochondrial membrane. This process is known as the carnitine shuttle (Figure 
1.4), and is the rate limiting step of lipolysis. Fatty acyl-CoA is reformed and 
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metabolised via the β-oxidation cycle. The end products of β-oxidation vary 
depending on fatty acid chain length, with one molecule each of FADH2, NADH 
and acetyl-CoA formed for every two carbon atoms. These products are then 
further metabolised via the TCA cycle and oxidative phosphorylation to produce 
ATP. 
 
The regulation of β-oxidation and fatty acid synthesis are closely coordinated, with 
both being under hormonal and allosteric regulation. Lipolysis is under precise 
regulation at multiple points by hormonal and biochemical signals which regulate 
the function of lipolytic enzymes (Duncan et al. 2007). Many of these regulation 
points are controls for the balance between lipolysis (when energy demands are 
high or other energy substrates are unavailable) and lipogenesis (when there is 
excess energy substrate and low energy demand). Regulation of HSL is primarily 
via glucagon and epinephrine, which activate lipolysis, and insulin, which inhibits 
fatty acid oxidation. Glucagon levels increase when blood glucose is low, and 
epinephrine production is increased during peak metabolic demand; in both 
instances, additional energy is required and the oxidation of fatty acids is 
subsequently increased to meet demand. In this case, glucagon and epinephrine 
can bind to G protein-coupled receptors, activating adenylate cyclase to increase 
cAMP production and protein kinase A activity. Following phosphorylation, protein 
kinase A activates HSL. When circulating glucose levels are high, insulin 
production is increased, inhibiting lipolysis; sufficient energy is available from 
glucose and fatty acid oxidation is not required. Protein phosphatase 2A is 
activated by insulin, and dephosphorylates HSL to inhibit its activity. Insulin also 
increased the activity of phosphodiesterases, which break down cAMP to prevent 
the phosphorylation of HSL by protein kinase A. Other control points include 
allosteric regulation by intermediaries from lipogenesis. For example, acetyl-CoA 
is carboxylated to form malonyl-CoA in the initial stages of lipogenesis, and 
inhibits β-oxidation at CPT1. High concentrations of malonyl-CoA indicate 
adequate energy substrate availability, as lipogenesis is occurring to store excess 
substrate, and therefore there is no requirement for β-oxidation. 
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Figure 1.1. Glycolysis 
Key regulator enzymes of the glycolytic pathway are highlighted in red. 
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Figure 1.2. The tricarboxylic acid cycle 
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Figure 1.3. The pentose phosphate pathway 
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Figure 1.4. The carnitine shuttle 
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1.3.3. Energy substrates utilised by oocytes and embryos 
 
1.3.3.1. Carbohydrates 
 
There is still debate regarding the ability of oocytes to take up glucose directly 
(Downs et al. 1998; Clark et al. 2011), with evidence that cumulus cells are largely 
responsible for metabolism of exogenous glucose through glycolysis with 
provision of products to the oocyte via gap junctions (Biggers et al. 1967; Sugiura 
et al. 2005; Gilchrist et al. 2008; Sutton-McDowall et al. 2010; Clark et al. 2011; 
Wang et al. 2012). Cumulus cells also utilise glucose via the hexosamine 
biosynthesis pathway for production of hyaluron to support expansion of the 
cumulus matrix (Sutton et al. 2003b). Live fluorescent staining of glucose uptake 
in murine COCs has shown that glucose is taken up by cumulus cells via 
facilitative glucose transporters (GLUTs) and then transferred to the oocyte via 
gap junctions (Wang et al. 2012). 
 
The oocyte itself appears to have a limited capacity for glucose utilisation (Biggers 
et al. 1967). The majority of glycolytic activity in the COC occurs within the 
cumulus cells, likely being utilised for cumulus cell functions such as cumulus 
expansion (Sutton-McDowall et al. 2004). Low levels of PFK activity are seen in 
denuded bovine oocytes, with a comparatively high level seen in the cumulus cells 
of the COCs (Cetica et al. 2002). Denuded oocytes also showed reduced glucose 
uptake compared to COCs in mice (Saito et al. 1994; Downs and Utecht 1999; 
Wang et al. 2012) and cattle (Zuelke and Brackett 1992). Further, the inhibition of 
GLUTs reduced glucose uptake in cumulus cells and oocytes of COCs, but had 
no effect on denuded oocytes (Wang et al. 2012), indicating differences in glucose 
transport pathways between CCs and oocytes. However, denuded porcine 
oocytes matured with 2.78mM glucose had greater nuclear maturation rates 
compared to those matured without glucose (Tsuzuki et al. 2008), indicating that 
glucose can still be utilised by denuded porcine oocytes to support nuclear 
maturation and this may be species specific. 
 
Both glycolysis and the PPP appear to have pivotal roles in the resumption of 
meiosis (Krisher and Bavister 1998; Downs and Utecht 1999; Cetica et al. 2002; 
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Herrick et al. 2006; Wang et al. 2012); however, very high levels of glucose do not 
provide any additional benefits (Downs and Hudson 2000) and may even lead to 
decreased maturation rates (Downs and Mastropolo 1994; Kumar et al. 2012) in 
some species. Activity of both the glycolytic pathway and the PPP increase 
throughout the maturation period (Cetica et al. 2002), although it is unclear 
whether this is a cause or a consequence of progression of maturation. 
 
The provision and concentration of glucose as an energy substrate has a major 
effect on the developmental capacity of porcine oocytes. The effect of glucose in 
maturation media is dose dependent. A low concentration of glucose (2mM) 
improved MII rates compared to oocytes matured without glucose (Tubman et al. 
2005). The addition of 5.55mM glucose to maturation medium increased the 
proportion of porcine oocytes reaching MII compared to those matured in the 
absence of glucose (Funahashi et al. 2008; Tsuzuki et al. 2008; Wu et al. 2011). 
At glucose concentrations greater than 11mM, nuclear maturation rates began to 
decline (Tsuzuki et al. 2008). High glucose concentrations during IVM increase 
intracellular ROS formation and decrease intracellular glutathione levels, which 
leads to increased oxidative stress and impaired nuclear maturation (Hashimoto et 
al. 2000). 
 
Glycolysis alone is insufficient to support proper maturation of porcine oocytes, 
with inhibition of the PPP reducing development to the MII stage (Herrick et al. 
2006; Sato et al. 2007; Funahashi et al. 2008). Bovine oocytes have low activity 
levels of PFK and high activity levels of G6PDH (Cetica et al. 2002), indicating 
that the glucose is directed predominantly through the PPP in oocytes. 
Intermediaries of the PPP act as substrates for synthesis of purine nucleotides, 
which play a role in the regulation of meiosis (Downs and Mastropolo 1994; 
Downs et al. 1998; Downs and Hudson 2000; Herrick et al. 2006), as well as 
products required for maturation, such as NADPH (Funahashi et al. 2008). 
Supporting this, ATP content of porcine oocytes was similar regardless of the 
presence or absence of glucose (Tsuzuki et al. 2008), suggesting greater activity 
of the PPP than ATP production via glycolysis in this species. 
 
20 
Pyruvate is also considered a requirement for the resumption of meiosis and 
development of the cell (Gonzales-Figueroa and Gonzales-Molfino 2005), with a 
greater proportion of oocytes remaining at the GV stage in the absence of 
pyruvate (Funahashi et al. 2008). Mouse (Biggers et al. 1967) and cattle (Geshi et 
al. 2000) oocytes can successfully complete nuclear maturation in the presence of 
pyruvate alone. In porcine oocytes, the addition of pyruvate to a glucose-free 
medium improved maturation rates in a dose-dependent manner up to 5mM; 
however, MII rates were still significantly inferior when compared with media 
containing both glucose and pyruvate (Sato et al. 2007; Funahashi et al. 2008). 
This is likely because pyruvate supports energy production via the TCA cycle, 
allowing glucose to primarily be metabolised via the PPP at this stage. 
 
In vivo matured oocytes have been shown to metabolise greater amounts of 
glucose compared to their in vitro matured counterparts (Spindler et al. 2000; 
Durkin et al. 2001; Krisher et al. 2007). In porcine oocytes, the most distinct 
metabolic difference is the activity of the PPP, being almost seven times greater in 
in vivo matured oocytes than those matured in vitro (Durkin et al. 2001; Krisher et 
al. 2007). Given the role that the PPP plays in meiotic resumption and the 
acquisition of developmental competence, this could potentially explain the 
different developmental outcomes observed in oocytes from the two sources. 
Glycolytic activity was also significantly lower in in vitro matured porcine oocytes 
(Durkin et al. 2001; Krisher et al. 2007), but by a smaller magnitude than the 
difference in PPP activity. In feline oocytes, the level of glucose oxidation and 
glycolytic activity during in vitro maturation correlated with embryo development 
following in vitro fertilisation (Spindler et al. 2000). This suggests that metabolism 
of glucose is a determining factor of oocyte quality, agreeing with observations of 
lower glucose metabolism and decreased developmental competence of in vitro 
oocytes compared to in vivo. Pyruvate utilisation is also decreased in in vitro 
matured porcine oocytes compared to their in vivo matured counterparts (Krisher 
et al. 2007). Given that pyruvate is the predominant energy substrate utilised 
throughout maturation, this may indicate improper and insufficient energy 
production at this time. 
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Energy production within mammalian embryos changes greatly throughout 
development. The predominant energy substrates utilised during the culture 
period are glucose, pyruvate, lactate and glutamine (Dumollard et al. 2009); 
however, the levels of utilisation of each substrate varies with the stage of embryo 
development and species. 
  
During early cleavage stages, the embryo relies predominantly on pyruvate, 
lactate and glutamine metabolism for ATP production (Leese 1995; Gardner 
1998). Lactate can be converted to pyruvate, and along with exogenous pyruvate, 
is metabolised via the TCA cycle for ATP production. Early embryos are capable 
of producing ATP by the direct oxidation of glutamine in the mitochondria up to the 
morula stage (Dumollard et al. 2009). 
 
Prior to compaction there is limited glucose metabolism (Biggers et al. 1967; 
Flood and Wiebold 1988) despite the presence of glycolytic and PPP enzymes 
(Cetica et al. 2002). High glucose utilisation at the early embryo stage was shown 
to result in impaired energy production and poor developmental outcomes (Lane 
and Gardner 1996; Gardner 1998). These poor outcomes have been attributed to 
abnormal glucose metabolism in in vitro produced embryos (Krisher and Bavister 
1998; Gardner et al. 2000b), with increased activity of the glycolytic pathway 
(Bavister 1995; Khurana and Niemann 2000). Temporary inhibition of oxidative 
phosphorylation at the compaction stage in bovine and porcine embryos was 
found to be beneficial to blastocyst development and quality (Machaty et al. 2000; 
Thompson et al. 2000); this coincides with low oxygen tension seen for in vivo 
embryos in the reproductive tract (Fischer and Bavister 1993). 
 
High glucose concentrations in media during early cleavage stages can 
compromise development (Flood and Wiebold 1988; Sturmey and Leese 2003). 
The combination of glucose and pyruvate in culture media significantly inhibits 
porcine embryo development to the morula and blastocyst stages (Iwasaki et al. 
1999; Park et al. 2005). Porcine embryos cultured in sequential media with 
glucose for days 3-7 only had greater blastocyst rates and increased cell numbers 
than those cultured in glucose for the entire period (Kikuchi et al. 2002b; Karja et 
al. 2006). Higher H2O2 levels seen in embryos cultured with glucose for the 7 d 
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culture period (Karja et al. 2006) may indicate an increased metabolic rate and 
subsequent rise in ROS production, leading to compromised embryo development 
and quality. 
 
As the embryo reaches the blastocyst stage, ATP demand increases due to 
greater activity of the sodium pump (Leese 1991; Donnay et al. 1999) and 
increased protein synthesis (Thompson et al. 1998). This leads to a decreased 
ATP:ADP ratio (Flood and Wiebold 1988; Dumollard et al. 2009), removing 
inhibition of PFK and increasing the glycolytic rate. At this stage, energy 
production shifts as glucose and glutamine are utilised as the predominant 
substrates (Flood and Wiebold 1988; Dumollard et al. 2009), and as such, 
attempts to culture porcine embryos for the entire culture period in media with 
lower glucose concentrations have been unsuccessful (Machaty et al. 1998). As a 
percentage of total glucose metabolised, PPP activity is the lowest at the 
blastocyst stage (Flood and Wiebold 1988), accounting for the majority of glucose 
being shunted through the glycolytic pathway for energy production. Oxygen 
consumption also increases (Leese 1995; Sturmey and Leese 2003), indicative of 
an overall increase in metabolic rate and energy production. Following expansion 
of the blastocoel, oxygen consumption decreases as the sodium pump is then 
required only to maintain homeostasis (Sturmey and Leese 2003).  
 
The difference in quality between in vitro and in vivo cultured embryos is well 
documented. In vitro produced embryos typically show delayed development, 
decreased cell number, altered morphology and metabolism, and produce poorer 
outcomes following transfer (reviewed in Thompson 1997). 
 
The glycolytic pathway is preferentially utilised at all stages by in vivo porcine 
embryos and after the two-cell stage in in vitro produced embryos, and activity 
increases throughout development in both in vitro and in vivo derived embryos, 
albeit earlier in in vitro produced embryos (Swain et al. 2002). In vitro culture 
caused an increase in the glycolytic rate in freshly flushed in vivo derived cattle 
(Khurana and Niemann 2000) and mouse (Gardner and Leese 1990) embryos, 
with lactate production (indicative of glycolytic activity) significantly lower in in vivo 
bovine embryos than those cultured in vitro (Khurana and Niemann 2000). 
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However, in porcine embryos, glucose utilisation was shown to be higher in in vivo 
embryos compared to in vitro produced embryos (Swain et al. 2002). This may be 
due to analysis techniques, where Khurana and Niemann (2000) assessed lactate 
production as a measure of glycolytic activity, while Swain et al. (2002) measured 
glucose uptake, which may not have accounted for any glucose utilised via the 
PPP. Alternatively, this may be due to species differences in embryonic 
metabolism. One possible explanation for increased glycolysis in in vitro produced 
embryos is stress-induced inactivation of ATP-consuming pathways. There are 
many stressors on cells cultured in vitro, and in response to stress 5’AMP-
activated protein kinase (AMPK) inactivates ATP-consuming pathways and 
activates ATP-regenerating pathways, including glucose transport and glycolysis 
(Leese 2002). 
 
While IVC is known to compromise embryo development (Kikuchi et al. 1999), IVP 
embryos are already predisposed to a range of inborn problems due to reduced 
cell quality following IVM and IVF. This can make it difficult to determine whether 
any quality differences are due to embryo culture differences, or perturbations in 
metabolic processes intrinsic to the oocyte resulting from IVM. 
 
1.3.3.2. Amino acids 
 
Amino acids serve a variety of roles within biological systems, including serving as 
precursors for proteins and nucleotides, acting as osmolytes, signalling molecules 
and energy substrates, protecting against oxidative stress, and regulating pH. A 
range of amino acids are present in both oviductal and uterine fluids at a range of 
concentrations (Iritani et al. 1974). 
 
Intact COCs are capable of utilising amino acids as an energy substrate during 
IVM. In cattle oocytes, addition of non-essential and essential amino acids during 
IVM increased subsequent cleavage, blastocyst development rates and cell 
number, and resulted in higher oocyte maternal mRNA levels compared with 
media without amino acid or serum supplementation (Watson et al. 2000). In 
porcine oocytes, use of a commercial amino acid mix (Gibco) as the sole energy 
substrate during IVM increased meiosis and glycolytic rates compared to media 
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with 0.01mM pyruvate and 6mM lactate alone, but was not able to support 
subsequent blastocyst development to the extent of complete media (Tubman et 
al. 2005). 
 
In pigs, IVM has improved greatly with the addition of cysteine to maturation 
media. Cysteine availability is a limiting factor of GSH synthesis, a requirement for 
proper cytoplasmic maturation and male pronuclear formation. Addition of 
cysteine during porcine oocyte maturation increased GSH content of oocytes 
(Abeydeera et al. 1999) as well as improving blastocyst formation rates following 
IVF (Grupen et al. 1995; Abeydeera et al. 1999). Owing to the increased GSH 
rates with cysteine supplementation, it is likely that the beneficial effects are due 
to the antioxidant activity of GSH protecting the oocytes from ROS damage, with 
there being no effect of cysteine supplementation on the ATP content of porcine 
oocytes (Tsuzuki et al. 2009). 
  
During porcine embryo in vitro culture, the addition of a commercial mix of 
essential amino acids (Sigma) increased blastocyst formation rates, with the 
addition of a non-essential amino acids mix (Sigma) increasing blastocyst cell 
number (Suzuki and Yoshioka 2006). The essential amino acid mix includes L-
arginine, L-cystine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-
phenylalanine, L-threonine, L-tryptophan, L-tyrosine, L-valine, while the non-
essential amino acid mix contains L-alanine, L-asparagine, L-aspartic acid, L-
glycine, L-serine, L-proline and L-glutamic acid. In mice, amino acid 
supplementation has been shown to stimulate hatching rates and attachment and 
growth following transfer, as well as contributing to the alleviation of in vitro culture 
blocks (Gardner et al. 1996). Sequential addition of non-essential amino acids 
during early cleavage stages and essential amino acids for the remainder of 
culture increased blastocyst cell number of porcine embryos (Beebe et al. 2007; 
Hashem et al. 2007). Concentration of amino acids was also found to influence 
their efficacy, with 20µl/ml essential amino acid mix and 10µl/ml non-essential 
amino acid mix shown to increase the mean number of ICM cells, but not total cell 
number (Hashem et al. 2007). Addition of amino acids had the most beneficial 
effect when added at a low concentration (1:100 dilution of commercial mix) to 
porcine embryo culture medium (Beebe et al. 2009). Amino acids degrade to form 
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ammonia, and at high concentrations may cause a toxic accumulation of ammonia 
in the media. 
 
Glutamine has been shown to play a prominent role in embryo development, both 
as an energy substrate and for its role in regulatory processes. Glutamine 
metabolism has been shown to be highest at the early blastocyst stage in porcine 
embryos (Humpherson et al. 2005). Increased glutamine consumption at this 
stage may be linked to glucose metabolism, which also produces intermediaries 
required for high rates of DNA and RNA synthesis at this stage. Glutamine can be 
converted to glutamate, then α-ketogluterate which can then enter the TCA cycle 
for ATP production. Specific supplementation with 0.25-1mM glutamine during 
embryo culture increased blastocyst development rates relative to media with no 
glutamine (14.9-24.0% vs 2.9%), with 2-4mM glutamine showing higher blastocyst 
rates again (25.3-30.9%; Suzuki and Yoshioka 2006). Addition of 2mM glutamine 
also increased blastocyst cell number (42.9 average cells per blastocyst vs 20.3 in 
the control; Suzuki and Yoshioka 2006). In vitro produced porcine embryos 
cultured with 1mM glutamine metabolised constant amounts through the TCA 
cycle, while glutamine uptake increased throughout development of in vivo 
derived embryos (Swain et al. 2002). This indicates that the glutamine 
concentration may have been too low in the IVC medium, supporting the finding 
that 2-4mM glutamine was optimal for blastocyst development (Suzuki and 
Yoshioka 2006). However, 1- and 2-cell in vivo-derived porcine embryos were 
shown to be capable of forming blastocysts when cultured in vitro with 1mM 
glutamine as the sole energy substrate (Petters et al. 1990), suggesting that 
amino acid metabolism may be impaired in in vitro produced embryos. 
 
1.3.3.3. Fatty acids 
 
Fatty acids are a form of dense energy storage. The complete oxidation of 
palmitate, for example, generates 106 molecules of ATP, compared to oxidation of 
glucose which yields approximately 30 ATP molecules. The role of fatty acids as 
an energy substrate during oocyte maturation is contentious. The availability of 
lipid reserves and levels of lipase activity would suggest that the oocyte is able to 
use lipids as oxidative substrates after it is separated from the CCs during 
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maturation, however results in this area are widely varied, making it difficult to 
gain a definitive answer. 
 
Endogenous lipid plays an as yet undetermined role during oocyte maturation. As 
early as the mid-1970s it was recognised that oocytes likely had at least partial 
reliance on endogenous substrates for energy generation during maturation in 
vitro (Zeilmake and Verhamme 1974), now believed to be intracellular lipids stored 
as triglycerides in cytoplasmic lipid droplets. Triglyceride levels within the ooplasm 
have been shown to decrease over the course of the maturation period (Sturmey 
and Leese 2003; Romek et al. 2011b) with a concomitant increase in oxygen 
consumption being correlated to triglyceride depletion (Sturmey and Leese 2003). 
A similar trend has been reported in cattle oocytes (Ferguson and Leese 1999). 
However, the upregulation of β-oxidation during maturation of porcine oocytes has 
shown varied results, with some studies reporting improved rates of nuclear 
maturation and blastocyst development (Somfai et al. 2011; Wu et al. 2011), and 
others reporting no effect (You et al. 2012). Although the precise reasons for 
these differences are unknown, it may be due to differences in the composition of 
media used. Inhibition of β-oxidation during porcine oocyte maturation impairs 
nuclear maturation and prevents cleavage and blastocyst development (Sturmey 
et al. 2006). The results of chemical alteration of fatty acid oxidation implies that 
this pathway plays an important role during oocyte maturation in a range of 
species, including mice (Dunning et al. 2010a; Dunning et al. 2011) and cattle 
(Ferguson and Leese 2006; Yamada et al. 2006). 
 
Changes to lipid droplet size, arrangement and density, during in vitro maturation 
gives further evidence of a metabolic role for endogenous fatty acids. Oocytes 
treated with olocmoucine, an inhibitor of nuclear maturation, showed no reduction 
in the size of lipid droplets, whereas untreated oocytes displayed a reduction in 
size of large lipid droplets, which was correlated with meiotic progression (Niimura 
et al. 2002). The triglyceride, phospholipid and cholesterol content of lipid droplets 
have also been shown to decrease over the course of in vitro maturation, as 
determined by fluorescent staining (Romek et al. 2011b). 
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Oocytes of some species appear to be capable of developing in the absence of 
exogenous energy substrates. Bovine oocytes held in media without exogenous 
substrates showed no difference in oxygen consumption to those in media with 
energy substrates present (Ferguson and Leese 2006); however, when cultured in 
media lacking energy substrates with the addition of an inhibitor of fatty acid 
oxidation, oxygen consumption was significantly lower than those cultured in the 
absence of the inhibitor. Further, the activity of lipase enzymes in bovine oocytes 
was higher than that of either G6DPH or PFK (Cetica et al. 2002), indicating a 
greater rate of lipolysis than either PPP or glycolysis. Comparatively, murine 
oocytes are known to have a very small intracellular triglyceride complement 
compared with cattle oocytes (Loewenstein and Cohen 1964; McEvoy et al. 
2000), and had significantly reduced maturation rates when cultured without 
exogenous substrates (Downs and Hudson 2000). Porcine oocytes are known to 
contain large amounts of triglyceride reserves (McEvoy et al. 2000), suggesting 
that, similarly to cattle oocytes, they are capable of utilising these endogenous 
reserves for energy production. When matured without glucose or pyruvate, the 
rate of progression to MII in porcine oocytes was significantly increased by the 
presence of a β-oxidation stimulant (Wu et al. 2011). 
 
It has been suggested that exogenous fatty acids do not play a role in energy 
production. The addition of a commercial fatty acid solution to medium had no 
effect on maturation rates (Tubman et al. 2005). However, the fatty acid 
composition of this solution was not given, and potentially the fatty acids 
supplemented were not preferentially utilised by porcine oocytes.  
 
In vitro maturation itself is known to alter metabolic processes. In vitro maturation 
of mouse COCs led to dysregulation of gene transcripts associated with lipid 
metabolism (Yuan et al. 2011) and reduced the rate of fatty acid oxidation by 2.8-
fold (Dunning et al. 2014) compared to in vivo maturation. Furthermore, inhibition 
of lipid metabolism during IVM decreased the abundance of gene transcripts 
involved in fatty acid oxidation, glycolysis and oxidative stress in porcine oocytes 
(Paczkowski et al. 2013). In vitro matured cattle oocytes also showed significantly 
down-regulated expression of genes related to lipid metabolism, including Chol 
acyl-transferase (ACAT1) and fatty acid synthase (FASN; Gonzalez-Serrano et al. 
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2013), compared to in vivo matured oocytes. Interestingly, these genes were over-
expressed in in vitro produced cattle blastocysts compared with in vivo sourced 
blastocysts, possibly accounting for the increased lipid seen in in vitro blastocysts.  
 
There is a large body of evidence supporting a role for endogenous lipids in 
energy production throughout in vitro embryo culture. The embryos of numerous 
species have been reported to be capable of oxidising fatty acids for the 
production of energy during early cleavage stages, including rabbit (Khandoker 
and Tsujii 1998), mouse (Hillman and Flynn 1980) and cattle (Ferguson and 
Leese 1999,  2006). Embryos of some species have been shown to be capable of 
developing in the absence of exogenous energy substrates, suggesting reliance 
on endogenous reserves for ATP production. When cultured without exogenous 
energy substrates, almost half of IVP cattle zygotes underwent at least one 
cleavage division (Ferguson and Leese 1999). Further, oxygen consumption by 5- 
to 8-cell cattle embryos was similar whether cultured in the presence or absence 
of exogenous nutrients (Ferguson and Leese 2006), implying continued oxidation 
and metabolism of energy substrates likely from endogenous sources. 
Developmental rates decreased with the addition of a β-oxidation inhibitor 
(Ferguson and Leese 2006). In contrast, mouse zygotes were reported to arrest 
and degenerate early in culture when deprived of exogenous energy substrates 
(Manser and Leese unpublished, cited in Ferguson and Leese 2006). This 
difference may be due to cattle embryos containing a far greater amount of 
endogenous lipid than mouse embryos. 
 
In porcine embryos, the success of culture using endogenous substrates alone 
appears to depend on upregulation of the β-oxidation pathway. When IVF zygotes 
were cultured in defined medium excluding exogenous energy substrates, 
cleavage rates were reduced and blastocyst formation was prevented, suggesting 
that lipids alone may be insufficient to support viable embryo development (Park 
et al. 2005). However, these developmental failures may be attributable to an 
inability to completely oxidise the products of β-oxidation for the full energy 
allowance. When porcine embryos were cultured in a defined media containing 
oxaloacetate in the absence of carbohydrates, blastocyst rates were similar to 
those of embryos cultured in media containing glucose; further, there was a 
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significant decrease in blastocyst triglyceride content (Park et al. 2005; Sturmey 
and Leese 2008). Oxaloacetate alone cannot generate ATP, but primes the TCA 
cycle to allow for complete oxidation of metabolic products; this further supports a 
metabolic role for triglyceride during embryo development.  
 
Inhibition of β-oxidation during embryo culture causes developmental arrest in 
numerous species (Ferguson and Leese 2006; Sturmey and Leese 2008; Dunning 
et al. 2010a). Culture of porcine zygotes with a β-oxidation inhibitor led to 
increased glucose consumption and higher lactate production (Sturmey and 
Leese 2008), indicative of increased glycolytic rate and suggesting that other 
pathways can be upregulated to compensate for an inability to utilise lipids as an 
energy substrate. However, no embryos developed beyond the 1-cell stage when 
cultured with the inhibitor (Sturmey and Leese 2008), showing the importance of 
the β-oxidation pathway to embryo development. 
 
There have been varying results regarding changes in oocyte and embryo fatty 
acid content during culture. Analysis of lipid content via the fluorescent probe Nile 
Red found that while fatty acid content remained constant from the zygote to 
morula stage, it decreased at the blastocyst stage and again at hatching (Romek 
et al. 2009; Romek et al. 2011b). Formation of the blastocoel and blastocyst 
hatching are two stages of development which are energetically expensive; thus 
decreased fatty acid content at these stages is consistent with a metabolic role. In 
contrast, an earlier study found that the triglyceride content of porcine embryos did 
not differ throughout embryo development, as measured via an assay based on 
the enzymatic hydrolysis of triglyceride, although there was considerable variation 
between individual embryos (Sturmey and Leese 2003). However, this does not 
preclude the use of fatty acids during embryo culture. Due to the energy-dense 
nature of lipid, only very small amounts would be required to produce large 
amounts of energy; potentially, significant differences in the volumes of lipid 
utilised may be below the limits of detection using the reported methods. The 
specific nature of the assay, only accounting for triglyceride degradation, may also 
account for discrepancies between studies, if other fatty acids are also utilised 
during embryo development. 
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1.4. Sources of energy substrates 
 
1.4.1. In vivo systems 
 
Between species, the concentrations of fatty acids within reproductive tract fluids 
differ, but the fatty acid composition is similar (Khandoker et al. 1997). This 
indicates that oocytes and embryos of different species have similar exogenous 
fatty acid requirements for maturation, fertilisation and development, and that the 
type of fatty acid is more important than the concentration present for oocyte 
maturation and embryo culture. 
 
Oocyte and embryo composition changes depending on culture media, as 
substrate uptake and incorporation varies with nutrient availability (Aardema et al. 
2011). Understanding the composition of reproductive tract fluid may help predict 
substrate utilisation by embryos in vivo and the effect on development. 
 
1.4.1.1. Follicular fluid 
 
Follicular fluid accumulates within antral follicles during the process of 
folliculogenesis. It is known to be composed of a variety of substances, including 
proteins, amino acids, sugars, enzymes, lipids, hormones (LH, FSH, prolactin, 
oestrogens, androgens and progestagens), and salts (Huang et al. 2002). Primary 
follicular fluid is secreted by granulosa cells during folliculogenesis, while 
secondary follicular fluid mainly transudes from the blood plasma and 
accumulates as the follicle matures (Huang et al. 2002). Due to the porous nature 
of the follicular epithelial cells, the fatty acid and protein profile of follicular fluid 
found in larger follicles generally reflects that of blood serum (Huang et al. 2002; 
Sutton et al. 2003a; Aardema et al. 2011); further, maternal nutrition can affect the 
substrate concentrations of the follicular fluid (Warzych et al. 2011).  
 
The composition of follicular fluid is important owing to its role in oocyte 
maturation and development. As the arrested oocyte and surrounding granulosa 
cells are supported by follicular fluid, it plays a major role in the biochemical and 
metabolic processes during this time, being responsible for the provision of energy 
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substrates and nutrients, regulation of meiotic arrest and the resumption of 
meiosis (Hunter 2000).  
 
Follicular glucose concentrations are positively correlated with ovarian follicle size 
in several species, including pigs, cattle, buffalo and sheep (Brad et al. 2003b; 
Leroy et al. 2004; Nandi et al. 2008; Sutton-McDowall et al. 2010; Ying et al. 2011; 
Bertoldo et al. 2013). Reports of concentrations of glucose in porcine follicular 
fluid vary, with 2.1-4.8mM reported in 3-6mm follicles up to the pre-ovulatory stage 
(Chang et al. 1976) but as low as 0.8mM being found in follicular fluid from small 
follicles and 1.0mM in large follicles (Bertoldo et al. 2013). Lactate concentrations 
also differed between follicular fluid from small (3-4mm) and large (5-8mm) 
follicles, reported at 12mM and 10mM respectively (Bertoldo et al. 2013). Pyruvate 
concentrations in follicular fluid were similar between small and large follicles at 
0.01-0.02mM (Brad et al. 2003b).  
 
Although it has been noted that there are no differences in total lipid 
concentrations between follicular fluid sourced from small, medium or large 
follicles (Chang et al. 1976; Huang et al. 2002), there is a general tendency 
observed for concentrations of triglycerides, phospholipids and total cholesterol to 
decrease as follicular maturation progresses (Chang et al. 1976). Transient 
changes in lipid concentration were observed following PMSG injections, with 
increased lipid concentrations consistent with steroidogenesis during growth of 
early follicles, and decreasing concentrations in larger follicles correlating with 
follicular degeneration (Huang et al. 2002).  
 
There is a negative correlation between total concentrations of free fatty acids in 
follicular fluid and follicle size (Yao et al. 1980). The predominant fatty acids 
detected in follicular fluid were oleic (18:1), palmitic (16:0) and stearic (18:0) acids 
(Yao et al. 1980; Khandoker et al. 1997). Linolenic (18:3) and stearic acids as well 
as total polyunsaturated fatty acid (PUFA) concentrations were positively 
correlated with follicle size, while concentrations of palmitic and oleic acids 
decreased with increasing follicle size (Yao et al. 1980). Further, addition of 
follicular fluid derived from large follicles (5-8mm diameter) to media during 
porcine oocyte maturation had a greater beneficial effect on developmental 
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competence than follicular fluid from small follicles (2-4mm diameter; Algriany et 
al. 2004; Ito et al. 2008). Follicular fluid derived from sow ovaries was also more 
beneficial than follicular fluid from prepubertal gilts (Grupen et al. 2003). Specific 
fatty acids may play a role in the resumption and completion of meiosis, given the 
changes in concentrations with follicle size. Further, supplementation of 
maturation media with palmitic or stearic acid had detrimental effects on the 
developmental competence of bovine oocytes, while oleic acid improved 
blastocyst development, increased lipid storage, and could counteract the adverse 
effects of saturated fatty acids (Aardema et al. 2011). Supplementation of media 
with specific exogenous fatty acids to support maturation should be further 
examined. 
 
1.4.1.2. Oviductal fluid 
 
Oviductal fluid is secreted by the epithelial cells of the oviduct, and is the in vivo 
medium for fertilisation and early embryo development. Greater quantities of 
oviductal fluid are present around the time of ovulation and fertilisation, and 
declines as the embryo leaves the oviduct and enters the uterus (Iritani et al. 
1974; Leese 1995).  
 
Oviductal fluid contains numerous energy substrates, including glucose, lactate, 
pyruvate and fatty acids. Concentrations of glucose decrease following ovulation, 
from around 1.65mM to 0.43mM in unmated pigs (Nichol et al. 1992), but with no 
differences in glucose depending on the presence or absence of an embryo 
(Nichol et al. 1998). Pyruvate concentrations remained similar throughout pre- and 
post-ovulatory phases (Nichol et al. 1992; Nichol et al. 1998), while lactate 
concentrations were higher in oviductal fluid of mated animals compared with pre-
ovulatory levels (6.83mM vs 3.86mM; Nichol et al. 1992) independent of whether 
an embryo was present or not (Nichol et al. 1998). Similarities in glucose, 
pyruvate and lactate concentrations between oviductal fluid from ovariectomised 
animals and those with embryos present (Nichol et al. 1998) suggest systemic 
regulations of concentrations rather than local effects of embryos. However, the 
changing concentrations do reflect a dynamic microenvironment for fertilisation 
and early embryo development in vivo. 
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The total lipid content of oviductal fluids during the oestrous period was shown to 
be 43.7±7.6mg/100ml (Iritani et al. 1974).  The three main fatty acids found within 
oviductal secretions were oleic acid (36.24% of total fatty acids), palmitic acid 
(21.09%), and stearic acid (17.30%; Khandoker et al. 1997), following similar 
compositional trends for fatty acid content of uterine fluid, follicular fluid and 
oocytes. The predominant polyunsaturated fatty acids in oviductal fluid were 
linoleic acid, linolenic acid and arachidonic acid, present at 3.48%, 9.07% and 
10.82% respectively (Khandoker et al. 1997). There is no known data available 
regarding changes in lipid and fatty acid concentrations of porcine oviductal fluid 
during pre- and post-ovulatory periods. 
 
1.4.1.3. Uterine fluid 
 
The uterine environment is important as the site of embryo development. The pre-
implantation embryo relies upon substrates within the uterine tract fluid to support 
growth, with glucose, pyruvate, lactate, amino acids and free fatty acids present. 
 
In pig uterine fluid, there was no significant variation in glucose concentrations 
recorded with stage of oestrus, from 18.4mg/100ml at diestrus to 27.5mg/100ml at 
oestrus (Iritani et al. 1974). During the oestrous period, total lipid content of 
uterine fluid was four-fold higher than that of oviductal fluid, with 177.7mg/100ml 
(Iritani et al. 1974). Oleic acid was the most common fatty acid, accounting for 
34.91% of total fatty acids, followed by palmitic acid (23.79%) and stearic acid 
(14.03%) (Khandoker et al. 1997). The three predominant PUFAs were linoleic 
acid (4.38%), linolenic (9.85%) and arachidonic acid (8.61%; Yao et al. 1980; 
Khandoker et al. 1997). High concentrations of oleic and palmitic acids may serve 
as a storage pool of metabolic precursors, and as substrates for fatty acid 
elongation and desaturation in embryo development (Khandoker et al. 1997). The 
addition of specific fatty acids to embryo culture media has been shown to affect 
development. Supplementation of culture media with linoleic acid increased 
cleavage and blastocyst development of bovine embryos (Miyashita et al. 2012), 
while linolenic decreased blastocyst development and altered gene expression (Al 
Darwich et al. 2010). Given that in vivo embryos are exposed to these fatty acids 
34 
while in the tract, they are likely to play a role in embryo development and 
supplementation of media should be further examined. 
 
1.4.2. In vitro systems 
 
Media for in vitro applications typically contain salts with one or more energy 
substrates provided, often in the form of glucose, lactate or pyruvate. The majority 
of the literature available on oocyte and embryo metabolism has predominantly 
focused on carbohydrate metabolism; as such, most current IVP media 
formulations, including those used for porcine embryos, were developed based on 
requirements for glucose, pyruvate and lactate as energy substrates throughout 
maturation and culture periods. 
 
In standard protocols, embryos may be exposed to three discrete media during in 
vitro development, with a different medium used for each phase of IVP – ie. IVM, 
IVF and IVC. Effects on developmental potential as the embryo attempts to adjust 
to changes in osmolarity, pH and substrate availability indicates there are potential 
benefits to having a single base medium supplemented as appropriate for each 
stage (Yoshioka et al. 2008). Bovine oocytes can be matured, fertilised and 
cultured in a single basic medium appropriately supplemented for specific stages 
of development (Gandhi et al. 2000). 
 
1.4.2.1. IVM medium 
 
See Table 1.1 for common porcine IVM media formulations. 
 
In vitro maturation medium was originally developed from medium designed for 
somatic cell or tissue culture. Maturation media are typically supplemented with 
follicular fluid or serum, as well as gonadotrophins and hormones. Following 
development of the North Carolina State University (NCSU) series of media in the 
1990s (Petters and Wells 1993), these became the favoured media for porcine 
IVM. Subsequently, porcine oocyte medium (POM; Yoshioka et al. 2008) was 
developed as a fully defined medium modelled on the composition of oviductal 
fluid. Oocytes matured in POM with PVA had greater rates of normal penetration 
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and similar blastocyst rates to those matured in NCSU-37 supplemented with 
follicular fluid, but cell number was reduced, indicating a poorer quality of these 
blastocysts (Yoshioka et al. 2002). 
 
Energy substrates supplied to oocytes in IVM media are generally glucose, 
pyruvate, lactate and amino acids, these having been identified as important 
metabolites for full embryo developmental potential. As events during oocyte 
maturation impact on early stages of embryo development, ensuring an 
appropriate and adequate supply of metabolic substrates to the COC during IVM 
is essential to support subsequent embryo development. Despite evidence of free 
fatty acids being present in oviductal fluid, none of these media supply a defined 
exogenous fatty acid source during IVM. Although follicular fluid and serum 
supplementation can provide fatty acids, these are undefined substances and 
variation between batches is unavoidable. 
 
1.4.2.2. IVF medium 
 
See Table 1.2 for common porcine IVF media formulations. 
 
In vitro fertilisation medium has to meet the requirements for both oocytes and 
sperm at the time of fertilisation. The composition of IVF medium can affect a 
range of parameters including the acrosome reaction, sperm penetration, 
polyspermy and male pronucleus formation, as well as zona hardening and 
subsequent blastocyst formation (Coy et al. 2002). Commonly used media in pig 
IVF are tissue culture medium (TCM-199; Cheng 1987; Mattioli et al. 1989; Coy et 
al. 1999); Tyrode’s albumin lactate pyruvate medium (TALP; Bavister 1989; 
Yoshida et al. 1993); and Tris-buffered medium (TBM; Abeydeera and Day 1997; 
Abeydeera et al. 1999). 
 
It has been suggested that poor outcomes of in vitro produced porcine embryos 
has to do with the IVF procedure itself (Coy et al. 1999). While the three common 
IVF media used have resulted in the birth of piglets following embryo transfer 
(Cheng 1987; Mattioli et al. 1989; Yoshida et al. 1993; Abeydeera et al. 1998c; 
Rath et al. 1999), none of these media are considered to be optimal given the 
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current low efficiency of porcine IVF. Media formulations have been shown to 
affect the rates of polyspermic fertilisation, a common problem in pig IVF systems, 
as well as other factors including the acrosome reaction, cortical reaction and 
zona pellucida hardening, which all influence successful fertilisation (Coy et al. 
2002). Further research is required to optimise the fertilisation conditions and 
ensure a high IVF efficiency is consistently achieved. 
 
1.4.2.3. IVC medium 
 
See Table 1.3 for common porcine IVC media formulations. 
 
The culture medium has a substantial impact upon the success of in vitro embryo 
production. These include factors such as pH and osmolarity, as well as the 
composition of the medium. Energy substrate preferences change throughout 
maturation and culture, and media must be able to meet the needs of each stage 
of development to effectively support growth. There is evidence that the 
composition of culture medium influences not only substrate uptake, but also the 
metabolic pathways utilising these substrates in porcine oocytes and embryos at 
different stages of development (Gandhi et al. 2001). 
 
The formulation of in vitro culture medium has a significant impact upon 
development, with porcine embryos held in culture medium for up to seven days. 
Early media was developed from somatic cell culture systems, but pre-
implantation embryos cultured in vitro arrested at the four-cell stage. Development 
of semi-defined embryo-specific media based on the composition of oviductal fluid 
were beneficial for in vitro culture. NCSU-23 (Petters and Reed 1991; Reed et al. 
1992; Petters and Wells 1993) was a commonly used medium, and was shown to 
consistently support higher blastocyst development rates in porcine embryos than 
other media available at the time. Several studies have shown that PZM is 
superior to other media, including NCSU media (Yoshioka et al. 2002; Im et al. 
2004; Wang et al. 2009). The development of PZM-4 medium, with PVA replacing 
BSA, heralded the first report of live births from porcine embryos cultured in vitro 
in a fully defined media system (Yoshioka et al. 2002). 
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Sequential media systems were developed to adapt to the changing substrate 
preference of embryos. These systems involve culture for the first 48 to 72 hours 
in one medium before moving embryos into a different medium formulation, often 
with altered concentrations of glucose, pyruvate and lactate (Kikuchi et al. 2002b; 
Karja et al. 2004; Beebe et al. 2007). Sequential media systems were shown to 
have a beneficial effect on blastocyst development and quality, likely due to the 
metabolic support more closely resembling that of the in vivo environment. 
 
 
 
Table 1.1. Formulations of media commonly used for porcine oocyte in vitro 
maturation. TCM-199 = Tissue Culture Medium 199; NCSU-23 = North Carolina 
State University medium 23; POM = Porcine Oocyte Medium.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aTCM-199 (Gibco, catalogue number 11150), also contains a complex mixture of amino 
acids and vitamins 
bBasic formulation (Petters and Wells 1993) 
cAlso contains commercial mixtures of essential and non-essential amino acids (Yoshioka 
et al. 2008) 
 
 
Component (mM) TCM-199a NCSU-23b POMc
NaCl 116.36 108.73 108.00
KCl 5.36 4.78 10.00
KH2PO4 - 1.19 0.35
MgSO4 0.81 1.19 0.40
NaHCO3 26.19 25.07 25.00
CaCl2 1.80 1.70 -
Glucose 5.55 5.55 4.00
Sodium pyruvate 0.91 - 0.20
Calcium (lactate)2 - - 2.00
Glutamine 0.68 1.00 2.00
Taurine - 7.00 -
Hypotaurine - 5.00 5.00
Cysteine (µM) 0.57 - 600.00
BSA (mg/ml) 1.00 4.00 3.00
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Table 1.2. Formulations of media commonly used for porcine in vitro fertilisation. 
TCM-199 = Tissue Culture Medium 199; TALP = Tyrode’s albumin lactate 
pyruvate; TBM = Tris-buffered medium; PGMtac4 = Porcine Gamete Medium, 
theophylline adenosine cysteine; Pig-FM = Pig fertilisation medium. 
 
 
aTCM-199 (Gibco, catalogue number 11150), also contains a complex mixture of amino 
acids and vitamins 
bBavister 1989 
cAbeydeera and Day 1997 
dYoshioka et al. 2003 
eSuzuki et al. 2000. 
Component (mM) TCM-199a TALPb TBMc PGMtac4d Pig-FMe
NaCl 116.36 114.00 113.10 108.00 90.00
KCl 5.36 3.16 3.00 10.00 12.00
KH2PO4 - - - 0.35 -
MgSO4 0.81 0.50 - 0.40 0.50
NaHCO3 26.19 25.00 - 25.00 25.00
HEPES - - - - 10.00
CaCl2 1.80 2.00 7.50 - 8.00
NaH2PO4 1.01 0.35 - - 0.50
Glucose 5.55 5.00 11.00 4.00 -
Sodium pyruvate 0.91 0.10 5.00 0.20 2.00
Calcium (lactate)2 8.75 3.00 - 4.00 -
Sodium lactate - 10.00 - 10.00
Glutamine 0.68 - - - -
Caffeine 3.60 2.00 1.00 - 2.00
Tris - - 20.00 - -
Cysteine (µM) 0.57 - 0.57 0.25 -
Adenosine (µM) - - - 1.00 -
Theophylline - - - 2.50 -
Phenol red (mg/ml) 0.02 0.01 - - -
BSA (mg/ml) 1.00 3.00 2.00 - 5.00
PVA (mg/ml) - 1.00 - 3.00 -
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Table 1.3. Formulations of media commonly used for porcine embryo in vitro culture. NCSU = North Carolina State University; 
PZM = Porcine Zygote Medium. 
 
aPetters and Wells 1993 
bYoshioka et al. 2002 
cBeebe et al. 2007 
dKikuchi et al. 2002, Karja et al. 2004
Media 1 Media 2 Media 1 Media 2
NaCl 108.73 108.73 108.00 108.00 108.73 108.73 108.73 108.73
KCl 4.78 4.78 10.00 10.00 4.78 4.78 4.78 4.78
KH2PO4 1.19 1.19 0.35 0.35 1.19 1.19 1.19 1.19
MgSO4 1.19 1.19 0.40 0.40 1.19 1.19 1.19 1.19
NaHCO3 25.07 25.07 25.07 25.07 25.07 25.07 25.07 25.07
CaCl2 1.70 1.71 - - 1.70 1.70 1.71 1.71
Glucose 5.55 5.55 - - - 5.55 - 5.55
Sodium pyruvate - - 0.20 0.20 0.20 - 0.17 -
Calcium (lactate)2 - - 2.00 2.00 5.70 - - -
Sodium lactate - - 2.73 -
Glutamine 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Taurine 7.00 - - - 7.00 7.00 - -
Hypotaurine 5.00 - 5.00 5.00 5.00 5.00 - -
Sorbitol - 12.00 - - - - 12.00 12.00
BME amino acids (ml/l) - - 20.00 20.00 - - - -
MEM non-essential amino acids (ml/l) - - 10.00 10.00 - - - -
PVA (mg/ml) - - - 3.00 - - - -
BSA (mg/ml) 4.00 4.00 3.00 - 4.00 4.00 4.00 4.00
NCSU-37 sequential mediad
Component (mM) NCSU-23a NCSU-37a PZM-3b PZM-4b
NCSU-23 sequential mediac
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1.5. Lipid studies 
 
‘Lipid’ is a general term referring to a broad range of substances, loosely defining 
any molecules that are insoluble in water and soluble in organic solvents. There is 
a wide range of lipid species, including glycerolipids, glycerophospholipids, 
sphingolipids, sterols, prenols, saccharolipids and polyketides. Due to their 
diverse nature, lipids fulfil a wide range of roles within biological systems. These 
include their main metabolic roles in energy storage and the formation of 
biological membranes, as well as having roles in cell signalling and the retention 
of fat-soluble vitamins and steroid hormones. 
 
1.5.1. Endogenous lipids 
 
One of the major functions of lipids is energy storage. Excess energy, from 
increased feed intake or decreased energy requirements, is stored as 
triglycerides, which are then broken down and metabolised at times when energy 
supplies are limited or during a spike in energy consumption. Metabolism of 
triglycerides for energy production yields a greater amount of energy per molecule 
compared with carbohydrate metabolism. 
 
The majority of fatty acids within porcine oocytes are stored as triglycerides within 
cytoplasmic lipid droplets, with an average of 74ng present within the oocyte, 
accounting for 46% of the total lipid fraction (McEvoy et al. 2000). A later study 
reported the triglyceride content as almost double this, at 135ng in immature 
oocytes and 122ng following IVM (Sturmey and Leese 2003). Differences in 
analysis methods may have affected results, with one study using gas 
chromatography (McEvoy et al. 2000) compared with an assay based on 
enzymatic hydrolysis of triglycerides (Sturmey and Leese 2003). Triglycerides are 
comprised of a glycerol backbone with three fatty acid side chains, with properties 
varying depending on the identity of the fatty acids. The predominant fatty acids 
found in immature porcine oocytes are palmitic acid (34.9% of total fatty acids), 
oleic acid (21.7%) and stearic acid (14.4%; McEvoy et al. 2000). Bovine oocytes 
with higher developmental competency were found to contain oleic, linoleic and 
arachnidonic acids in higher proportions (Kim et al. 2001). The exact role these 
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specific fatty acids play during oocyte maturation is not fully understood, and the 
effect of exogenous supplementation is unknown. 
 
Unsaturated fatty acids are more readily stored as triglycerides compared with 
saturated fatty acids (Listenberger et al. 2003), and can assist in improving the 
incorporation of saturated fatty acids to triglyceride stores. Increased intracellular 
lipid content in porcine oocytes may be due to higher levels of unsaturated fatty 
acids within oviductal fluid, with oleic acid comprising 36% of total free fatty acids 
compared to 22% in cattle oviductal fluid (Khandoker et al. 1997).  
 
Evolution of the lipid component of oocytes begins within the primordial follicle. 
Oocytes at this stage have numerous dark, round lipid droplets within the 
cytoplasm (Silva et al. 2011). While lipid droplets within oocytes were abundant 
throughout follicular development (Silva et al. 2011), their changing morphology 
from homogenous dark droplets to a grey or streaked appearance indicates lipid 
utilisation throughout folliculogenesis (Isachenko et al. 2001; Silva et al. 2011). 
Immature oocytes contain the highest proportion of triglycerides, phospholipids 
and cholesterols than any other stage of development (Romek et al. 2011b). 
Cytoplasmic lipid droplets have been shown to translocate during in vitro 
maturation, following the patterns of mitochondrial rearrangement (Sturmey et al. 
2006; Somfai et al. 2011), further supporting a role for their use as an energy 
substrate. 
 
Lipid droplets tend to appear more homogenous and electron dense in in vivo 
oocytes and embryos compared to their in vitro counterparts (Kikuchi et al. 
2002a). In regards to lipid utilisation, an early study found that the number of lipid 
droplets increased following resumption of meiosis in in vivo sourced oocytes 
(Cran 1985). A subsequent comparative study found that in vitro and in vivo 
matured oocytes contained similar numbers of small, medium and large sized lipid 
droplets (Niimura et al. 2002). In feline oocytes, which are similar to porcine 
oocytes in terms of the rich endogenous lipid content, in vivo matured oocytes 
oxidised greater amounts of palmitate than in vitro oocytes (Spindler et al. 2000). 
In vivo oocytes may be capable of incorporating or utilising exogenous fatty acids 
present in reproductive tract fluids, and thus any metabolic differences in fatty acid 
42 
oxidation between in vitro and in vivo matured oocytes may not be evident by 
comparing lipid droplet number and size alone. 
 
Porcine embryo lipid content remains unchanged from early cleavage stages 
through to morula, before significantly decreasing at the blastocyst stage and 
again at the late blastocyst stage; this is seen in both in vitro and in vivo cultured 
embryos (Romek et al. 2009). There was no change in triglyceride content 
detected throughout embryo development, with triglyceride levels remaining 
constant at around 117ng from early cleavage onwards (Sturmey and Leese 
2003). This suggests that there are potentially changes in other lipid species, such 
as phospholipids within membranes, during embryo culture. 
 
While lipid droplet morphology and distribution was similar between in vivo 
embryos and those cultured in vitro in NCSU-23 medium, the triglyceride content 
of lipid droplets was significantly lower in in vivo cultured embryos (Romek et al. 
2010). Potentially, the higher carbohydrate metabolic rates seen in in vitro 
cultured embryos may lead to a lower lipid utilisation, thus accounting for higher 
lipid levels in these cells when compared with in vivo embryos. At the early 
blastocyst stage, mitochondrial membrane potential (MMP) is lower in in vitro than 
in vivo embryos (Romek et al. 2011c). As the electron transport generates MMP, 
used to drive ATP synthesis through oxidative phosphorylation, MMP is a key 
indicator of cell metabolic activity relating to oxygen consumption and cellular 
energy needs. Increased intracellular lipid may also be due to abnormal lipid 
accumulation during in vitro culture, as suggested by the finding that culture in 
media containing serum increased intracellular lipid content (Ferguson and Leese 
1999). 
 
1.5.2. Addition of undefined fluids 
 
The use of a fully defined medium is preferential in in vitro systems, allowing 
repeatable results in research applications and reducing disease risk in 
commercial settings. However, the addition of undefined biological fluids to 
maturation media is often beneficial to in vitro development. 
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The addition of follicular fluid to maturation medium has been shown to be 
advantageous in in vitro systems. Follicular fluid is known to be rich in nutrients, 
containing proteins, amino acids, sugars, enzymes, mucopolysaccharides, 
hormones, salts and fatty acids (Huang et al. 2002). Follicular fluid is released 
from the follicle at ovulation, with a portion transported into the oviduct along with 
the COC. However, it has been estimated that less than 1% of follicular fluid is 
retained in the oviduct following ovulation, with oviductal fluid being the medium of 
transport and maturation of in vivo ovulated oocytes (Leese 1988). Despite this, 
the addition of follicular fluid to maturation medium has been shown to have a 
range of beneficial effects. These include improved nuclear and cytoplasmic 
maturation rates, male pronucleus formation, cumulus cell expansion, male 
pronucleus formation, monospermic fertilisation, and greater cleavage and 
blastocyst rates following IVF (Naito et al. 1989; Rath et al. 1995; Algriany et al. 
2004; Ito et al. 2008). The concentration of follicular fluid in maturation medium 
impacts on efficacy, with up to 30% found to be optimal depending on the IVM 
medium used while higher concentrations led to inhibited meiotic resumption (Kim 
et al. 1996). 
 
There is a follicle size effect, with follicular fluid from larger follicles having a 
greater beneficial effect than that from small follicles (Algriany et al. 2004; Ito et al. 
2008). It is likely that there is an accumulation of beneficial factors, such as 
steroids (Grupen et al. 2003), as well as decreasing concentrations of meiosis-
inhibiting factors (Bertoldo et al. 2013), in follicular fluid from large follicles closer 
to ovulation compared with small follicles. Further to this, oocytes aspirated from 
large follicles have greater developmental competence than those from small 
follicles (Marchal et al. 2002; Algriany et al. 2004; Bagg et al. 2007). This suggests 
that the factors accumulated as the follicle increases in size are important for later 
stages of development, and can further aid in oocyte maturation and 
development. 
 
However, the composition of follicular fluid has a marked effect on the outcome of 
its use in media systems. Mouse oocytes cultured in follicular fluid rich in fatty 
acids had poorer developmental outcomes than oocytes cultured in follicular fluid 
with low levels of fatty acids (Yang et al. 2012). In developing porcine ovarian 
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follicles, the fatty acid concentration of follicular fluid was found to decrease with 
increasing follicle size (Yao et al. 1980); it may be that supplementation with fatty 
acids at this stage, or the provision of specific fatty acids, can be detrimental to 
oocyte maturation. Variation between follicular fluid preparations and the 
undefined nature of the product can therefore have a variable effect on 
maturation. 
 
Culture in certain undefined substances (such as serum) can lead to abnormal 
accumulation of lipid droplets (Ferguson and Leese 1999), as fatty acids from 
medium substrates are taken up and this excess energy substrate is used to 
synthesise lipids which are stored as lipid droplets in the cytoplasm. Because of 
this, the lipid profile of oocytes and embryos often mirrors that of serum products 
in culture media (Abe et al. 2002). 
 
1.5.3. Addition of specific fatty acids 
 
The fatty acid composition of low and high quality oocytes has been shown to 
differ (Aardema et al. 2011). Because oocyte composition often reflects the 
substrates available within the medium (Aardema et al. 2011), the 
supplementation of maturation medium with fatty acids has the potential to affect 
oocyte developmental potential. Experiments using radiolabelled fatty acids have 
shown that cattle oocytes uptake and incorporate exogenous fatty acids, with 
greater than 95% metabolised within the oocyte and 5% recovered in the free fatty 
acid component (Aardema et al. 2011). Oleic acid was found to be more efficiently 
incorporated into stored triglycerides, compared with relatively poor incorporation 
of palmitic or stearic acids. Addition of palmitic and stearic acids to the culture 
medium, either singly or in conjunction, resulted in poorer developmental 
outcomes (Aardema et al. 2011; McKeegan and Sturmey 2012). However, when 
oleic acid was added in conjunction with either palmitic or stearic or both, it 
counteracted the adverse effects and restored development to levels similar to 
controls with no fatty acid supplementation (Aardema et al. 2011).  
 
Early studies worked to quantify the quantity and composition of fatty acids 
present in reproductive tract fluid (Iritani et al. 1974; Chang et al. 1976; Yao et al. 
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1980; Homa et al. 1986; Khandoker et al. 1997), and found a wide variety of fatty 
acids within tract fluid. Despite the large amount of research focussed on 
improving IVP through media composition refinement, the supplementation of 
media with specific fatty acids is not commonplace. 
 
Saturated fatty acids are poorly incorporated into triglyceride reserves in non-
adipose tissues and can cause lipotoxicity and increased apoptosis in cells 
(Listenberger et al. 2003). The addition of palmitic (16:0) or stearic (18:0) acids, 
either singly or in conjunction, to maturation medium for bovine oocytes reduced 
the cleavage and blastocyst rates following IVF, as well as reducing the number 
and size of lipid droplets in the oocytes, although nuclear maturation rates to MII 
were unaffected (Aardema et al. 2011; McKeegan and Sturmey 2012). 
Interestingly, in feline oocytes, oxidation of palmitic acid increased throughout 
GVBD (Spindler et al. 2000); further, it is the most abundant fatty acid found in 
porcine oocytes (Homa et al. 1986; Sturmey et al. 2009). It is possible that these 
fatty acids play a role in oocyte maturation of certain species, with varying 
responses to specific fatty acids. Oleic acid (18:1) supplementation counteracted 
adverse effects of palmitic and stearic acids in bovine oocytes (Aardema et al. 
2011). The addition of 500µM oleic acid also increased both the number and size 
of lipid droplets in MII stage oocytes (Aardema et al. 2011). Greater 
developmental outcomes were seen from lipid rich porcine oocytes, and higher 
quality porcine oocytes were found to have greater proportions of oleic, linoleic 
(18:2) and arachidonic (20:4) acids than those in poorer quality oocytes (Kim et al. 
2001). Unsaturated fatty acids also appear to serve a protective function against 
lipotoxicity and apoptosis by increasing triglyceride storage (Listenberger et al. 
2003; Aardema et al. 2011).  
 
Further, the addition of linolenic acid (18:3) to maturation medium improved MII 
development of cattle oocytes and resulted in higher cleavage and blastocyst 
rates following IVF, as well as increasing the activity of MAPK signalling pathways 
(Marei et al. 2009). In contrast, adding linoleic acid (18:2) inhibited CC expansion 
and reduced meiotic progression and cAMP levels, with a subsequent reduction of 
cleavage and blastocyst development rate, in a dose-dependent manner (Marei et 
al. 2010). The concentration of linolenic acid in follicular fluid was found to be 
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similar in small and large follicles, while the linoleic acid concentration decreased 
with increasing follicle size (Homa and Brown 1992). There is an obvious effect of 
supplementation with fatty acids at concentrations seen in in vivo tract fluids, and 
it is likely that they contribute to oocyte composition, which affects maturation and 
subsequent quality. 
 
The supplementation of pig maturation medium with a commercial fatty acid mix 
(Gibco) had no effect on meiotic progression or blastocyst cell number (Tubman et 
al. 2005). Further, activity of glycolysis and the PPP in the resulting blastocysts 
were unaffected, suggesting a minimal role of exogenous fatty acids during 
porcine oocyte maturation. Elevated follicular free fatty acid levels have been 
correlated with poor COC morphology in humans (Jungheim et al. 2011) and 
altered mitochondrial distribution, increased ROS and morphologically abnormal 
zygotes in mice (Wakefield et al. 2008). 
 
It is likely that current media formulations exclude fatty acids in an attempt to 
avoid excessive lipid accumulation. However, it is apparent that exogenous fatty 
acids do exert some beneficial effect on oocytes, and a greater understanding of 
their role in maturation is required. It is evident that further research is required to 
examine species specific effects and determine the optimal concentrations. 
 
1.5.4. Alteration of lipid metabolism 
 
Prior studies have also looked at the addition of metabolic regulators to maturation 
and culture media in an attempt to alter the in vitro metabolism of oocytes and 
embryos, so that it more closely resembles that of in vivo grown counterparts. 
 
1.5.4.1. L-carnitine 
 
The artificial upregulation of lipid metabolism in oocytes and embryos aims to 
increase the rate of lipid oxidation, attempting to increase the ATP available to the 
cell from utilisation of endogenous lipid stores as energy substrates. Because in 
vivo embryos have lower lipid levels than in vitro produced embryos, it is thought 
that metabolic aberrations in in vitro oocytes and embryos alter their substrate 
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preferences and that they are therefore not utilising lipid stores in a ‘normal’ 
manner. 
 
The majority of studies examining the upregulation of lipid metabolism use L-
carnitine, a co-factor involved in the entry of activated fatty acids from the cytosol 
into the mitochondrial matrix, which is the rate limiting step of fatty acid oxidation. 
Its addition to maturation medium has been shown to have beneficial effects 
across a number of species. In mice, the addition of 1mM L-carnitine during IVM 
increased the rate of β-oxidation and led to improved developmental competence 
following fertilisation in these oocytes (Dunning et al. 2010a). In cattle, oocyte 
maturation and blastocyst development rates were increased after the addition of 
L-carnitine during IVM (Yamada et al. 2006; Phongnimitr et al. 2013), as well as 
affecting the diffusion of mitochondria within the cytoplasm of oocytes (Yamada et 
al. 2006). However, a later study found no effect of L-carnitine on bovine oocyte 
maturation or embryo development (Chankitisakul et al. 2013). Differences in 
composition of media used between studies may account for the varied results 
seen, although further studies are required to confirm this. 
 
In porcine oocyte maturation studies, the results of adding L-carnitine to IVM 
medium have been varied. One study reported that the addition of L-carnitine at 
doses between 3.04-25.30mM increased the proportion of mature oocytes at 44 h 
(Somfai et al. 2011). A subsequent study showed that 2.53mM L-carnitine 
hastened nuclear maturation, with a greater number of oocytes reaching MII by 36 
h compared to the control, although similar maturation rates were achieved by 44 
h of maturation (Wu et al. 2011). It was later shown that 10mM L-carnitine had no 
effect on nuclear maturation (You et al. 2012), although in this study the high 
proportions of oocytes reaching MII in the control group (91.6% at 44 h) may have 
masked any beneficial effects of the L-carnitine treatment. With regards to 
cytoplasmic maturation, the presence of 3.04-25.30mM L-carnitine during 
maturation improved cleavage rates following IVF (52.0-54.8% vs 41.7%), but 
blastocyst development was not improved (Somfai et al. 2011). In contrast, other 
studies showed that L-carnitine treatment did not alter the cleavage rate, but 
increased the blastocyst development rate following parthenogenetic activation 
(Wu et al. 2011; You et al. 2012). These conflicting results may be due to the 
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developmental differences between IVF and parthenogenetic embryos. Utilising 
IVF to produce blastocysts introduces a range of sperm factors which can 
influence developmental outcomes, potentially accounting for differences between 
these studies. All studies reported similar cell numbers between L-carnitine and 
control groups. Similar penetration rates, male pronuclear formation and 
monospermic fertilisation rates were reported, but the successful formation and 
extrusion of two polar bodies was significantly higher (92.0% vs 76.8%) in groups 
of L-carnitine treated oocytes (Somfai et al. 2011). Extrusion of both polar bodies 
may be related to rates of MII maturation, with MI oocytes being able to be 
fertilised but incapable of forming a second polar body. The presence of L-
carnitine during maturation was also shown to reduce ROS levels and the 
proportion of apoptotic cells in resulting blastocysts (Wu et al. 2011), likely due to 
the antioxidant property of L-carnitine. 
 
Comparisons of these three studies is difficult owing to differences in media 
composition and maturation conditions, and further research is required to 
examine how these variables, such as the presence or absence of dibutyryl 
cAMP, follicular fluid, BSA and synthetic macromolecules, interact with lipid 
metabolism to affect maturation. 
 
Further effects of L-carnitine have been reported on mitochondrial and lipid droplet 
distribution. The addition of 7.4mM L-carnitine to maturation medium was reported 
to increase the density of active mitochondria within the central and peripheral 
areas of the oocyte, and result in translocation of lower density lipid droplets to the 
centre of the ooplasm (Somfai et al. 2011). The co-localisation of lipid droplets 
and mitochondria has previously been documented for porcine oocytes (Kikuchi et 
al. 2002a; Sturmey et al. 2006), as has the translocation of active mitochondria 
(Sun et al. 2001; Krisher et al. 2007) and lipid droplets (Sturmey et al. 2006) from 
peripheral to central during IVM. As the movement of active mitochondria and lipid 
droplets during in vivo maturation has yet to be examined in detail, the 
significance of these findings is unclear. 
 
L-carnitine is also known to act as an antioxidant, having been shown to alter the 
redox state via mitochondrial pathways in animal somatic cells (Pillich et al. 2005; 
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Ye et al. 2010). There is a consensus between studies that the addition of L-
carnitine to media at a range of concentrations reduced intracellular ROS levels 
(Somfai et al. 2011; Wu et al. 2011; You et al. 2012), while also increasing GSH 
concentrations within the oocytes (Wu et al. 2011; You et al. 2012) and reducing 
the proportion of apoptotic cells in blastocysts (Hashimoto et al. 2008; Wu et al. 
2011). Addition of 9-25µM L-carnitine to medium supplemented with H2O2 
decreased intracellular hydrogen peroxide and lipid peroxide levels and increased 
nuclear maturation rates in porcine oocytes (Yazaki et al. 2013). Given the 
induced oxidative stress in these cells, a lower dose of L-carnitine was found to 
improve maturation parameters compared with other reports. It is undetermined 
whether L-carnitine treatment has a dual beneficial effect as an antioxidant and a 
regulator of lipolysis or if there is a single effect leading to beneficial outcomes 
following IVM. The effects of adding other sources of antioxidants have been 
varied, with cysteamine showing improved maturation (Grupen et al. 1995), while 
other antioxidants have led to no improvement (Tatemoto et al. 2004; Choe et al. 
2010). The decrease in lipid content following application of lipolytic stimulators 
(Fu et al. 2011; Romek et al. 2011a; Somfai et al. 2011) would infer that lipid is 
indeed being used to a greater extent in these oocytes. Further, the rate of β-
oxidation was increased by the addition of L-carnitine to maturation medium in 
mouse oocytes (Dunning et al. 2010a), providing evidence that lipolysis is the 
primary effect. 
 
To date, there are no studies regarding the effects of the addition of metabolic 
regulators during the IVF period on oocyte developmental potential. The use of L-
carnitine in sperm medium has been shown to increase intracellular GSH levels in 
the sperm, leading to improved fertilisation rates (Luberda 2005). There is an 
increased demand for ATP during fertilisation, and oocytes may be capable of 
utilising endogenous lipid substrates at this stage to meet energy requirements. 
 
The use of lipolytic stimulators in embryo culture media has shown improvements 
in development to the blastocyst stage and a reduction in ROS formation in mice 
(Abdelrazik et al. 2009) and cattle (Sutton-McDowall et al. 2012) embryos. The 
lipid content of bovine embryos cultured with L-carnitine was decreased (Sutton-
McDowall et al. 2012), and cryosurvival increased in these cells. In pigs, the 
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addition of L-carnitine to culture medium had no effect on cleavage rates, 
blastocyst development rates or cell number, or intracellular GSH content of 
parthenogenetic embryos (Wu et al. 2011), despite the intracellular ROS levels 
and incidence of apoptosis in blastocyst cells being reduced. Continued research 
into the use of lipolytic stimulators is required to fully understand the role of 
endogenous lipids during oocyte maturation and embryo culture, further to 
developing culture media to better support this aspect of metabolism. 
 
1.5.4.2. Inhibitors 
 
Several studies have examined the effect of inhibiting lipid metabolism in oocytes 
and embryos, with the aim of understanding the level of contribution of this 
pathway to energy generation and cell development. In mice, inhibition of lipolysis 
prevented meiotic resumption in COCs and denuded oocytes, hypothesised to be 
due to interference with the AMPK-induced meiotic induction pathway (Downs et 
al. 2009). A subsequent study showed that inhibition of CPT1 in mouse COCs 
using 100µM etomoxir did not inhibit development to MII, but significantly inhibited 
activity of the β-oxidation pathway (Dunning et al. 2010a). Following IVF of these 
oocytes, embryo development was significantly reduced, suggesting that lipid 
metabolism may also have a role in cytoplasmic maturation of mouse oocytes. 
Similarly in cattle oocytes, addition of 1 or 5mM methyl palmoxirate during IVM 
reduced blastocyst development compared with the control group (14%, 7% and 
22% respectively; Ferguson and Leese 2006). While 250µM etomoxir was 
required to inhibit nuclear maturation in mouse oocytes, doses of only 100µM and 
10µM were required to have the same effect in bovine and porcine oocytes, 
respectively (Paczkowski et al. 2013). Given the differing lipid content in oocytes 
of these species, this strongly suggests that the use of endogenous lipids is 
species-specific. Furthermore, in both mice and cattle, increased glucose 
consumption corresponded with a decrease in lipolysis (Paczkowski et al. 2013).  
 
In cattle embryos, culture with 1 to 5mM methyl palmoxirate decreased blastocyst 
development (11-13% vs 22% control), while doses as low as 0.5mM also led to a 
reduction in blastocyst cell number (Ferguson and Leese 2006). There was a 
corresponding reduction in O2 consumption during culture with 1 to 5mM methyl 
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palmoxirate, implying that energy generation from endogenous lipids plays a 
necessary role in embryo development. 
 
In pigs, the reported effects of inhibition of lipolysis vary. Addition of 0.5 to 1.0mM 
methyl palmoxirate during IVM prevented any subsequent cleavage and 
blastocyst development (Sturmey et al. 2006). Doses of 0.1 to 1.0mM of 
mercaptoacetate during IVM had no effect on cleavage or blastocyst 
development, while a 10mM dose inhibited blastocyst formation (Sturmey et al. 
2006). Differences in responses may be attributable to the type of inhibitors used. 
Methyl palmoxirate works by inhibiting the activity of the carnitine shuttle, 
preventing entry of free fatty acids into the mitochondria for β-oxidation. 
Mercaptoacetate is a competitive inhibitor of 3-hydroxyacyl CoA dehydrogenase, 
a key enzyme in the β-oxidation pathway. Lower response with mercaptoacetate 
is likely due to competitive inhibition, whereby higher concentrations of substrates 
would lead to lower effectiveness of the inhibitor. 
 
The addition of 10µM etomoxir was sufficient to inhibit nuclear maturation in 
porcine oocytes, with the majority of oocytes arresting at MI following treatment 
with 10 to 100µM etomoxir; at doses of 250µM, oocytes arrested primarily at the 
GVBD stage (Paczkowski et al. 2013). Etomoxir has a similar mode of action as 
methyl palmoxirate, whereby activity of the carnitine shuttle is inhibited. However, 
this study used TCM-199 medium, which contains 5mM glucose and 0.01mM 
pyruvate. As pyruvate is an important factor for the resumption of meiosis, the low 
concentration present in this medium may not have supported meiotic progression 
adequately. Further, exposure to etomoxir during IVM decreased the relative 
abundance of genes involved in fatty acid oxidation and glycolysis (Paczkowski et 
al. 2013). In contrast to mice and cattle, there was no increase in glucose 
consumption in porcine oocytes treated with etomoxir (Paczkowski et al. 2013). 
Interestingly, there was also no change in lipid content or ADP/ATP ratio following 
etomoxir treatment (Paczkowski et al. 2013), suggesting lipid metabolism was a 
requirement for cell viability. Given the high lipid content in porcine oocytes, this 
pathway may be of greater importance in this species than in others. 
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1.6. Concluding remarks and objectives of the present study 
 
The low efficiency of IVP and the poor quality of resulting embryos is a major 
impediment to the application of ARTs in pig production. The purpose of the high 
lipid content of porcine oocytes and embryos remains unknown, despite this being 
a major hurdle to improving IVP outcomes in pigs. The discrepancies in quality 
and development between in vivo- and in vitro-derived embryos are likely 
attributable to altered metabolism resulting from the in vitro conditions. Supporting 
this notion is the progress made so far in improving the media formulations – as 
these have been refined to more closely resemble the composition of the 
reproductive tract fluids, blastocyst quality and development rates have increased 
together with a rise in live birth rates following transfer. However, there is still a 
lack of understanding regarding the contribution of lipid substrates to energy 
generation in porcine oocytes and embryos. 
 
The limited studies in pigs that have examined IVM or IVC have used completely 
different media, some of which are undefined. Therefore there is little knowledge 
about the interactions of carbohydrate and lipid metabolism at these stages of 
IVP. There are variable reports regarding the effects of lipolytic stimulants and 
inhibitors, suggesting that other factors during culture, including carbohydrate 
composition of the media, may affect the use of lipid stores. There are no known 
studies examining the involvement of lipids during porcine IVF. This thesis 
examines lipid metabolism at each stage of the IVP process in detail using a semi-
defined medium, and explores the interaction of carbohydrate and lipid 
metabolism. It is hypothesised that porcine oocytes and embryos utilise 
endogenous lipid substrates during the IVP process, and that changes in 
concentrations of carbohydrate substrates will impact upon use of lipids. Further, 
given the changing nutrient requirements seen throughout the stages of IVP, it is 
hypothesised that the level of lipid usage will vary with stage of development. 
 
To this end, the overall aim of this thesis was to identify the role of lipid 
metabolism during in vitro production of porcine embryos. The specific aims of the 
thesis studies were: 
 
53 
i. To determine the effects of upregulating and inhibiting lipolysis in a defined 
medium on oocyte nuclear maturation and developmental competence 
during IVM 
ii. To determine the effects of upregulating and inhibiting lipolysis in a 
carbohydrate deficient medium on oocyte nuclear maturation and 
developmental competence during IVM 
iii. To determine the effects of upregulating lipolysis during IVF on fertilisation 
and embryo development 
iv. To determine the effects of upregulating lipolysis during IVF on embryo 
survival following vitrification 
v. To determine the effects of upregulating lipolysis in defined single and 
sequential media systems on embryo development during IVC 
vi. To determine the effects of upregulating lipolysis in a carbohydrate-
deficient media on embryo development during IVC 
vii. To determine the effects of upregulation of lipolysis in a defined media 
system on embryo survival following vitrification 
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CHAPTER 2. MATERIALS AND METHODS 
 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (St 
Louis, MO, USA). 
 
2.1. In vitro maturation 
 
Ovaries from prepubertal gilts were collected immediately after slaughter at a local 
abattoir (Wollondilly Abattoir Pty Ltd, Picton NSW) and transported to the 
laboratory at 34-38oC in 0.9% NaCl (Baxter, Deerfield, IL) supplemented with an 
antibiotic/antimycotic solution (100 IU penicillin G, 0.25µg/ml streptomycin 
sulphate and 0.85% amphotericin B; Gibco) within 1 h. Cumulus oocyte 
complexes (COCs) were aspirated from follicles 3-6mm in diameter through a 21-
gauge needle under constant suction (1L/min). Cellular debris and COCs were 
allowed to sediment, then aspirated and spread over the bottom of a 10cm Petri 
dish (Falcon; Becton-Dickinson, NJ, USA). Under a stereomicroscope, oocytes 
were collected by mouth pipette attached to a modified glass Pasteur pipette. 
Collected cumulus-oocyte complexes (COCs) were washed twice in HEPES-
buffered porcine X medium (PMX; 108mM NaCl, 10mM KCl, 0.35mM KH2PO4, 
0.40mM MgSO4, 5mM NaHCO3, 25mM Hepes, 0.2mM Na-pyruvate, 2mM Ca-
(lactate)2, 3.00 mg/ml PVA; Yoshioka et al. 2008). Oocytes with an evenly 
granulated cytoplasm and at least three layers of compact cumulus cells were 
selected and washed in pre-equilibrated porcine oocyte media (POM; Yoshioka et 
al. 2008), supplemented with 3mg/ml fatty acid-free bovine serum albumin (BSA; 
IVP grade gamma irradiated, MP Biomedicals, Auckland, New Zealand), and 
10ng/ml epidermal growth factor (EGF), 10 IU/ml equine chorionic gonadotropin 
(eCG) and 10 IU/ml human chorionic gonadotropin (hCG). Washed COCs were 
transferred to 4-well dishes (Nunc) containing 500µl maturation media covered 
with mineral oil, and cultured at 38.5oC in a humidified atmosphere of 6% CO2 in 
air. 
 
2.2. In vitro fertilisation 
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After 44 h maturation, oocytes were partially denuded by gentle pipetting in PMX 
after brief exposure (<1 min) to 0.5mg/ml hyaluronidase. Oocytes were washed 
and transferred into Nunc wells containing 500µl TALP-PVA media (Bavister 
1989), under 250µl mineral oil pre-equilibrated in 6% CO2 in air at 38.5
oC. 
Meanwhile, frozen spermatozoa were thawed by agitating in a water bath at 42oC 
for 20 s. Spermatozoa were then processed through a 45%:90% PureSperm 
(Nidacon) gradient at 720 x g for 10 min using TALP medium (114mM NaCl, 
3.16mM KCl, 5mM glucose, 0.5mM MgCL2, 0.35mM NaH2PO4, 25mM NaHCO3, 
4.72mM CaCl2, 1mg/ml PVA, 0.002mg/ml phenol red, 0.0075mg/ml penicillin-G, 
0.0125mg/ml streptomycin sulfate) supplemented with 0.05% BSA (spermTALP). 
Following this, the pellet was gently aspirated, and made up to 1ml in volume with 
spermTALP medium and centrifuged at 310 x g for 5 min. The supernatant was 
removed and the pellet was gently resuspended in 400µl medium. Motility and 
concentration were assessed. Spermatozoa were added to fertilisation wells at a 
concentration of 200 motile sperm/oocyte. Gametes were co-incubated for 30 min 
at 38.5oC in 6% CO2 in air, after which oocytes and bound spermatozoa were 
placed into fresh, pre-equilibrated TALP-PVA medium for a further 5 h, for a total 
5.5 h co-incubation (Grupen and Nottle 2000; Gil et al. 2004). 
 
2.3. In vitro culture 
 
Presumptive zygotes were denuded of remaining cumulus cells and loosely bound 
spermatozoa, then placed in 50µl droplets (maximum 15 zygotes/droplet) of 
porcine zygote medium-3 (PZM-3; Yoshioka et al. 2002) and cultured at 38.5oC in 
6% CO2, 5% O2 in nitrogen. Media dishes were equilibrated for a minimum of 3 h 
prior to use. On Day 4, cleavage was assessed, with embryos expected to be at 
the morula stage, although those at earlier stages were still counted as cleaved. 
Uncleaved embryos were removed from culture, and 10% foetal calf serum (FCS; 
heat inactivated, qualified, Australian origin, Gibco) was added to each droplet. 
Addition of serum to culture medium during late cleavage stages has been shown 
to improve blastocyst development and hatching (Pollard et al. 1995; Dobrinsky et 
al. 1996; Koo et al. 1997). While standard PZM-3 does not include the addition of 
FCS, in these experiments FCS was added to culture medium to promote 
optimum blastocyst development to ensure blastocyst numbers were sufficient to 
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see experimental treatment effects. The blastocyst development rate, determined 
as a percentage of cleaved embryos, and embryo cell number were assessed on 
Day 7. 
 
2.4. Determination of blastocyst cell number 
 
Blastocysts were removed from culture, washed in PMX medium supplemented 
with 1mg/ml PVA and transferred into 0.3mg/ml Hoechst 33342 in ethanol. After 
staining for 30 min, blastocysts were transferred into absolute ethanol and fixed 
overnight in the dark at 4oC. Embryos were slide mounted and assessed using 
fluorescent microscopy (Olympus BX61; Olympus, Tokyo, Japan) with excitation 
by UV light (350nm) and emission measured at 460-490nm. An image of each 
blastocyst was captured and cell numbers were determined using ImageJ 
software (v. 1.46r, National Institutes of Health, USA). 
 
2.5. ATP assay 
 
The total ATP content of oocytes was measured using a commercial assay kit 
(FL-ASC; Sigma). Briefly, oocytes were completely denuded of cumulus cells, and 
washed three times in PBS supplemented with 3mg/ml PVP. Oocytes were 
transferred in groups of ten into Eppendorf tubes containing 50µL ice-cold PBS 
and stored at -80oC until analysis. For analysis, sample tubes were thawed on ice 
protected from light. Ice-cold somatic cell reagent (100µl) was added to each tube, 
briefly centrifuged, and incubated on ice for 5 min. Next, ice-cold assay mix 
solution (diluted 1:25 with ATP assay mix dilution buffer; 100µl) was added, and 
each tube was briefly centrifuged and incubated on ice for 5 min. For experiments 
in chapter 3, the ATP content was measured using a TD-20/20 single-tube 
luminometer (Turner Biosystems; California, USA) with high sensitivity 
(0.01pM/tube). For experiments in chapter 4, the ATP content was measured in a 
flat bottom 96-well plate (Greiner Bio-One, Frickenhausen, Germany) using a 
microplate reader with luminescence optics (POLARstar Optima; BMG Labtech, 
Ortenburg, Germany). A seven-point standard curve (0-60pM/tube) was included 
in each assay to allow calculation of ATP content of samples. 
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2.6. Embryo vitrification and thawing 
 
Day 7 grade 1 blastocysts (Gardner et al. 2000a) were vitrified according to the 
methods of Vajta et al. (1998). All manipulations were conducted at room 
temperature. Briefly, in groups of up to 10, blastocysts were washed in holding 
medium (HEPES-buffered Medium 199 supplemented with 20% FCS) for 5 min. 
Blastocysts were then transferred into equilibration medium (holding medium 
supplemented with 7.5% ethylene glycol and 7.5% DMSO) and held for 3 min 
before being moved into vitrification medium (holding medium supplemented with 
17% ethylene glycol, 17% DMSO, 0.4M sucrose) for 30 s. Embryos were then 
loaded into a super-fine open-pulled straw (SOPS; Minitube, Tiefenbach, 
Germany) within 30 s and immediately plunged into liquid nitrogen. To thaw, the 
open end of the SOPS was placed directly into thaw medium 1 (holding medium 
supplemented with 0.14M sucrose), and blastocysts were held in this solution for 
6 min before a 5 min hold in each of thaw medium 2 (holding medium 
supplemented with 0.075M sucrose) and holding medium. Blastocysts were then 
washed in culture medium (PZM-3 supplemented with 20% FCS), and transferred 
into 50µl culture droplets under mineral oil pre-equilibrated at 38.5oC in 6% CO2, 
5% O2 and balanced nitrogen. Survival was assessed after 24 h of post-thaw 
culture, with surviving blastocysts classified as those in which the blastocoel had 
re-expanded. 
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CHAPTER 3. INVOLVEMENT OF LIPID 
METABOLISM DURING IN VITRO MATURATION OF 
PORCINE OOCYTES 
 
3.1. Abstract 
 
Porcine oocytes contain a large amount of endogenous lipid, which is thought to 
function as an intracellular source of energy. This study was conducted to 
determine the effects of upregulating or inhibiting lipid metabolism using L-
carnitine or etomoxir, respectively, on the maturational competence of porcine 
oocytes cultured in the presence or absence of carbohydrates. When matured in 
POM, the addition of 0-12mM L-carnitine had no effect on nuclear maturation 
rates (P>0.05). Removal of glucose from maturation medium increased the 
proportion of oocytes arresting at MI after 44 h maturation (P<0.05). The addition 
of 12mM L-carnitine to medium had no effect on nuclear maturation, cleavage or 
blastocyst development with either 1.5 or 4mM glucose. Cleavage was reduced in 
oocytes matured without glucose regardless of L-carnitine supplementation 
(P<0.05).  In the absence of pyruvate and lactate and with 1.5mM glucose, 
supplementation of media with 12mM L-carnitine significantly increased nuclear 
development to MII (P<0.05). Exclusion of pyruvate and lactate in maturation 
medium resulted in decreased oocyte ATP content at 44 h. When matured with 
1.5mM glucose, 10µM etomoxir was required to significantly inhibit nuclear 
maturation (P<0.05) compared to maturation in 4mM glucose, where development 
to MII was only reduced with the addition of 250µM etomoxir (P<0.05). These 
results show that carbohydrate substrates are necessary for oocyte maturation, 
and that stimulating lipid metabolism can compensate to some extent for 
insufficient exogenous carbohydrates. 
 
3.2. Introduction 
 
In vitro maturation (IVM) is a key process in the in vitro production of embryos. It 
allows for the recovery and use of immature oocytes, increasing the available pool 
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of mature oocytes for research and commercial applications. Oocytes matured in 
vitro have reduced developmental capacity compared to in vivo matured oocytes 
(Krisher 2013), and resulting embryos are of poorer quality with altered 
metabolism (Swain et al. 2002). Optimal in vitro medium conditions are required to 
ensure adequate metabolic support and attainment of optimal oocyte quality. 
 
The majority of research into the provision of exogenous energy substrates during 
IVM has focussed on carbohydrate utilisation. Consequently, media formulations 
are predominantly based on carbohydrate requirements. In porcine oocytes, both 
glucose and pyruvate have been shown to be essential for the resumption of 
meiosis and acquisition of developmental competence (Tubman et al. 2005; 
Funahashi et al. 2008; Tsuzuki et al. 2008; Wu et al. 2011). Only recently has 
attention focussed on lipid metabolism. Porcine oocytes contain large stores of 
endogenous lipids compared with those of other domestic livestock species 
(McEvoy et al. 2000). However, the contribution to energy generation and the 
reason for such high amounts of intracellular lipids is still poorly understood. It is 
unknown whether endogenous lipid substrates can be utilised in place of 
exogenous carbohydrates by porcine oocytes. 
 
Lipid substrates can be used for ATP production via β-oxidation, and there is 
strong evidence supporting a metabolic role for endogenous triglyceride reserves 
during oocyte maturation. The triglyceride fraction in porcine oocytes decreases 
during the course of IVM (Romek et al. 2011b) with a concomitant increase in 
oxygen consumption (Sturmey and Leese 2003). Cattle oocytes have been shown 
to be capable of resuming meiosis and reaching MII without exogenous 
carbohydrates present in media (Ferguson and Leese 1999), suggesting reliance 
on endogenous substrates for ATP production. Inhibition of the β-oxidation 
pathway in mouse and cattle oocytes has been shown to negatively impact upon 
maturation and subsequent developmental outcomes (Ferguson and Leese 2006; 
Dunning et al. 2010a), while stimulation of fatty acid oxidation has led to increased 
rates of nuclear maturation in mouse oocytes (Dunning et al. 2010a). In pigs, the 
addition of lipolytic stimulants has had a variable response in regards to nuclear 
maturation and embryo development (Somfai et al. 2011; Wu et al. 2011; You et 
al. 2012) and translocation of lipid droplets and mitochondria (Sun et al. 2001; 
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Kikuchi et al. 2002a; Sturmey et al. 2006; Krisher et al. 2007). Comparisons 
between studies are difficult due to variations in carbohydrate composition of the 
base culture media used, which may have masked the impact of energy 
generation by lipid metabolism. 
 
The aims of this study were to examine the role that lipid metabolism plays in 
energy generation during porcine oocyte maturation and subsequent blastocyst 
development, and determine the influence of carbohydrates on this role. L-
carnitine, a co-factor required for the entry of fatty acids into the mitochondrial 
matrix for metabolic breakdown through the β-oxidation pathway, and etomoxir, 
an inhibitor of the carnitine shuttle at CPT1, were used to upregulate or block fatty 
acid oxidation respectively, to examine its role during in vitro maturation. 
 
3.3. Materials and methods 
 
3.3.1. Assessment of cumulus expansion 
 
Oocytes were matured in vitro as described in section 2.1, with IVM medium 
altered as per experimental design. After 22 h of maturation, a digital image was 
taken of each oocyte (Nikon Digital Sight DS-L2; Nikon, Tokyo, Japan) and used 
to assess cumulus expansion. Individual oocytes were scored on a subjective 
scale of 0 to 4 based on expansion of the cumulus mass. The mean score (0.0 to 
4.0) for each group per replicate was calculated to give the cumulus expansion 
index (Vanderhyden et al. 1990). 
 
3.3.2. Evaluation of oocyte nuclear status 
 
To assess nuclear maturation, oocytes were denuded of cumulus cells and fixed 
in acetic acid:ethanol (1:3) for a minimum of 24 h at room temperature. Following 
fixation, oocytes were slide mounted and stained with 1% (w/v) orcein in acetic 
acid for 1 h, destained with glycerol:acetic acid:water (1:1:3) and examined using 
phase-contrast microscopy at 400x magnification. Oocytes were classified as 
being at either the germinal vesicle (GV), metaphase-I (MI; including diakenesis 
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stage) or metaphase-II (MII; including the anaphase-I and telophase-I stages) 
stage based on descriptions from Motlik and Fulka (1976). 
 
3.3.3. Lipid staining 
 
Oocytes were completely denuded of cumulus cells then washed through 1, 2, 3 
and 4% solutions of paraformaldehyde (PFA) in PBS supplemented with 2mg/ml 
PVP (PBS-PVP). Oocytes were fixed overnight at 4oC in 4% PFA, protected from 
light. Fixed oocytes were washed three times for 15 min each in PBS-PVP, and 
then stained with Nile Red (10µg/ml in 0.9% NaCl supplemented with 1mg/ml 
PVP) for 1 h in the dark at room temperature. Following staining, oocytes were 
washed twice in PBS-PVP and twice in antifade solution (SlowFade Component 
B; Invitrogen). Oocytes were mounted between paraffin lines on glass slides 
under coverslips with minimum pressure in antifade solution supplemented with 
10µg/ml Hoechst for nuclear staining. Coverslips were sealed with nail varnish, 
and slides were stored in the dark and assessed within 6 h. 
 
Slides were examined under a laser-scanning confocal microscope (Nikon D-
Eclipse C1; Nikon, Tokyo, Japan) equipped with an argon-krypton and helium-
neon ion laser using a 543nm excitation filter. An image was taken at the 
equatorial plane of each oocyte using identical gain and offset settings for each 
sample. Images were analysed for relative lipid content and distribution of lipid 
droplets as described by Chankitisakul et al. (2013). Lipid content was analysed 
using ImageJ (v.1.46r, National Institutes of Health, USA). Original files were 
converted into 8-bit greyscale images. Relative lipid content of oocytes was 
determined by the mean intensity of Nile Red-positive pixels in total area of the 
equatorial section. 
 
Lipid droplet distribution was assessed after 22 and 44 h IVM, with the stage of 
nuclear maturation recorded (as confirmed by nuclear staining). Oocytes were 
classed as having one of three lipid droplet distributions: ‘peripheral’, where lipid 
droplets were localised in the peripheral region of the oocyte (Figure 3.1a); ‘semi-
peripheral’, characterised by lipid droplets found predominantly in the periphery of 
the oocyte with a low abundance of lipid droplets in the centre of the oocyte 
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(Figure 3.1b); and ‘diffuse’, with lipid droplets dispersed evenly throughout the 
cytoplasm (Figure 3.1c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Patterns of lipid droplet distribution in IVM porcine oocytes stained 
with Nile red. Lipid droplets showed peripheral (a), semi-peripheral (b), or diffuse 
(c) patterns of distribution. Images were taken at the equatorial section of each 
oocyte using laser scanning confocal microscopy. 
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3.3.4. Experimental design 
 
Experiments 1, 2, 3, 5 and 6 were conducted at the Faculty of Veterinary Science, 
The University of Sydney. Experiment 4 was conducted at the National Agriculture 
and Food Research Organisation Institute of Livestock and Grassland Science, 
Animal Breeding and Reproduction Research Division, Tsukuba, Japan. 
 
Experiment 1: L-carnitine dose response in complete medium 
Oocytes were matured in complete POM (4mM glucose, 0.2mM pyruvate, 2mM 
lactate) and treated with 0, 1.5, 3, 6 or 12mM L-carnitine. Oocytes were fixed and 
assessed for stage of nuclear maturation at 40, 44 and 48 h maturation. Three 
replicate experiments were performed with 10 to 16 oocytes assessed per 
treatment group at each time within each replicate. 
 
Experiment 2a: Effect of L-carnitine and glucose in the presence of pyruvate and 
lactate on nuclear maturation and cumulus expansion 
Oocytes were matured in POM (0.2mM pyruvate, 2mM lactate) with 0, 1.5 or 4mM 
glucose, and treated with 0 or 12mM L-carnitine. Cumulus expansion was 
assessed after 22 h of maturation. Oocytes were fixed and assessed for stage of 
nuclear maturation after 22 and 44 h maturation. Three replicate experiments 
were performed with 13 to 20 oocytes assessed per treatment group at each time 
within each replicate. 
 
Experiment 2b: Effect of L-carnitine and glucose in the presence of pyruvate and 
lactate on developmental competence 
Oocytes were matured in POM (0.2mM pyruvate, 2mM lactate) with 1.5 or 4mM 
glucose, and treated with 0 or 12mM L-carnitine. IVF was performed after 44 h 
maturation. Cleavage was assessed on Day 4 of IVC, and blastocyst development 
and cell number were assessed on Day 7. Four replicate experiments were 
performed with 30 to 40 oocytes inseminated per treatment group within each 
replicate. 
 
Experiment 3: Effect of L-carnitine and glucose in the absence of pyruvate and 
lactate on nuclear maturation and cumulus expansion 
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Oocytes were matured in modified POM (0mM pyruvate, 0mM lactate) with 0, 1.5 
or 4mM glucose, and treated with 0 or 12mM L-carnitine. Cumulus expansion was 
assessed after 22 h of maturation. Oocytes were fixed and assessed for stage of 
nuclear maturation after 22 and 44 h maturation. Three replicate experiments 
were performed with 10 to 18 oocytes assessed per treatment group at each time 
within each replicate. 
 
Experiment 4: Effect of L-carnitine and glucose in the absence of pyruvate and 
lactate on ATP content, lipid droplet distribution and fluorescence intensity of Nile 
Red staining 
This experiment was conducted at the National Agriculture and Food Research 
Organisation Institute of Livestock and Grassland Science, Animal Breeding and 
Reproduction Research Division, Tsukuba, Japan. Ovaries from pre-pubertal gilts 
were collected from a local slaughterhouse and transported to the laboratory 
within 1 h in dPBS (Nissui Pharmaceutical Co. Ltd, Tokyo, Japan). Cumulus 
oocyte complexes were collected by slicing open follicles 3-6mm in diameter with 
a scalpel blade. The aspirated fluid was collected into a tube and cellular debris 
and COCs were allowed to sediment for ten minutes. The sediment was then 
aspirated into a 35mm Falcon dish and COCs were isolated and washed in PMX 
medium. Oocytes were matured in Nunc wells with 50 oocytes per well, in 
modified POM that contained 1.5mM glucose, with or without pyruvate and 
lactate, and treated with 0 or 12mM L-carnitine. Oocytes were assessed for ATP 
content, lipid droplet distribution and fluorescence intensity prior to IVM (0 h), and 
after 22 and 44 h maturation. For ATP measurements, six replicate experiments 
were performed with 10 oocytes pooled at each time point for analysis. For lipid 
staining, four replicate experiments were performed, with 5 to 10 oocytes 
assessed per treatment group at each time within each replicate. 
 
Experiment 5: Etomoxir dose response in complete medium 
Oocytes were matured in complete POM (4mM glucose, 0.2mM pyruvate, 2mM 
lactate) supplemented with 0, 62, 125 or 250µM etomoxir. Oocytes were fixed and 
assessed for stage of nuclear maturation at 22 and 44 h maturation. Three 
replicate experiments were performed with 12 to 18 oocytes assessed per 
treatment group at each time within each replicate. 
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Experiment 6: Interaction between etomoxir and glucose in the absence of 
pyruvate and lactate 
Oocytes were matured in modified POM without pyruvate and lactate, with 1.5 or 
4mM glucose and 0, 10 or 250µM etomoxir. Oocytes were fixed and assessed for 
stage of nuclear maturation at 22 and 44 h maturation. Three replicate 
experiments were performed, with 10 to 20 oocytes assessed per treatment group 
at each time within each replicate. 
 
3.3.5. Statistical analysis 
 
All analyses were conducted using GenStat (v.16, VSN International Ltd). Nuclear 
maturation, cleavage, blastocyst development and embryo cell number data were 
analysed by one-way analysis of variance (A  VA). Fisher’s protected LS  post-
hoc test was used when significant differences between treatments were 
detected. Fluorescence intensity and ATP assay data were log transformed and 
analysed via a restricted maximum likelihood (REML) model. Lipid distribution 
data were log transformed and analysed by general linear mixed model (GLMM). 
For all analyses, P<0.05 was considered significant. 
 
3.4. Results 
 
Experiment 1: L-carnitine dose response in complete medium 
There was no effect of L-carnitine dose on nuclear maturation at 40, 44 or 48 h 
maturation (P>0.05, Table 3.1). 
 
Experiment 2a: Effect of L-carnitine and glucose in the presence of pyruvate and 
lactate on nuclear maturation and cumulus expansion 
Cumulus expansion was reduced in groups matured without glucose (1.11-1.22) 
compared with groups matured in the presence of 1.5 or 4mM glucose (2.63-2.74; 
P<0.05, Figure 3.2a). L-carnitine supplementation did not affect cumulus 
expansion (P>0.05). After 22 h maturation, oocytes matured without glucose had 
the highest proportions of oocytes remaining at GV (69.11-82.40%) compared 
with oocytes matured in the presence of 1.5 or 4mM glucose (12.86-22.34%; 
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P<0.05, data not shown). After 44 h maturation, a higher proportion of oocytes 
matured without glucose remained at the MI stage (32.26-37.17%) compared with 
those matured in the presence of 1.5 or 4mM glucose (3.63-11.96%; P<0.05, 
Figure 3.3a). Oocytes matured with 4mM glucose without L-carnitine, and those 
matured with 1.5 or 4mM glucose in the presence of L-carnitine, had higher rates 
of development to MII compared to those matured without glucose (P<0.05). 
Supplementation of 12mM L-carnitine had no effect on nuclear maturation 
(P>0.05).  
 
Experiment 2b: Effect of L-carnitine and glucose in the presence of pyruvate and 
lactate on developmental competence 
Following IVF, oocytes matured without glucose had reduced cleavage rates 
(63.75-68.13%) compared with oocytes matured with no L-carnitine and either 
1.5mM or 4mM glucose (81.73-83.27%; P<0.05, Figure 3.3b). Further, in groups 
treated with 12mM L-carnitine, the cleavage rate was reduced in oocytes matured 
with no glucose (63.75%) compared with those matured with 1.5mM glucose 
(80.65%; P<0.05). There was no effect of IVM treatment on blastocyst 
development rate (P>0.05, Figure 3.3b). There was no significant difference in 
embryo cell number between treatments (P>0.05), although there was a strong 
trend for a decreased cell number in embryos derived from oocytes matured with 
4mM glucose and 12mM L-carnitine (25.45 average cell number) compared with 
those matured with 0mM L-carnitine and 1.5 or 4mM glucose (46.75-58.15 
average cell number, P=0.06). 
 
Experiment 3: Effect of L-carnitine and glucose in the absence of pyruvate and 
lactate on nuclear maturation and cumulus expansion 
There was no effect of treatment on cumulus expansion (1.23-1.46; P>0.05, 
Figure 3.2b). After 22 h maturation, GV and MI rates were similar among 
treatments (P>0.05). MII rates did not differ for all levels of glucose when there 
was no L-carnitine present (2.22-8.28%; P>0.05). When supplemented with 12mM 
L-carnitine, MII rates were greater in the 4mM glucose group compared to the 
0mM glucose group (15.85% vs 0%; P<0.05). After 44 h maturation, the rate of 
maturation to MII was greater in oocytes matured with 4mM glucose (41.03%) 
than in those matured in 0mM (10.83%) and 1.5mM (9.58%) glucose when L-
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carnitine was not added (P<0.05, Figure 3.4). The addition of 12mM L-carnitine 
increased the MII rate of oocytes matured in 1.5mM glucose (35.88% v 9.58%; 
P<0.05, Figure 3.4), but had no effect on oocytes matured in 0mM or 4mM 
glucose (P>0.05). 
 
Experiment 4: Effect of L-carnitine and glucose in the absence of pyruvate and 
lactate on ATP content, lipid droplet distribution and fluorescence intensity of Nile 
Red staining 
There was no effect of treatment, stage of nuclear maturation, or time on oocyte 
fluorescence intensity (P>0.05). There was no effect of L-carnitine treatment on 
the distribution of lipids within oocytes (P>0.05). The relative frequency of 
peripheral distribution increased at 44 h compared with 22 h (15.46% vs 3.55% 
respectively; P<0.05), with no detectable changes in the relative frequency of 
disperse or semi-peripheral distribution over the two times (P>0.05). Further, MII 
stage oocytes tended to have a higher occurrence of peripheral distribution of lipid 
droplets compared to GV or MI stage oocytes (P=0.07). Maturation in medium 
with pyruvate and lactate decreased the relative frequency of peripheral lipid 
distribution in MII oocytes after 44 h IVM (3.10-4.59% vs 12.74-16.65%; P<0.05, 
Figure 3.5).  
 
In oocytes matured in medium with pyruvate and lactate and treated with 12mM L-
carnitine, the ATP content was greater at 44 h than at 0 and 22 h (P<0.05, Figure 
3.6). The ATP content did not change significantly over the 44 h maturation 
interval for the other groups. At 44 h IVM, regardless of L-carnitine 
supplementation, oocytes matured with pyruvate and lactate had a higher ATP 
content (2.01-2.42pM ATP/oocyte) compared with oocytes matured without 
pyruvate and lactate (1.46-1.66pM ATP/oocyte; P<0.05, Figure 3.6). 
 
Experiment 5: Etomoxir dose response in complete medium 
All doses of etomoxir increased the proportion of oocytes remaining at GV after 22 
h of maturation (33.33-50.37%) compared with oocytes matured without etomoxir 
(17.02%; P<0.05, Figure 3.7a). Progression to MI was lower with 250µM etomoxir 
(34.80%) than with 0 or 62µM etomoxir (59.74 and 58.97% respectively; P<0.05).  
After 44 h of maturation, a greater proportion of oocytes remained at MI in oocytes 
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matured with etomoxir (32.77-50.11%) compared with those matured without 
etomoxir (10.46%; P<0.05, Figure 3.7b). 
 
Experiment 6: Interaction between etomoxir and glucose in the absence of 
pyruvate and lactate 
After 22 h maturation, the proportion of oocytes reaching MI was lowest when 
medium contained 250µM etomoxir and either 1.5mM or 4mM glucose (12.11 and 
12.17% respectively), compared with groups matured with no etomoxir and 
1.5mM or 4mM glucose (34.85% and 47.98% respectively; P<0.05), or 10µM 
etomoxir with 4mM glucose (41.28%; P<0.05, Figure 3.8a). A decreased 
proportion of oocytes reached MII stage after 44 h of maturation when matured 
with 1.5mM glucose and 10 or 250µM etomoxir (2.38% and 17.73% respectively) 
or 4mM glucose and 250µM glucose (9.95%) compared with other treatments 
(P<0.05, Figure 3.8b). 
 
 
 
Table 3.1. Nuclear maturation after 40, 44 and 48 h IVM supplemented with 0, 
1.5, 3, 6 or 12mM L-carnitine. Mean ± SEM maturation to MII after 40, 44 and 48 h 
IVM. Oocytes were matured in complete POM (4mM glucose, 0.2mM pyruvate, 
2mM lactate), and supplemented with either 0, 1.5, 3, 6 or 12mM L-carnitine. 
 
 
 
 
 
  
40 h 44 h 48 h
0 100 ± 0.0 90 ± 6.3 88 ± 7.9
1.5 96 ± 2.2 93 ± 0.3 87 ± 10.2
3 87 ± 5.0 92 ±  4.3 94 ± 5.6
6 96 ± 4.2 90 ± 5.1 91 ± 4.3
12 96 ± 2.2 85 ± 5.3 95 ± 2.3
L-carnitine (mM)
% MII oocytes
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Figure 3.2. Mean ± SEM cumulus expansion index (CEI) after 22 h IVM. 
Individual oocytes were scored on a subjective scale of 0 to 4 based on expansion 
of the cumulus mass, and the mean score (0.0 to 4.0) for each group per replicate 
was calculated to give the CEI. Oocytes were matured in medium formulated with 
(a) or without (b) 0.2mM pyruvate and 2mM lactate, and supplemented with 0, 1.5 
or 4mM glucose and 0 or 12mM L-carnitine. Groups within each graph 
represented by bars without a common letter differ significantly (P<0.05). 
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Figure 3.3. Nuclear maturation, cleavage rates and blastocyst development after 
IVM with pyruvate and lactate, supplemented with 0, 1.5 or 4mM glucose and 0 or 
12mM L-carnitine. Mean ± SEM rate of nuclear maturation after 44 h IVM (a), and 
cleavage and blastocyst development rates following IVF (b). Oocytes were 
matured in POM with 0.2mM pyruvate and 2mM lactate, supplemented with 0, 1.5 
or 4mM glucose and 0 or 12mM L-carnitine. Cleavage data is presented as a 
percentage of total oocytes inseminated; blastocyst development is presented as 
a percentage of cleaved embryos. Within GV, MI and MII (a) and cleavage rates 
and blastocyst development (b), groups represented by bars without a common 
letter differ significantly (P<0.05). Groups without letters have no significant 
differences (P>0.05). 
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Figure 3.4. Nuclear maturation after 44 h IVM without pyruvate and lactate, 
supplemented with 0, 1.5 or 4mM glucose and 0 or 12mM L-carnitine. Mean ± 
SEM rate of nuclear maturation after 44 h IVM. Oocytes were matured in POM 
without pyruvate and lactate, supplemented with 0, 1.5 or 4mM glucose and 0 or 
12mM L-carnitine. Within GV, MI and MII, groups represented by bars without a 
common letter differ significantly (P<0.05). 
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Figure 3.5. Mean frequency of lipid droplet distribution type in MII oocytes after 44 
h IVM with 1.5mM glucose, with or without pyruvate and lactate, and treated with 
0 or 12mM L-carnitine. Oocytes were matured in modified POM (1.5mM glucose), 
with (+PL) or without (-PL) 0.2mM pyruvate and 2mM lactate, and treated with 0 
or 12mM L-carnitine. Lipid droplets within oocytes were classified as being 
‘peripheral’ (P), where lipid droplets were localised in the peripheral region of the 
oocyte; ‘semi-peripheral’ (SP), characterised by lipid droplets found predominantly 
in the periphery of the oocyte with a low abundance of lipid droplets in the centre 
of the oocyte; or ‘diffuse’ (D), with lipid droplets dispersed evenly throughout the 
cytoplasm. Within P, SP and D, groups without a common letter differ significantly 
(P<0.05). 
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Figure 3.6. ATP concentration in oocytes after 0, 22 and 44 h IVM with 1.5mM 
glucose, with or without pyruvate and lactate, and treated with 0 or 12mM L-
carnitine. Mean ± SEM pM ATP/oocyte at 0, 22 and 44 h IVM. Oocytes were 
matured in modified POM (1.5mM glucose), with (+PL) or without (-PL) 0.2mM 
pyruvate and 2mM lactate, and treated with 0 (-LC) or 12mM (+LC) L-carnitine for 
the duration of maturation. Significant differences (P<0.05) between times within 
treatments are denoted with the letters a and b. Significant differences (P<0.05) 
between treatments within times are denoted with the letters c and d. 
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Figure 3.7. Nuclear maturation after 22 and 44 h IVM supplemented with 0, 62, 
125 or 250µM etomoxir. Mean ± SEM rate of nuclear maturation after 22 h (a) and 
44 h (b) IVM. Oocytes were matured in complete POM (4mM glucose, 0.2mM 
pyruvate, 2mM lactate), supplemented with 0, 62, 125 or 250µM etomoxir. Within 
GV, MI and MII, groups represented by bars without a common letter differ 
significantly (P<0.05).  
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Figure 3.8. Nuclear maturation after 22 and 44 h IVM without pyruvate and 
lactate, supplemented with 1.5 or 4mM glucose and 0, 10 or 250µM etomoxir. 
Mean ± SEM rate of nuclear maturation after 22 h (a) and 44 h (b) IVM. Oocytes 
were matured in POM without pyruvate and lactate, supplemented with 1.5 or 
4mM glucose and 0, 10 or 250µM etomoxir. Within GV, MI and MII, groups 
represented by bars without a common letter differ significantly (P<0.05). 
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3.5. Discussion 
 
This study examined the role of lipid metabolism in energy generation during the 
in vitro maturation of porcine oocytes. Previous studies have suggested a 
metabolic role for cytoplasmic lipids (Sturmey and Leese 2003), but the 
contribution of lipids to ATP production in the presence and absence of 
carbohydrate substrates has not been examined. The results show that fatty acid 
oxidation can compensate for insufficient levels of carbohydrate substrates to 
some degree, although carbohydrate substrates are required for optimal nuclear 
maturation. 
 
In complete POM containing 4mM glucose, 0.2mM pyruvate and 2mM lactate, 
upregulation of lipid metabolism with L-carnitine, at concentrations varying from 
1.5-12mM, showed no effect on the progression of nuclear maturation. This 
contrasts with the findings of prior studies (Somfai et al. 2011; Wu et al. 2011) that 
reported positive effects of L-carnitine on nuclear progression at doses of 3.72-
31.02mM and 3.10mM respectively. These two studies utilised NCSU-37 medium, 
which is formulated without pyruvate and lactate, and with the sole carbohydrate 
substrate being 5.55mM glucose. A further study (You et al. 2012) showed no 
effect of 10mM L-carnitine on nuclear progression using TCM-199 medium, which 
contains 0.91mM pyruvate and 5.55mM glucose. Supporting these results, when 
pyruvate and lactate were removed from POM, and glucose was supplied at a low 
(1.5mM) concentration, the addition of 12mM L-carnitine improved meiotic 
progression to MII. Therefore, in IVM medium that does not contain pyruvate and 
lactate, such as NCSU-37, treatment with L-carnitine exerts a beneficial effect. 
 
Previous studies on oocyte metabolism and substrate utilisation have shown that 
both pyruvate and glucose are essential for the resumption of meiosis and 
acquisition of developmental competence (Krisher and Bavister 1998; Downs and 
Utecht 1999; Cetica et al. 2002; Herrick et al. 2006; Wang et al. 2012). The roles 
played by these substrates are not limited to energy production. Activity of the 
pentose phosphate pathway (PPP) increases throughout IVM in porcine oocytes 
(Cetica et al. 2002), and provides intermediaries of other metabolic pathways. In 
cattle oocytes, increasing glucose consumption with constant lactate production 
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suggests that glycolysis may not be the primary metabolic fate of glucose during 
maturation (Sutton et al. 2003b). In porcine COCs, there was no increase in 
glucose consumption observed after treatment with an inhibitor of lipid metabolism 
(Paczkowski et al. 2013), further supporting that glucose is not metabolised via 
glycolysis for ATP production at this time. It is likely that there is a higher 
utilisation of these substrates through the PPP, with a similar ATP content in 
porcine oocytes regardless of the presence or absence of glucose (Tsuzuki et al. 
2008). Further, mouse oocytes exposed to dehydroepiandrosterone (DHEA), an 
inhibitor of the PPP, had reduced lipid content, citrate levels, and glucose-6-
phosphate dehydrogenase activity compared with untreated control oocytes 
(Jimenez et al. 2013), indicating that metabolism via the TCA cycle is altered in 
mouse oocytes in which the PPP is inhibited. Given the effect of L-carnitine was 
only evident in the absence of glucose or pyruvate, this suggests that in vitro 
matured porcine oocytes require these carbohydrate substrates for the acquisition 
of developmental competence, despite the partial compensatory contribution of 
lipid substrates to ATP production. However, while the level of ATP in the cell 
gives an indication of the available energy, this measurement alone is limited in 
that it does not indicate the energy requirement of the cell. Measurement of ATP 
with reciprocal ADP levels provides a measure of energy demand of the cell, and 
indicates cell viability. Potentially, low energy demand led to unchanged levels of 
ATP, and future studies should also examine the ATP:ADP ratio. 
 
In POM with 1.5mM glucose and without pyruvate and lactate, 10µM etomoxir 
inhibited nuclear maturation. This is consistent with the results of an earlier study, 
in which an inhibitory dose of 10µM etomoxir was observed when using media 
containing 5mM glucose and 0.01mM pyruvate (Paczkowski et al. 2013). When 
oocytes were matured in complete POM with 4mM glucose, 0.2mM pyruvate and 
2mM lactate, inhibition of lipid metabolism had a minimal effect on nuclear 
progression. Etomoxir doses of 100µM and 250µM resulted in inhibition of nuclear 
maturation in cattle and mouse oocytes respectively (Paczkowski et al. 2013). The 
minimum effective inhibitory doses correlate negatively with the amount of lipid 
within the ooplasm in these species (Loewenstein and Cohen 1964; McEvoy et al. 
2000), suggesting the level of reliance on lipid metabolism differs between 
species. Further, glucose consumption was increased in both mouse and cattle 
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COCs, while there was no change in glucose uptake by porcine COCs, in 
response to the etomoxir treatments (Paczkowski et al. 2013). In that study, 
however, glucose consumption was only measured in the final 18 h of maturation 
in porcine oocytes. Progression to MI after 22 h IVM with 10µM etomoxir 
treatment was 1.6 times higher in groups matured with 4mM glucose compared to 
1.5mM glucose, although this was not significantly different. This suggests that 
glucose utilisation may be greater during the initial 24 h of IVM. Further, treatment 
with 10µM etomoxir in POM without pyruvate and lactate had a lesser effect in the 
presence of 4mM glucose compared to 1.5mM glucose. This implies that 
carbohydrate substrates are required for resumption of meiosis, and that there is a 
heavier reliance on lipid metabolism when these substrates are deficient.  
 
Cumulus expansion was observed to be reduced in COCs matured without 
pyruvate or lactate, regardless of glucose supplementation. When pyruvate and 
lactate were included in the maturation medium, cumulus expansion was reduced 
only in groups matured without glucose. Cumulus cells metabolise glucose via the 
hexosamine biosynthesis pathway to produce hyaluronic acid that supports 
cumulus expansion (Sutton-McDowall et al. 2010), accounting for the poor 
cumulus expansion seen in oocytes matured in the absence of glucose. Although 
there are conflicting results regarding the correlation between morphology and 
expansion of the cumulus mass with nuclear and cytoplasmic maturation (Ali and 
Sirard 2002; Qian et al. 2003; Luciano et al. 2004; Somfai et al. 2004; Alvarez et 
al. 2009), cumulus cells are known to be responsible for providing the oocyte with 
nutrients and other regulatory signals to promote maturation (Sutton-McDowall et 
al. 2010). Oocytes have a limited ability to utilise glucose, with cumulus cells 
metabolising the majority of glucose to supply metabolic intermediaries to the 
oocyte (Biggers et al. 1967). Owing to the metabolic substrates and pathways 
utilised by cumulus cells, lipids appear to be unable to compensate for 
carbohydrate deficiencies to support cumulus cell health, even when lipid 
metabolism is upregulated. Appropriate metabolic support for the cumulus cell 
mass should also be considered in medium formulations due to their vital 
relationship with the oocyte.  
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In POM with 1.5mM glucose containing 0.2mM pyruvate and 2mM lactate, 
inclusion of L-carnitine promoted a significant increase in oocyte ATP content over 
the IVM period. During IVM of mouse oocytes, the addition of L-carnitine to media 
increased the β-oxidation rate (Dunning et al. 2010a). Bovine oocytes 
morphologically graded as ‘good’ had significantly higher levels of ATP and 
developed into blastocysts at higher rates with greater cell numbers than 
morphologically poor oocytes (Stojkovic et al. 2001). In humans, oocytes with 
≥2pM ATP displayed higher rates of embryonic development and implantation 
(Van Blerkom et al. 1995). Although not seen in this study, previous reports have 
shown that the lipid content of porcine oocytes decreases throughout maturation 
(Fu et al. 2011; Romek et al. 2011b; Somfai et al. 2011). Lipids are an energy 
dense substrate, producing several times the ATP that is generated from the 
complete oxidation of glucose. In the present study, it is possible that only small 
amounts of lipid were utilised to increase the ATP content of oocytes, with the 
decrease in lipid content being outside the range of detection in this study. 
 
After 44 h IVM, oocytes matured with pyruvate and lactate had a higher ATP 
content than those matured without pyruvate and lactate, despite both groups of 
oocytes having similar ATP levels after 22 h of IVM. Generation of ATP plays an 
important role in determining oocyte quality and subsequent blastocyst 
development. Despite similar levels of ATP after 22 h of IVM, there were two- to 
three-fold higher rates of oocytes remaining at GV when they were matured 
without pyruvate and lactate, supporting the proposal that pyruvate is required for 
the resumption of meiosis (Gonzales-Figueroa and Gonzales-Molfino 2005; 
Funahashi et al. 2008). There was no effect of L-carnitine treatment during IVM on 
oocyte ATP content. Gene transcripts relating to lipid metabolism were 
dysregulated in in vitro matured mouse COCs and the rate of fatty acid oxidation 
was reduced by 2.8-fold compared to in vivo matured COCs (Dunning et al 2014). 
Further, inhibition of lipid metabolism in porcine oocytes decreased the relative 
abundance of gene transcripts involved in fatty acid oxidation, glycolysis and 
oxidative stress (Paczkowski et al. 2013). This suggests that lipid metabolism is 
compromised in IVM oocytes, and perturbation of this pathway has negative 
effects on other metabolic functions within the oocyte. Oocytes matured in vitro 
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may be unable to utilise lipids effectively to compensate for deficiencies in energy 
generation caused by insufficient provision of carbohydrate substrates. 
 
In this study, maturation in medium with pyruvate and lactate decreased the 
proportion of oocytes with peripheral distribution of lipid droplets. This distribution 
type was also more commonly found at 44 h than at 22 h. These results are 
consistent with those of prior studies, where oocytes matured in NCSU-23 
(5.55mM glucose, 0mM pyruvate and 0mM lactate) had more lipid droplets 
located in peripheral areas with low abundance in central areas after 44 h IVM 
(Somfai et al. 2011). Maturation in TCM-199 (5.55mM glucose, 0.91mM pyruvate, 
0mM lactate) also showed a similar pattern at 44 h (Sturmey et al. 2006). 
Supplementation of maturation medium with 12mM L-carnitine had no effect on 
lipid droplet distribution in this study. In contrast, the addition of L-carnitine 
increased the proportion of oocytes with lipid droplets located within the central 
region in porcine oocytes matured in NCSU-23 (Somfai et al. 2011) and cattle 
oocytes matured in TCM-199 (Chankitisakul et al. 2013). Oocytes with a central 
distribution of lipid droplets at the end of maturation, rather than dispersed 
throughout the cytoplasm, had a higher blastocyst development rate following IVF 
(Hiraga et al. 2013). Analysis using fluorescence resonance energy transfer 
suggests a molecular association between lipid droplets and mitochondria 
(Sturmey et al. 2006). In porcine oocytes, active mitochondria translocate from 
peripheral to central regions of the oocytes during meiotic progression (Sun et al. 
2001; Krisher et al. 2007), indicating that centrally distributed lipid droplets may be 
more closely associated with mitochondria. Inhibition of the PPP inhibited 
migration of mitochondria in cattle oocytes (Gutnisky et al. 2013), while in porcine 
oocytes glucose metabolism through the PPP has been shown to be a stimulus 
for meiotic resumption and progression of nuclear maturation (Tubman et al. 
2005; Funahashi et al. 2008). With the low glucose concentration (1.5mM) used in 
this study, PPP rate may have been reduced, resulting in improper maturation and 
leading to altered mitochondrial and lipid droplet translocation. Further studies 
should examine the effect of glucose and pyruvate concentrations on lipid droplet 
and mitochondrial distribution and activity. 
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This study has demonstrated that the carbohydrate composition of media alters 
the effect of L-carnitine treatment, which stimulates lipid metabolism, on oocyte 
maturation. The differential effects of L-carnitine supplementation observed in the 
various experimental groups of the present study, in which glucose, pyruvate and 
lactate levels were manipulated in POM, explains the inconsistent findings of 
previous studies reporting either a positive or negligible effect of L-carnitine on 
porcine oocyte maturation. When L-carnitine was added to media containing 
standard levels of pyruvate, lactate and glucose, there was no effect on nuclear 
maturation or subsequent embryo development. However, L-carnitine 
supplementation in media without pyruvate and lactate and a low glucose 
concentration improved nuclear maturation and led to a greater increase in oocyte 
ATP content over the course of IVM. In the absence of glucose, there was no 
effect of L-carnitine treatment, regardless of the presence or absence of pyruvate 
and lactate. Inhibiting lipid metabolism had a greater detrimental effect on nuclear 
maturation in the absence of pyruvate and lactate when glucose was supplied at a 
low concentration. Together, these findings suggest that endogenous lipid 
substrates can to some extent compensate for carbohydrate deficiencies, and the 
effect of upregulating lipid metabolism varies with the presence or absence of 
carbohydrate substrates. Prior studies have identified glucose and pyruvate as 
required media components for porcine oocytes (Funahashi et al. 2008), and this 
conclusion is supported by this study. These results suggest optimal IVM media 
composition should contain a minimum 4mM glucose and 0.2mM pyruvate, as 
supplied in POM, to meet metabolic requirements to support oocyte maturation. 
Treatment with L-carnitine appears to only be effective in media with carbohydrate 
concentrations lower than these levels. Understanding the roles that lipid and 
carbohydrate substrates play in energy generation during porcine oocyte 
maturation will allow for continuing refinements to culture media formulations that 
better support oocyte metabolic requirements in vitro. 
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CHAPTER 4. THE EFFECT OF L-CARNITINE 
IMMEDIATELY PRIOR TO AND DURING IN VITRO 
FERTILISATION ON PORCINE EMBRYO 
DEVELOPMENT AND CRYOSURVIVAL 
 
4.1. Abstract 
 
The ability of oocytes to generate sufficient ATP is a critical factor to ensure 
proper fertilisation and embryo development, as decreased ATP content at 
fertilisation is detrimental to developmental competency. This study utilised L-
carnitine, a co-factor of β-oxidation, to examine the role of lipid metabolism 
immediately prior to and during fertilisation. In vitro matured oocytes were 
fertilised in IVF medium (TALP) supplemented with 3, 6, 12 or 24mM L-carnitine 
for the duration of co-culture with spermatozoa. The proportion of oocytes 
fertilised was higher in the control group compared with the 6-24mM groups 
(P<0.05). Cleavage was similar amongst groups (P>0.05), while blastocyst 
development was reduced with 6-24mM L-carnitine. Subsequently, 3mM L-
carnitine was included for either 1 h incubation of oocytes prior to co-culture; 
during the first 30 min of gamete co-culture; during the subsequent 5 h co-culture; 
for the entire co-culture period; included in the medium used for spermatozoa 
preparation; or not added for the duration of IVF (control). All groups had similar 
rates of fertilisation (P>0.05). The cleavage rate was increased in the group 
incubated in medium supplemented with L-carnitine for 1 h prior to insemination 
(P<0.05) compared with the other oocyte treatment groups, while blastocyst 
development rate and cell number were similar amongst groups (P>0.05). Finally, 
ATP content and post-thaw survival following vitrification were compared between 
groups incubated with or without 3mM L-carnitine for 1 h prior to insemination. 
The ATP content of oocytes was similar among groups following the 1 h 
incubation (P>0.05), and this was similar to the ATP content seen prior to 
incubation (P>0.05). Post-thaw survival was increased in embryos derived from 
oocytes incubated in L-carnitine (P<0.05). In conclusion, incubation of oocytes in 
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fertilisation medium supplemented with 3mM L-carnitine for 1 h prior to 
insemination increased cleavage rates, but not blastocyst development, and 
improved cryosurvival following vitrification. Further studies are required to 
determine if this is due to increased lipid metabolism within oocytes, or attributable 
to the antioxidant properties of L-carnitine. 
 
4.2. Introduction 
 
At the time of fertilisation, there is an increased adenosine triphosphate (ATP) 
requirement to support calcium oscillations and calcium homeostasis (Dumollard 
et al. 2004). In aged oocytes, noted for having poor developmental outcomes, 
deficient ATP content at fertilisation is believed to lead to altered calcium 
oscillation patterns and homeostasis (Igarashi et al. 2005). Sufficient ATP is also 
required to support cellular events triggered by fertilisation, including 
polymerisation of microtubules, cell cycle regulation, segregation of chromosomes 
and membrane biosynthesis (Chappel 2013). ATP production and accumulation 
during oocyte maturation is likely to be an important factor for fertilisation. 
Dysfunctional or low numbers of mitochondria, resulting in lower ATP content of 
oocytes at fertilisation, has been shown to lead to a higher incidence of fertilisation 
failure (Van Blerkom et al. 1995; May-Panloup et al. 2005; Swain and Pool 2008; 
Chappel 2013). Cattle oocytes morphologically graded as being of higher quality 
had a higher ATP content following IVM and had increased blastocyst 
development following IVF (Stojkovic et al. 2001). Further, the ATP content of 
both mice and human oocytes has been positively correlated with embryo viability 
(Ginsberg and Hillman 1973; Quinn and Wales 1973; Van Blerkom et al. 1995). In 
mouse oocytes, ATP content peaks at the time of extrusion of the first polar body, 
with MII stage oocytes consuming greater amounts of ATP than those arrested at 
GV (Dalton et al. 2014). Further, in aged porcine oocytes, the electron density of 
lipid droplets decreased over time to 56 h IVM (Hao et al. 2009). This higher 
consumption of ATP by MII stage oocytes, coupled with decreasing lipid stores, 
suggests that oocytes may be utilising lipid substrates during MII arrest prior to 
fertilisation.  
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In toad eggs, fertilisation triggers a decrease in triglycerides, hypothesised to be 
due to metabolic breakdown of lipid substrates for ATP production to meet 
increased energy requirements (Alonso et al. 1986). Porcine oocytes contain large 
amounts of endogenous lipid (McEvoy et al. 2000), and although they differ 
physiologically from toad eggs, this lipid fraction may play a similar role. Also, 
following sperm penetration of porcine oocytes, electron density of lipid droplets 
decreases, implying a reduction of lipid content at this time (Kikuchi et al. 2002a). 
Given that lipids are a very efficient fuel source, it may be that the β-oxidation 
pathway is utilised during fertilisation.  
 
The impact of supplementing IVF medium with metabolic regulators is poorly 
understood. L-carnitine is a key co-factor involved in the carnitine shuttle, with this 
being the rate-limiting step in the entry of activated fatty acids to the mitochondrial 
matrix for metabolic breakdown, and is also known to have strong antioxidant 
properties. L-carnitine has also been shown to have an effect on in vitro sperm 
parameters. The addition of 1.76mM L-carnitine to testicular mouse spermatozoa 
increased motility and chromatin quality following 30-180 min incubations at room 
temperature (Aliabadi et al. 2012). Further, inclusion of 3.1mM L-carnitine led to 
higher human sperm motility after 2 h incubation at 37oC, although there was no 
effect on DNA oxidation or sperm viability (Banihani et al. 2012). The positive 
effects on sperm are believed to be due to the antioxidant activity of L-carnitine. 
Accumulation of reactive oxygen species (ROS) in spermatozoa causes ATP 
depletion, lipid peroxidation and axonemal phosphorylation (Dokmeci 2005), 
affecting sperm motility.  
 
Upregulation of the β-oxidation pathway by using L-carnitine during IVM has been 
shown to improve rates of nuclear maturation in mice (Dunning et al. 2010a), 
cattle (Ferguson and Leese 2006) and porcine oocytes (Somfai et al. 2011; Wu et 
al. 2011). Inclusion of L-carnitine in culture media decreased lipid content and 
increased cryosurvival in cattle embryos (Sutton-McDowall et al. 2012). It is 
believed that by stimulating lipid metabolism, greater amounts of lipid stores are 
used to generate ATP to support development while also improving cryotolerance 
due to decreased lipid content. Potentially, stimulating lipid metabolism during 
fertilisation may increase ATP levels to support requirements during fertilisation. 
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Any beneficial effect seen from inclusion of L-carnitine during IVF would need to 
be clarified as affecting spermatozoa or oocytes. 
 
The aim of this study was to determine if L-carnitine supplementation either during 
or immediately prior to fertilisation of IVM porcine oocytes enhances fertilisation 
and developmental outcomes. Further, this study examined the effect of L-
carnitine supplementation in IVF medium on embryo cryosurvival following 
vitrification. 
 
4.3. Materials and methods 
 
4.3.1. In vitro fertilisation 
 
Oocytes were matured in vitro as described in section 2.1. Mature oocytes were in 
vitro fertilised as described in section 2.2. For experiments with a pre-IVF 
incubation period, oocytes were held in treatment medium for 1 h, and then 
transferred to the fertilisation medium with or without L-carnitine (as per 
experimental design) immediately prior to insemination. 
 
4.3.2. Evaluation of fertilisation status 
 
To assess fertilisation, presumptive zygotes were fixed in acetic acid:ethanol (1:3) 
12 h after insemination for a minimum 3 d at room temperature. Following fixation, 
zygotes were slide mounted and stained with 1% (w/v) orcein in 45% acetic acid 
for 1 h, destained with glycerol:acetic acid:water (1:1:3) and examined using 
phase-contrast microscopy at 400x magnification. Zygotes were classified as 
unfertilised (meiotic spindle and one polar body present), polyspermic (multiple 
pronuclei and/or multiple decondensed sperm heads present), penetrated (one 
pronuclei and/or decondensed sperm head present), or fertilised (two pronuclei 
with two polar bodies present). 
 
4.3.3. Experimental design 
 
Experiment 1: L-carnitine dose-response during gamete co-incubation 
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TALP-PVA fertilisation medium was supplemented with 0, 3, 6, 12 or 24mM L-
carnitine for the entire 5.5 h duration of co-culture. Approximately 15 presumptive 
zygotes per treatment group were fixed 12 h after insemination, and stained to 
assess sperm penetration and pronuclear formation. The remaining zygotes were 
cultured and assessed for cleavage, blastocyst development and embryo cell 
number. Four replicate experiments were performed with 30 to 45 presumptive 
zygotes used per treatment group within each replicate. 
 
Experiment 2: Effect of L-carnitine during sperm pre-IVF treatment and gamete 
co-incubation 
IVF was conducted with the addition of 3mM L-carnitine for defined periods. This 
dose was selected based on the results of experiment 1. Oocytes were subjected 
to a 1 h incubation prior to insemination, and then co-incubated with spermatozoa, 
either with or without L-carnitine supplementation as defined in Table 4.1. 
Spermatozoa were prepared in two batches, in standard spermTALP or 
spermTALP supplemented with 3mM L-carnitine. Approximately 15 presumptive 
zygotes per treatment group were fixed 12 h after insemination, and stained to 
assess fertilisation. The remaining zygotes were cultured and assessed for 
cleavage, blastocyst development and embryo cell number. Four replicate 
experiments were performed with 30 to 45 presumptive zygotes used per 
treatment group within each replicate. 
 
Experiment 3: Effect of L-carnitine treatment on ATP content of oocytes and post-
thaw survival of resulting blastocysts 
Oocytes were fertilised in vitro after a 1 h incubation in TALP-PVA supplemented 
with 3mM L-carnitine followed by co-incubation in standard TALP, or without L-
carnitine supplementation for the entire duration. Oocytes were removed and 
assayed to determine ATP content after 44 h maturation, and again following the 
1 h incubation. The remaining oocytes were fertilised, cultured and assessed for 
cleavage and blastocyst development, with grade 1 blastocysts vitrified on Day 7. 
Survival was assessed 24 h after thawing. Four replicate experiments were 
performed with n=44 and n=37 embryos vitrified for the L-carnitine treated and 
untreated control groups respectively. 
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4.3.4. Statistical analysis 
 
All analyses were conducted using GenStat (v. 16, VSN International Ltd). ATP 
content, cleavage, blastocyst development and embryo cell number data were 
analysed by one-way analysis of variance (A  VA). Fisher’s protected LS  post-
hoc test was used when significant differences between treatments were 
detected. Survival data was analysed by Generalised Linear Mixed Model 
(GLMM). For all analyses, P<0.05 was considered significant. 
 
 
Table 4.1. Experiment 2 design. LC = supplementation of media with 3mM L-
carnitine; 0 = media used as standard. Sperm = sperm preparation in spermTALP 
media. All oocyte incubations and gamete co-incubations were conducted in 
TALP-PVA media. 
 
 
 
4.4. Results 
 
Experiment 1: L-carnitine dose-response during gamete co-incubation 
The proportion of fertilised oocytes was higher in the control group compared with 
the groups fertilised in medium supplemented with 6-24mM L-carnitine (41.43% vs 
0-25.00%; P<0.05). Cleavage rates were similar amongst treatments (P>0.05). 
Assessment of fertilisation by staining at 12 h post-insemination coincides with the 
time of pronuclear formation in normally fertilised oocytes. While 0% fertilisation 
was observed in certain treatment groups, this more correctly means that 0% of 
oocytes had formed pronuclei normally 12 h after IVF. Cleavage rates, as noted in 
Figure 4.1, suggests that delayed or abnormal fertilisation and pronuclear 
formation subsequently occurred in some of the oocytes cultured for 7 d. Further, 
Group Sperm 1h incubation 30m co-incubation 5h co-incubation
1 LC 0 0 0
2 0 LC 0 0
3 0 0 LC 0
4 0 0 0 0
5 0 LC LC LC
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a small proportion of oocytes may have undergone cytoplasmic fragmentation, 
which is difficult to distinguish from early embryonic cleavage without staining. 
Blastocyst development was reduced with the addition of 6-24mM L-carnitine 
relative to the control (P<0.05, Figure 4.1). Blastocyst cell numbers did not differ 
with treatment (36-72 cells/blastocyst; P>0.05).  
 
Based on these results, 3mM L-carnitine was selected for use in subsequent 
experiments, as higher doses had a detrimental effect on fertilisation and 
blastocyst development rates. 
  
Experiment 2: Effect of L-carnitine during sperm pre-IVF treatment and gamete 
co-incubation 
The period of L-carnitine supplementation during IVF had no effect on the 
fertilisation status of oocytes (10.36-30.36%; P>0.05). The cleavage rate of 
oocytes treated with a 1 h pre-IVF incubation in 3mM L-carnitine tended to be 
higher than those of oocytes in other treatment groups (P=0.10, Figure 4.2). 
Blastocyst development rates (7.40-21.00%, Figure 4.2) and average cell 
numbers (61-103 cells per blastocyst) were similar amongst groups (P>0.05).  
 
Experiment 3: Effect of L-carnitine treatment on ATP content of oocytes and post-
thaw survival of resulting blastocysts 
ATP content was similar between oocytes before incubation and after incubation 
(P>0.05, Figure 4.3). There was no difference in ATP content of oocytes 
incubated with or without L-carnitine (P>0.05, Figure 4.3). Post-thaw survival was 
increased in embryos derived from oocytes pre-incubated in medium with L-
carnitine prior to IVF (42%, n=44 embryos vitrified) compared to embryos derived 
from oocytes pre-incubated without L-carnitine (25%, n=37 embryos vitrified; 
P<0.05). 
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Figure 4.1. Mean ± SEM rates of cleavage and blastocyst development for 
porcine oocytes fertilised in vitro in TALP-PVA medium supplemented with 0, 3, 6, 
12 or 24mM L-carnitine for the duration of gamete co-culture. Cleavage data is 
presented as a percentage of total oocytes inseminated; blastocyst development 
is presented as a percentage of cleaved embryos. Within cleavage rate and 
blastocyst development, groups represented by bars without a common letter 
differ significantly (P<0.05). 
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Figure 4.2. Mean ± SEM cleavage rates and blastocyst development of porcine 
oocytes fertilised in vitro in TALP-PVA medium with L-carnitine supplementation 
either for 1 h prior to co-culture; the initial 30 min of gamete co-culture; for the 
duration of gamete co-culture; no L-carnitine supplementation; or L-carnitine 
supplementation of sperm preparation medium. Group 1 = 3mM L-carnitine 
supplementation of sperm preparation medium; Group 2 = 3mM L-carnitine 
supplementation of TALP-PVA for 1 h prior to insemination; Group 3 = 3mM L-
carnitine supplementation during the initial 30 min co-culture with spermatozoa; 
Group 4 = no L-carnitine supplementation; Group 5 = 3mM L-carnitine 
supplementation for the duration of co-culture. Cleavage data is presented as a 
percentage of total oocytes inseminated; blastocyst development is presented as 
a percentage of cleaved embryos. Within cleavage rate and blastocyst 
development, groups represented by bars without a common letter differ 
significantly (P=0.10). 
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Figure 4.3. ATP concentration in oocytes before and after a 1 h incubation in 
fertilisation medium supplemented with or without L-carnitine. Mean ± SEM pM 
ATP/oocyte before and after incubation in TALP-PVA medium supplemented with 
or without 3mM L-carnitine for 1 h. 
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4.5. Discussion 
 
This study examined the potential of L-carnitine treatments immediately prior to 
and during IVF to elevate ATP levels in porcine oocytes and thereby improve 
fertilisation outcomes. The capacity of oocytes and early stage embryos to 
generate ATP has been correlated with developmental competence and embryo 
development in cattle, mice and humans (Ginsberg and Hillman 1973; Quinn and 
Wales 1973; Van Blerkom et al. 1995; Stojkovic et al. 2001; Nagano et al. 2006). 
L-carnitine treatments during in vitro maturation have previously been found to 
increase ATP levels in mouse oocytes (Dunning et al. 2010a). However, the 
results of this study indicate that the relatively brief L-carnitine treatment did not 
alter ATP levels significantly or improve fertilisation. Rather, when included for the 
duration of gamete co-culture, supplementation of 6-24mM L-carnitine exerted 
detrimental effects on fertilisation. 
 
Incubation of oocytes in fertilisation medium supplemented with L-carnitine for 1 h 
prior to gamete co-incubation increased the post-thaw survival of vitrified Day 7 
blastocysts. Porcine oocytes and embryos have large amounts of intracellular lipid 
droplets (Youngs et al. 1994; McEvoy et al. 2000), which is known to be the 
reason for their poor cryotolerance (Dobrinsky and Johnson 1994; Nagashima et 
al 1995; Abe et al. 2002; Sudano et al. 2011). Prior studies have shown that 
inclusion of L-carnitine during bovine embryo culture decreased lipid content 
(Sutton-McDowall et al. 2012) and increased cryosurvival (Ruiz et al. 2013; 
Takahashi et al. 2013). The results of this study show that only a short exposure 
to L-carnitine significantly improved the cryotolerance of resulting blastocysts. 
Future studies are required to determine if a decrease in lipid content is the 
reason for the improved cryotolerence, and the optimum L-carnitine incubation 
time to maximise post-thaw survival. 
 
Embryo cleavage rates were increased following IVF of oocytes incubated with L-
carnitine for 1 h prior to the addition of spermatozoa. Mitochondrial ATP is 
essential for sustaining calcium oscillations triggered by fertilisation events, which 
then subsequently upregulate ATP production to satisfy energy demands 
(Dumollard et al. 2004; Campbell and Swann 2006). In humans, total carnitine 
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content of follicular fluid was not correlated to embryo developmental outcomes 
following IVF, although enzymes involved in β-oxidation were strongly expressed 
in mature oocytes and the expression of enzymes involved in carnitine synthesis 
was not detected (Montjean et al. 2012). Given this, the addition of exogenous L-
carnitine may aid in upregulating β-oxidation rates in the oocyte. Higher ATP 
content in mature oocytes has been correlated to greater developmental success 
(Van Blerkom et al. 1995; Stojkovic et al. 2001), with the majority of ATP derived 
from oxidative phosphorylation (Dumollard et al. 2004; Igarashi et al. 2005; Dalton 
et al. 2014). Acetyl- oA, produced via β-oxidation, is metabolised through the 
TCA cycle to produce NADH and FADH2, both of which are then fully metabolised 
via oxidative phosphorylation to produce ATP. However, in this study, there was 
no associated increase in ATP content of oocytes following incubation in medium 
supplemented with L-carnitine.  
 
Other studies have found no correlation between ATP content of oocytes and 
developmental competence (Combelles and Albertini 2003; Brevini et al. 2005). In 
some homozygous mouse strains, excessive ATP production and increased 
cytoplasmic lipid deposition is associated with early cleavage arrest (Ginsberg and 
Hillman 1975). It is possible that rather than a critical level of ATP being required 
to support fertilisation, the higher ATP content is indicative of a healthy, functional 
mitochondria population necessary for embryo development. Measurement of 
ATP:ADP ratio would be beneficial for future studies to indicate cellular energy 
demand and cell viability. Current media formulations do not contain co-factors to 
support β-oxidation. In humans, IVF patients with higher reproductive potential 
have decreased levels of total carnitine in serum and follicular fluid, suggesting 
upregulation of lipolytic pathways and depletion of carnitine stores in these 
patients (Varnagy et al. 2013). Expression of carnitine synthesis enzymes is low in 
human oocytes and early embryos, while β-oxidation enzymes are strongly 
expressed (Montjean et al. 2012), supporting a role for the supplementation of 
exogenous carnitine in embryo culture media. 
 
Alternatively, the beneficial effect of L-carnitine may be attributable to its strong 
antioxidant properties. Markers of oxidative stress in human follicular fluid have 
been correlated to fertilisation and pregnancy outcomes following IVF (Sabatini et 
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al. 1999; Oyawoye et al. 2003; Pasqualotto et al. 2004), with higher fertilisation 
success seen in oocytes recovered from follicular fluid with higher antioxidant 
levels (Oyawoye et al. 2003). Addition of L-carnitine to medium for the duration of 
porcine oocyte maturation decreased levels of intracellular ROS, hydrogen 
peroxides and lipid peroxides, reduced apoptosis, and increased GSH 
concentrations (Hashimoto et al. 2008; Somfai et al. 2011; Wu et al. 2011; You et 
al. 2012; Yazaki et al. 2013). Oxidative stress is proposed to be the catalyst for 
post-ovulatory aging (Lord and Aitken 2013), which is associated with reduced 
fertilisation rates and poor embryo quality. Certain compounds with antioxidative 
activity have been shown to delay signs of post-ovulatory aging (Kuo et al. 2000; 
Goud et al. 2008; Lord et al. 2013). The antioxidative properties of L-carnitine may 
have assisted in maintaining oocyte developmental competence prior to 
fertilisation. However, fertilisation rates were decreased following inclusion of 6-
24mM L-carnitine for the duration of gamete co-culture. High concentrations of 
antioxidants included in medium during bovine IVF decreased cleavage and 
blastocyst rates (Ali et al. 2003). Reactive oxygen species are required for 
fertilisation (Miesel et al. 1993; Fujii and Tsunoda 2011), playing a role in sperm 
function, sperm-oocyte interactions and sperm capacitation (de Lamirande et al. 
1998; de Lamirande and O'Flaherty 2008). This indicates that higher doses or 
longer exposure to L-carnitine may be detrimental during IVF due to its antioxidant 
properties suppressing the concentrations of vital ROS. Further research is 
required to determine the optimal concentration and incubation time to maximise 
the beneficial effects of L-carnitine at fertilisation. 
 
Although there was no beneficial effect on fertilisation, cleavage or blastocyst 
development rate when sperm preparation medium was supplemented with L-
carnitine, prior research suggests that this is an area for future research. 
Spermatozoa have a low antioxidant defence capacity and are particularly 
susceptible to oxidative damage due to a high lipid content of membranes (Saleh 
and Agarwal 2002). Incubation in L-carnitine has been shown to increase motility 
and chromatin quality of testicular mouse spermatozoa (Aliabadi et al. 2012), as 
well as motility in human spermatozoa (Banihani et al. 2012). However, given that 
cleavage rates were increased in oocytes incubated in L-carnitine prior to 
fertilisation with spermatozoa prepared without L-carnitine, there is clearly a 
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beneficial effect of L-carnitine on oocytes as well as spermatozoa, and the 
individual effects of L-carnitine on male and female gametes needs to be further 
clarified with future studies. 
 
In conclusion, incubation of oocytes in fertilisation medium supplemented with 
3mM L-carnitine for 1 h prior to co-culture with sperm increased oocyte 
developmental competency and post-thaw survival of blastocysts. Inclusion of L-
carnitine for any period of gamete co-culture had no effect on fertilisation rates or 
further development. Fertilising ability of spermatozoa was unaffected by L-
carnitine supplementation during preparation. These findings indicate that there is 
little benefit of L-carnitine supplementation immediately prior to or during IVF in 
terms of ATP levels. Therefore, it appears that the antioxidant properties of L-
carnitine are beneficial for the maintenance of oocyte viability, although not 
necessarily for sperm functionality, during the pre-insemination period. Detailed in 
vitro assessments are needed to determine the influence of the L-carnitine 
treatment on sperm parameters. 
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CHAPTER 5. L-CARNITINE SUPPLEMENTATION 
DURING IN VITRO CULTURE OF PORCINE 
EMBRYOS IMPROVES BLASTOCYST QUALITY 
AND CRYOSURVIVAL 
 
5.1. Abstract 
 
Although porcine oocytes and embryos contain large amounts of endogenous 
lipid, little is known regarding its metabolic role during development. The objective 
of this study was to investigate the role of lipid metabolism and the interaction 
between carbohydrate and lipid substrates in pre-implantation porcine embryos. 
Abattoir-derived porcine COCs were cultured and fertilised in vitro. Post-
fertilisation, embryos were transferred into PZM-3 medium supplemented with L-
carnitine, a co-factor in entry of fatty acids into mitochondrial matrix for metabolic 
breakdown via β-oxidation. In standard PZM-3 medium, 3mM L-carnitine improved 
cleavage rates (P<0.05); when supplemented in modified PZM-3 medium with no 
carbohydrate substrates, all doses from 1.5-12mM L-carnitine increased cleavage 
rates (P<0.05). Embryos cultured in standard PZM-3 medium had lower blastocyst 
cell numbers when compared to those cultured in sequential culture medium 
(P<0.05). The addition of 3mM L-carnitine for the first 3 d of culture in standard 
PZM-3 restored blastocyst cell numbers to the levels observed in the sequential 
medium. Post-thaw survival was increased when embryos were cultured in a 
single medium containing L-carnitine for 7 d, and a sequential media containing L-
carnitine for the first 3 d only, compared with the single medium, untreated control 
(P<0.05). In conclusion, a greater effect of L-carnitine was seen in the absence of 
carbohydrates, suggesting a preference for carbohydrate substrates for metabolic 
requirements in pre-implantation porcine embryos. Supplementation of L-carnitine 
for the first 3 d of embryo culture improved embryo quality and improved 
cryosurvival, suggesting that the treatment decreased intracellular lipid content via 
increased β-oxidation. 
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5.2. Introduction 
 
The in vitro production (IVP) of porcine embryos is an important technology for 
biomedical research purposes, as well as permitting the application of advanced 
reproductive technologies (ARTs), including vitrification and embryo transfer, to 
support commercial animal breeding programs. However, in vitro derived porcine 
embryos display low developmental rates and are generally of poorer quality 
compared with in vivo-derived embryos (Thompson 1997; Leese et al. 1998; 
Machaty et al. 2000; Yoshioka et al. 2002), limiting these applications. Major 
differences seen between in vitro and in vivo embryos include altered metabolic 
processes (Thompson 1997; Durkin et al. 2001) and changes in lipid droplet 
morphology, size and number (Plante and King 1994; Kikuchi et al. 2002a). These 
differences are likely to contribute to variations in developmental competence and 
quality. 
 
While common media preparations include exogenous carbohydrate substrates to 
support energy requirements, there is evidence that embryos are capable of 
utilising endogenous lipid reserves for ATP production. There is a decrease in 
fatty acid content (Romek et al. 2009; Romek et al. 2011a), with a corresponding 
increase in O2 consumption (Sturmey and Leese 2003) during development of 
porcine embryos to the blastocyst stage. Further, the addition of L-carnitine, a 
stimulant of lipid metabolism, to murine (Dunning et al. 2010a) and bovine 
(Sutton-McDowall et al. 2012) embryo culture media improved embryo 
development. Porcine embryos have a higher intracellular lipid content compared 
to those of other production animal species (McEvoy et al. 2000), with in vitro 
produced embryos having a greater lipid content than in vivo derived embryos 
(Kikuchi et al. 2002a). Furthermore, lipid content is correlated with poor 
cryosurvival (Abe et al. 2002) limiting the application of vitrification in porcine 
embryos. 
 
Embryos have changing nutrient preferences associated with different 
developmental stages. Many culture systems rely on single medium formulations, 
with energy substrates unchanged for the duration of culture. While glucose, 
pyruvate and lactate have been identified as key carbohydrate substrates 
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supporting embryo development (Leese 1995; Gardner et al. 1998), there is 
evidence that substrate preference changes with the stage of development. In 
porcine embryos, glucose inhibits development when included in culture medium 
during early cleavage stages, while glucose consumption increases at the 
blastocyst stage (Flood and Wiebold 1988; Sturmey and Leese 2003). Sequential 
medium systems have been developed to better meet the energy requirements of 
the embryo, with altered concentrations of carbohydrate substrates provided for 
different stages of development. Such systems have led to increased blastocyst 
yields and improved blastocyst quality by including pyruvate and lactate for the 
first 48 h following fertilisation, and glucose for the remainder of the culture period 
(Kikuchi et al. 2002b; Kim et al. 2004; Beebe et al. 2007). 
 
Previous studies in mouse and cattle embryos have suggested a role for lipid 
metabolism during in vitro embryo culture. In the absence of exogenous glucose, 
pyruvate, lactate or an extracellular protein source, the addition of 5mM L-
carnitine to culture medium increased zygote cleavage to the 2-cell stage in IVF 
mouse embryos (Dunning et al. 2010a). For cattle embryos, supplementing 
complete culture medium (containing 0.5mM glucose, 0.35mM pyruvate and 
10.5mM lactate) with 5mM L-carnitine improved development to the morula stage 
(Sutton-McDowall et al. 2012). Porcine embryos contain a larger complement of 
endogenous lipids compared with embryos of other domestic livestock species, 
making them an ideal model for lipid studies. Supplementation with 3.10mM L-
carnitine during culture of porcine parthenotes decreased ROS levels and reduced 
apoptosis in blastocysts (Wu et al. 2011). Given the changing needs of the 
developing embryo, it was hypothesised that embryos may preferentially utilise 
lipids for energy production at specific stages of development. 
 
The aim of this study was to examine the role of lipid metabolism during porcine 
embryo culture. The effect of temporal upregulation of lipid metabolism pathways 
through the addition of L-carnitine on developmental rates and cryosurvival was 
assessed. 
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5.3. Materials and methods 
 
5.3.1. In vitro culture 
 
Oocytes were in vitro matured and in vitro fertilised as described in sections 2.1 
and 2.2, respectively. Embryos were cultured in vitro as described in section 2.3, 
with modifications. Embryo cleavage was assessed on Day 3, and embryos were 
transferred to different medium formulations as per experimental design. 
Uncleaved embryos were removed from culture. Media dishes were equilibrated 
for a minimum of 3 h prior to use. On Day 4, 10% FCS was added to each culture 
droplet. 
 
5.3.2. Experimental design 
 
Experiment 1: L-carnitine dose-response in standard PZM-3 
Presumptive zygotes were cultured in standard PZM-3 (PZM-PL; 0mM glucose, 
0.2mM pyruvate, 2mM lactate) with 0, 1.5, 3, 6 or 12mM L-carnitine for 7 d to 
determine the optimal L-carnitine dose. Embryos were assessed for cleavage and 
blastocyst development rates, and blastocyst cell number. Four replicate 
experiments were performed with 35 to 45 presumptive zygotes used per 
treatment group within each replicate. 
 
Experiment 2: L-carnitine dose-response in carbohydrate deficient medium 
Presumptive zygotes were cultured in modified PZM-3 containing no glucose, 
lactose or pyruvate, and with either 0, 1.5, 3, 6, or 12mM L-carnitine, or in PZM-PL 
(control medium), for 7 d. Embryos were assessed for cleavage and blastocyst 
development rates. Three replicate experiments were performed with 30 to 50 
presumptive zygotes used per treatment group within each replicate. 
 
Experiment 3: Temporal effects of L-carnitine in culture 
Using PZM-PL as the base medium, presumptive zygotes were cultured for 7 d 
either with or without 3mM L-carnitine for the entire period; with or without 3mM L-
carnitine for the entire period with a change to fresh medium after 3 d; without L-
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carnitine for the first 3 d, with a change to fresh medium containing 3mM L-
carnitine; or with 3mM L-carnitine for the first 3 d, with a change to fresh medium 
without L-carnitine. Embryos were assessed for cleavage and blastocyst 
development rates, and blastocyst cell number. Three replicate experiments were 
performed with 30 to 45 presumptive zygotes used per treatment group within 
each replicate. 
 
Experiment 4: Effect of L-carnitine in a sequential media system 
PZM-3 was used as standard (PZM-PL) or modified (PZM-GLU; 5.55mM glucose, 
0mM pyruvate, 0mM lactate). The glucose concentration was chosen based on 
that used in NCSU-23 medium (Petters and Wells 1993), a commonly used 
porcine embryo culture medium, and the concentration used in sequential porcine 
embryo culture media (Kikuchi et al. 2002b; Kim et al. 2004; Beebe et al. 2007). 
Presumptive zygotes were cultured for 7 d in either PZM-PL with or without 3mM 
L-carnitine for the first 3 d, then in PZM-PL without L-carnitine; PZM-PL with or 
without 3mM L-carnitine for the first 3 d then in PZM-GLU without L-carnitine; or 
PZM-GLU with or without 3mM L-carnitine for the first 3 d then in PZM-GLU 
without L-carnitine. Embryos were assessed for cleavage and blastocyst 
development rates, and blastocyst cell number. Three replicate experiments were 
performed with 30 to 50 presumptive zygotes used per treatment group within 
each replicate. 
 
Experiment 5: Effect of L-carnitine on cryosurvival 
Embryos were cultured for 7 d in either PZM-PL with 3mM L-carnitine (no media 
change; n=29 vitrified); PZM-PL without L-carnitine (no media change; n=71 
vitrified); or PZM-PL with 3mM L-carnitine for the first 3 d, then in PZM-GLU 
without L-carnitine (n=77 vitrified). These treatments were selected to examine the 
effects of L-carnitine on cryosurvival in the standard single medium system (+ or – 
L-carnitine in PZM-PL with no media change) compared to the cryosurvival of 
embryos treated with L-carnitine at an optimal stage in a sequential media system 
(PZM-GLU with L-carnitine for days 0-3 only). Blastocysts were vitrified on Day 7 
and assessed for survival at 24 h post-thaw. Six replicate experiments were 
performed. 
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5.3.3. Statistical analysis 
 
All analyses were conducted using GenStat (v. 16, VSN International Ltd).  
Cleavage rate, blastocyst development and embryo cell number data were 
analysed by one-way analysis of variance (A  VA). Fisher’s protected LSD post-
hoc test was used when significant differences between treatments were 
detected. Post-thaw survival data was analysed by Generalised Linear Mixed 
Model (GLMM). For all analyses, P<0.05 was considered significant. 
 
5.4. Results 
 
Experiment 1: L-carnitine dose-response in standard PZM-3 
The addition of 3mM L-carnitine increased cleavage rates relative to the control 
group (81% vs 66% respectively; P<0.05, Figure 5.1). Blastocyst development 
rate was reduced with the addition of 6mM L-carnitine during culture (8% vs 25% 
control; P<0.05). There was no difference in the mean cell number per blastocyst 
between treatments (14-26 average cells per blastocyst; P>0.05). 
 
Experiment 2: L-carnitine dose-response in carbohydrate deficient media 
In the absence of carbohydrate substrates, all doses of L-carnitine improved 
cleavage rates (27-42%) relative to the control (3%; P<0.05, Figure 5.2). 
Cleavage rate was significantly higher for embryos cultured in standard PZM-3 
(78%). Blastocyst development was inhibited in the absence of carbohydrates 
regardless of L-carnitine supplementation, and was higher in the standard PZM-3 
group (10%; P<0.05, Figure 5.2).  
 
Experiment 3: Temporal effects of L-carnitine in culture 
There was no difference in cleavage or blastocyst development rates between 
treatments (P>0.05, Figure 5.3). Blastocyst cell numbers were similar among 
treatment groups, although there was a strong trend for higher cell numbers in 
blastocysts obtained from embryos cultured with 3mM L-carnitine for the first 3 d 
only compared with blastocysts exposed to L-carnitine for the duration of culture 
(P=0.06). 
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Experiment 4: Effect of L-carnitine in a sequential media system 
Cleavage rates were decreased in groups cultured in PZM-G for the first three 
days compared with those in PZM-PL, regardless of L-carnitine supplementation 
(44% vs 68-77% respectively; P<0.05, Figure 5.4). Culture in PZM-G for the entire 
period also reduced blastocyst development rate (0-3%), compared with groups 
cultured in PZM-PL for Day 0-3 (18-20%; P<0.05). There was no difference in 
cleavage or blastocyst development rates between groups cultured in PZM-PL for 
the first three days, regardless of L-carnitine supplementation or subsequent 
medium formulation. Embryos cultured in PZM-PL medium without L-carnitine for 
the entire culture period had a lower mean cell number per blastocyst compared 
with those cultured in PZM-PL with 3mM L-carnitine for the first three days only, or 
PZM-PL for the first three days either with or without L-carnitine followed by PZM-
G for the remainder of culture (P<0.05, Table 5.1). 
 
Experiment 5: Effect of L-carnitine on cryosurvival 
Embryos cultured in PZM-PL without L-carnitine for the duration of culture with a 
change to fresh medium on Day 3 had a lower post-thaw survival rate (31%) 
compared with those cultured in PZM-PL with 3mM L-carnitine for the duration of 
culture with a change to fresh medium on Day 3 (48%) and those cultured in PZM-
PL with 3mM L-carnitine for the first three days and PZM-G without L-carnitine for 
the remainder of the culture period (48%; P<0.05, Table 5.2). 
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Figure 5.1. Mean ± SEM cleavage and blastocyst development rates in porcine 
embryos cultured in standard PZM-3 with 0, 1.5, 3, 6 or 12mM L-carnitine for the 
duration of culture. Cleavage data is presented as a percentage of total oocytes 
inseminated; blastocyst development is presented as a percentage of cleaved 
embryos. Within cleavage rate and blastocyst development, groups represented 
by bars without a common letter differ significantly (P<0.05). 
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Figure 5.2. Cleavage rates and blastocyst development of embryos cultured 
without L-carnitine in complete media, or without glucose, pyruvate and lactate 
and supplemented with 0, 1.5, 3, 6 or 12mM L-carnitine for the duration of culture. 
Mean ± SEM cleavage and blastocyst development rates of porcine embryos 
cultured in standard PZM-3 without L-carnitine (+carbs) or in modified PZM-3 
(0mM glucose, 0mM pyruvate, 0mM lactate) with 0, 1.5, 3, 6 or 12mM L-carnitine 
for the duration of culture. Cleavage data is presented as a percentage of total 
oocytes inseminated; blastocyst development is presented as a percentage of 
cleaved embryos. Within cleavage rate and blastocyst development, groups 
represented by bars without a common letter differ significantly (P<0.05). 
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Figure 5.3. Cleavage rates and blastocyst development of embryos cultured with 
or without L-carnitine for specific periods of culture. Mean ± SEM cleavage and 
blastocyst development rates in porcine embryos cultured in PZM-3 with (+) or 
without (-) 3mM L-carnitine for Days 0-3 or Days 4-7, or Days 0-7 with a medium 
change at Day 3. Procedural controls, without a medium change, were included. 
Cleavage data is presented as a percentage of total oocytes inseminated; 
blastocyst development is presented as a percentage of cleaved embryos.   
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Figure 5.4. Mean ± SEM cleavage and blastocyst development rates in porcine 
embryos cultured in standard PZM-3 (PL; 0.2mM pyruvate, 2mM lactate, 0mM 
glucose) or modified PZM-3 (G; 0mM pyruvate, 0mM lactate, 5.55mM glucose), 
and with (+) or without (-) 3mM L-carnitine, for specific periods of culture. 
Cleavage data is presented as a percentage of total oocytes inseminated; 
blastocyst development is presented as a percentage of cleaved embryos. Within 
cleavage rate and blastocyst development, groups represented by bars without a 
common letter differ significantly (P<0.05). 
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Table 5.1. Cell number of Day 7 embryos cultured in single or sequential 
carbohydrate media with or without L-carnitine for specific periods of culture. 
Mean ± SEM cell number of Day 7 porcine embryos cultured in standard PZM-3 
(PL; 0.2mM pyruvate, 2mM lactate, 0mM glucose) or modified PZM-3 (G; 0mM 
pyruvate, 0mM lactate, 5.55mM glucose), with (+) or without (-) 3mM L-carnitine 
for specific periods of culture. Values without a common letter differ significantly 
(P<0.05). 
 
 
 
 
 
Table 5.2. Post-thaw re-expansion rates of embryos vitrified after culture in single 
or sequential carbohydrate media supplemented with or without L-carnitine for 
specific periods of culture. Embryo culture was in standard PZM-3 (PL; 0.2mM 
pyruvate, 2mM lactate, 0mM glucose) or modified PZM-3 (G; 0mM pyruvate, 0mM 
lactate, 5.55mM glucose), with (+) or without (-) 3mM L-carnitine for specific 
periods of culture. Values without a common letter differ significantly (P<0.05). 
 
 
 
Day 0-3 Day 4-7
PL- G- 20 40.25 ± 6.68a
PL+ G- 12 40.08 ± 6.46a
PL- PL- 20 24.00 ± 3.04b
PL+ PL- 12 43.42 ± 6.28a
Treatment
Embryos (n)
Cell number (mean 
± SEM)
Day 0-3 Day 4-7
PL- PL- 71 22 30.99 ± 3.85a
PL+ PL+ 29 14 48.28 ± 4.98b
PL+ G- 77 37 48.05 ± 4.47b
Treatment
% re-expanded
Embryos 
vitrified (n)
24h post-thaw 
re-expansion (n)
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5.5. Discussion 
 
These results demonstrate the importance of tailoring culture media to meet 
metabolic lipid requirements of pre-implantation embryos. Prior research has 
predominantly focussed on the use of carbohydrate substrates by embryos, 
resulting in the design of specific culture media formulations to support these 
needs.  
 
In the absence of carbohydrate substrates, L-carnitine supplementation increased 
cleavage rates, although not to the levels achieved when carbohydrate substrates 
were included in the medium. When pyruvate, lactate and glucose were excluded 
from the medium, all doses of L-carnitine (1.5-12mM) increased cleavage rates, 
although only to half the rates achieved in standard medium (0.2mM pyruvate, 
2mM lactate) without L-carnitine. Contrary to this, cattle embryos showed similar 
cleavage rates regardless of carbohydrate or L-carnitine supplementation (Sutton-
McDowall et al. 2012). Blastocyst rates were not improved with L-carnitine in the 
absence of carbohydrates, and were significantly higher in standard medium. 
Similarly, cattle blastocysts arrested in the early cleavage stages when cultured 
without carbohydrates (Ferguson and Leese 2006). However, the addition of 1mM 
L-carnitine to culture medium without carbohydrates supported cattle morula 
development to the same level as that achieved in complete carbohydrate 
medium (4.7-5.3%); moreover, the addition of 5mM L-carnitine to carbohydrate-
deficient medium promoted a higher rate of morula development (20.4%; Sutton-
McDowall et al. 2012). Blastocyst development was not reported in that study. 
Carbohydrate substrates in culture are not necessarily used for energy 
generation, with certain metabolic pathways utilising carbohydrate substrates to 
produce intermediaries necessary for other cellular functions. For example, 
NADPH is produced by the PPP for biosynthetic reactions and as a reducing 
agent to protect against toxic ROS accumulation. These alternate purposes may 
account for why porcine embryos did poorly in the absence of carbohydrates 
despite stimulation of lipid metabolism. Intermediaries of alternate pathways are 
also required for full metabolic breakdown of lipid products. Carbohydrates are 
needed to produce oxaloacetate, which is required to react with acetyl-CoA to 
prime the tricarboxylic acid (TCA) cycle. The addition of oxaloacetate to 
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carbohydrate-free IVM medium improved subsequent blastocyst development to 
levels similar to that of oocytes matured with glucose, and decreased the 
triglyceride content (Sturmey and Leese 2008). It is possible that in the absence of 
carbohydrates, the required intermediaries for complete oxidation of lipid 
substrates are also lacking, preventing lipid from being an effective energy 
substrate. Further, embryos from ruminant species exhibit a higher level of 
glycolytic activity than porcine embryos (Thompson et al. 1991; Rieger et al. 1992; 
Gardner et al. 1993; Swain et al. 2002), which may account for some of the 
differences seen between species. 
 
When cultured in standard medium, the addition of 3mM L-carnitine for the 
duration of culture improved cleavage rates relative to no L-carnitine 
supplementation. However, this result was not replicated across experiments. 
Morphological assessment of cleavage is not a highly accurate measure of true 
cleavage, which is accurately assessed by staining the nuclei. This was not 
possible in this instance as blastocyst data after 7 d culture was also collected. 
Further, oocyte quality varies weekly and is also subject to seasonal effects, with 
oocyte quality being significantly lower in summer months. Poorer oocyte quality 
during certain experiments may have contributed to a greater proportion of 
oocytes undergoing cytoplasmic fragmentation, which is difficult to 
morphologically distinguish from normal cleavage, potentially masking the effect of 
L-carnitine. There is evidence that embryos from rabbits (Khandoker and Tsujii 
1998), mice (Hillman and Flynn 1980) and cattle (Ferguson and Leese 1999,  
2006) are capable of metabolising fatty acids to produce energy during early 
cleavage stages. Further, inhibition of β-oxidation during porcine embryo culture 
blocked development at the zygote stage (Sturmey and Leese 2008), suggesting 
a requirement for lipid metabolism at cleavage. In contrast, there was no 
difference detected in the cleavage rates (82-87%) of porcine parthenotes when 
cultured in PZM-3 supplemented with 0 to 12mM L-carnitine (Wu et al. 2011). 
Differences in the expression levels of genes relating to metabolism have been 
shown between bovine IVF embryos and parthenotes, including differences in 
glucose transporter genes and genes involved in the PPP (Gomez et al. 2009). It 
is possible that there may be differences in lipid metabolism between porcine 
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embryos derived from IVF and parthenogenetic activation to explain the 
inconsistent findings. 
 
Culture in a sequential carbohydrate media system was beneficial to blastocyst 
quality, supporting results found in earlier studies (Kikuchi et al. 2002b; Beebe et 
al. 2007). In a single medium system, with embryos cultured in medium containing 
pyruvate and lactate only for the duration of culture, the inclusion of 3mM L-
carnitine for the first 3 d only increased cell number to the same extent as 
sequential carbohydrate media systems. This result suggests that L-carnitine can 
increase energy production leading to higher quality embryos in systems where 
carbohydrate substrates may not be optimum. However, it is unknown whether the 
benefits of L-carnitine supplementation are attributable to lipolytic or antioxidant 
effects. 
 
Carnitine is an important co-factor of the carnitine shuttle for entry of free fatty 
acids into the mitochondrial matrix. Lipids provide a dense energy source, and 
contribute to ATP production via metabolic breakdown through β-oxidation and 
oxidative phosphorylation. Supplementation of IVM medium with L-carnitine led to 
decreased lipid droplet density in porcine oocytes (Somfai et al. 2011), increased 
levels of β-oxidation in mice oocytes (Dunning et al. 2010a) and a tendency for 
higher ATP content in bovine oocytes (Chankitisakul et al. 2013). In vitro culture of 
bovine embryos with L-carnitine decreased lipid droplet density and increased 
ATP levels in 2-cell embryos (Takahashi et al. 2013). L-carnitine may also protect 
against oxidative stress, having been shown to alter the redox state of animal 
somatic cells via mitochondrial pathways (Pillich et al. 2005; Ye et al. 2010). 
Addition of L-carnitine to embryo culture medium improved development to the 
blastocyst stage and reduced ROS formation in mice (Abdelrazik et al. 2009) and 
cattle (Sutton-McDowall et al. 2012) embryos. Similarly, in porcine parthenotes, L-
carnitine supplementation to embryo culture medium reduced intracellular ROS 
and decreased the incidence of apoptosis in cells of the resulting embryos (Wu et 
al. 2011). It is still unclear if there is a dual effect of lipid metabolism and 
antioxidant protection, or if one effect is more dominant than the other. 
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In this study, culture in glucose alone for the entire period was detrimental to 
cleavage and blastocyst development. This is in contrast to prior studies 
conducted using NCSU-23 (Petters and Wells 1993), which is formulated with 
5.55mM glucose and no pyruvate or lactate for the entire culture period, that have 
successfully produced blastocysts (Abeydeera et al. 1998c) and piglets following 
transfer  (Rath et al. 1995; Abeydeera et al. 1998b). However, direct comparison 
of NCSU-23 and PZM-3 showed that the rate of development to the blastocyst 
stage, as well as blastocyst inner cell mass and total cell numbers, were all higher 
when cultured in PZM-3 media compared with NCSU-23 (Yoshioka et al. 2002). 
Porcine embryos are capable of utilising glucose alone for the duration of pre-
implantation culture (Swain et al. 2001), although there is limited glucose 
metabolism prior to compaction (Biggers et al. 1967; Flood and Wiebold 1988) 
with the majority of ATP produced during embryo development being via oxidative 
phosphorylation (Sturmey and Leese 2003). Complete oxidation of the products 
from lipid metabolism occurs via the electron transport chain, which is coupled 
with oxidative phosphorylation. Sequential media systems are designed to meet 
the changing nutrient requirements of embryos to more closely mimic in vivo 
conditions and produce better quality in vitro embryos. Given that the inclusion of 
L-carnitine for the first three days of culture only in standard PZM-3 increased 
blastocyst quality to the same extent as a sequential media system, it is likely that 
lipid metabolism contributes to early embryo development through increased ATP 
production. 
 
The inclusion of L-carnitine, either for the entirety of the culture period or for the 
first three days in a sequential media system, significantly improved the 
cryosurvival of porcine embryos. Lipid content has been correlated to 
cryosensitivity (Dobrinsky and Johnson 1994; Abe et al. 2002; Sudano et al. 
2011), with lipids causing an increase in oxidative and mechanical damage during 
ice formation (Isachenko et al. 1998). Stimulation of lipolysis in embryos has 
proven successful in reducing lipid content and increasing cryotolerance. The 
addition of 10µM forskolin to culture medium for 24 h on Day 5 of culture 
increased lipolytic activity and increased survival following vitrification of Day 6 
porcine embryos (71% vs 37% control; Men et al. 2006). L-carnitine 
supplementation also improved the cryotolerance of buffalo embryos (Boccia et al. 
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2013), but did not affect the post-thaw survival of bovine embryos (Miyashita et al. 
2012). In the present study, lipid content was not measured. Therefore, it is 
uncertain whether the L-carnitine treatment reduced the lipid content of the 
blastocyst cells or, via the antioxidant activity of L-carnitine, provided protection 
against ROS formed during the freeze-thaw process.  
 
Accumulation of ROS is accelerated when embryos are exposed to environmental 
stressors, such as extreme temperatures experienced during vitrification. 
Oxidative stress can lead to mitochondrial damage, ATP depletion, apoptosis and 
developmental blocks (Guerin et al. 2001; Gupta et al. 2009). Due to increased 
levels of intracellular lipids, porcine embryos are susceptible to lipid peroxidation, 
with delipidation of porcine embryos shown to reduce intracellular accumulation of 
H2O2 (Yoneda et al. 2004). The addition of L-carnitine to maturation medium 
reduced lipid droplet density in porcine oocytes (Somfai et al. 2011) but did not 
reduce the proportion of apoptotic cells in parthenogenetic porcine blastocysts 
when added to culture medium, although it did decrease intracellular ROS levels 
(Wu et al. 2011). Culture of bovine embryos with 1.52 or 3.03mM L-carnitine 
lowered lipid droplet density and improved survival following slow freezing 
(Takahashi et al. 2013). Given that there was no reported improvement in 
cryosurvival of bovine embryos following the addition of alternative antioxidants to 
culture medium (Hosseini et al. 2009; Rocha et al. 2012), the improved 
cryosurvival observed in the present study is likely attributable to decreased lipid 
content. 
 
In conclusion, the addition of L-carnitine, a co-factor of β-oxidation, to porcine 
embryo culture medium increased cleavage rates, improved blastocyst quality and 
increased the cryosurvival of Day 7 blastocysts. The beneficial effects of the L-
carnitine treatments were most likely due to an increased utilisation of 
endogenous lipid reserves for energy production. Importantly, in the complete 
absence of carbohydrate substrates, the ability of fertilised oocytes to undergo the 
initial cleavage divisions was vastly improved by supplementing the culture 
medium with L-carnitine. This finding suggests that lipid metabolism plays an 
important role in energy generation during porcine embryo development, 
particularly in the interval immediately following fertilisation. Therefore, 
113 
supplementing culture medium with lipolytic stimulators, such as L-carnitine, 
during the early stages of embryo development is an effective strategy to improve 
the quality of in vitro produced porcine embryos. 
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CHAPTER 6. GENERAL DISCUSSION AND 
CONCLUSIONS 
 
The application of ARTs in pigs for biomedical or agricultural purposes is currently 
limited by the inefficiency of in vitro embryo production and the quality of embryos 
produced and maintained in these systems. Typically, porcine blastocyst rates are 
lower than those seen in other domestic livestock species, and have a low post-
thaw survival rate which limits their long-term storage and global movement. Many 
of these issues are attributable to the altered metabolic processes seen during the 
in vitro culture of oocytes and embryos, compared with their in vivo counterparts. 
There is a wealth of research regarding carbohydrate metabolism and many in 
vitro media formulations reflect this greater understanding. While it is likely that 
the carbohydrate requirements of embryos are being met, other metabolic needs 
are potentially not being supported by these media. Oocytes and embryos of 
different species contain varying amounts of intracellular lipid substrates, known to 
be a dense source of energy, although the extent to which these cells rely on 
endogenous substrates for ATP production is poorly understood. Porcine oocytes 
and embryos have a much greater intracellular lipid fraction compared with those 
of other domestic livestock species, making them an excellent model for studying 
lipid metabolism during IVP. 
 
The findings reported in this thesis contribute to an overall understanding of the 
metabolic substrates utilised by porcine oocytes and embryos during IVM, IVF and 
IVC, and the impact of lipid metabolism during these times. The results provide 
evidence to support plasticity of oocyte and embryo metabolism, with these cells 
showing some level of adaptability to the substrates available that support growth. 
This study identified reasons for the conflicting findings of prior studies, with the 
carbohydrate composition of media impacting on the differing responses of 
oocytes to upregulation or inhibition of lipid metabolism, highlighting the 
importance of specific media additives to cell growth. Other results show that by 
upregulating lipid metabolism during IVF or IVC, the cryosurvival of Day 7 
embryos can be improved. Collectively, these results support the hypothesis that 
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oocytes and embryos utilise endogenous lipid substrates during in vitro maturation 
and in vitro culture respectively, although not to the extent that is thought to occur 
in vivo. 
 
Varied results from prior studies examining the upregulation and inhibition of lipid 
metabolism are likely attributable to differences in the carbohydrate composition of 
the medium used. Beneficial effects of L-carnitine on nuclear maturation were 
seen in prior studies using NCSU-23 and NCSU-37 (no pyruvate) as the IVM 
media (Somfai et al. 2011; Wu et al. 2011) but not when TCM-199 (0.91mM 
pyruvate) was used (You et al. 2012). Similarly, this study demonstrated that while 
there was a lesser effect of upregulating or inhibiting nuclear maturation in 
complete POM media, there was a greater impact of these treatments seen in 
media with insufficient carbohydrates. When maturation media provides proper 
carbohydrate support, lipid metabolism appears to play a minor role during oocyte 
maturation in vitro. In the absence of pyruvate and lactate, the nuclear maturation 
rate was halved, and when all carbohydrate substrates were removed it was 
reduced nine-fold. This highlights the importance of providing an optimum media 
formulation, and demonstrates the requirement for carbohydrates to support 
nuclear maturation. These results show that oocyte metabolism is adaptable, and 
different metabolic pathways can be utilised to compensate for deficiencies in 
energy substrates to a degree.  
 
There is evidence that in vitro matured oocytes lack the necessary gene 
transcripts and enzymes involved in lipid metabolism. In mouse COCs, in vitro 
maturation led to dysregulation of gene transcripts that are related to lipid 
metabolism and reduced the rate of fatty acid oxidation by 2.8-fold compared to in 
vivo maturation (Dunning et al. 2014). Expression of genes relating to long-chain 
fatty acid synthesis, conversion of acetoacetyl-CoA to acetyl-CoA, and regulation 
of cholesterol levels were upregulated in bovine blastocysts derived from IVM 
oocytes compared with in vivo matured oocytes (Gonzalez-Serrano et al. 2013). 
The fatty acid oxidation genes acyl-CoA synthetase long-chain family member 3 
(ACSL3) and long-chain acyl-CoA dehydrogenase (ACADL) were differentially 
expressed between IVM and in vivo matured oocytes; further, these genes were 
dysregulated in IVM oocytes of poor developmental competence (Yuan et al. 
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2011). Inhibition of lipid metabolism during IVM decreased the abundance of gene 
transcripts involved in fatty acid oxidation, glycolysis and oxidative stress in 
porcine oocytes (Paczkowski et al. 2013). Further, the morphology of lipid droplets 
was found to differ between in vitro- and in vivo-derived porcine embryos (Kikuchi 
et al. 2002a). This suggests that lipid metabolism is altered in oocytes and 
embryos cultured in vitro, and that in vitro matured oocytes are less able to 
effectively utilise lipids for ATP production. This could also explain why 
supplementation of maturation medium with L-carnitine had little effect on meiotic 
progression and ATP production. Further studies are required to understand these 
deficiencies and to determine whether expression of relevant genes and enzymes 
can be improved prior to or during in vitro maturation. 
 
There are dual effects of L-carnitine that can complicate the interpretation of 
results. Supplementation of culture medium with L-carnitine may be beneficial due 
to its antioxidant activity or its stimulatory effect on lipid metabolism. In vitro 
assays have shown L-carnitine to be an effective antioxidant, with greater 
reducing power, DPPH radical and superoxide anion radical scavenging, 
hydrogen peroxide scavenging and metal chelating activities than other commonly 
used antioxidant compounds (Gulcin 2006). L-carnitine is also an important co-
factor involved in the entry of free fatty acid into the mitochondrial matrix, the site 
of β-oxidation. However, living systems must be maintained in a balance between 
metabolic rate and ROS production, to ensure the redox system can continue to 
effectively neutralise harmful radicals. At high L-carnitine concentrations, lipid 
metabolism may be increased to an extent that results in excess accumulation of 
ROS, leading to increased oxidative stress and an overall detrimental effect on 
cells. Where possible, these results have been compared with prior studies 
utilising alternative antioxidants in similar circumstances to indicate if the effects of 
L-carnitine are more likely attributable to its antioxidant activity or its role in lipid 
metabolism. Future studies would benefit from quantification of ROS levels 
following L-carnitine treatment to determine the primary effect within an IVP 
system. 
 
Very few prior studies have examined the role of lipid substrates during 
insemination. This period is marked by an increased ATP requirement to support 
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gamete fusion, calcium oscillations, the block to polyspermy, protein synthesis, 
completion of meiosis, pronuclear formation and other post-fertilisation cellular 
events. In this study, incubation of oocytes in 3mM L-carnitine for an hour prior to 
insemination increased cleavage rates; at higher doses, cleavage and blastocyst 
development were both inhibited, possibly due to the antioxidant properties of L-
carnitine. Low levels of ROS are required at fertilisation for normal sperm function 
and capacitation, sperm-oocyte interactions, cell signalling, homeostasis and 
growth (Miesel et al. 1993; de Lamirande et al. 1998; de Lamirande and 
O'Flaherty 2008; Finkel 2011; Fujii and Tsunoda 2011). This is consistent with a 
prior finding that high concentrations of antioxidants in IVF media decrease 
cleavage and blastocyst rates in cattle embryos (Ali et al. 2003). Conversely, 
addition of L-carnitine during sperm preparation had a beneficial effect on 
subsequent embryo development. Previous reports have shown improved sperm 
motility with the addition of L-carnitine during centrifugation (Banihani et al. 2012), 
and improved motility and chromatin quality with supplementation of L-carnitine 
during room temperature incubation (Aliabadi et al. 2012). L-carnitine has a dual 
role in providing beneficial effects for spermatozoa. The antioxidant activity has a 
protective role for sperm membranes against ROS (Agarwal and Said 2004; 
Gulcin 2006), while also promoting lipid metabolism and thereby decreasing lipid 
peroxidation. 
 
Incubating mature oocytes in fertilisation media supplemented with L-carnitine for 
1 h prior to co-incubation with sperm increased cleavage rates of the resulting 
embryos. These results suggest that there is a limited use of lipid substrates 
during fertilisation, and that the beneficial effects of L-carnitine are likely 
attributable to the antioxidant action. However, the addition of L-carnitine for the 
5.5 h duration of gamete co-culture did not improve developmental outcomes. In 
cattle, the inclusion of cysteine, N-acetyl-L-cysteine, catalase or super oxide 
dismutase for the duration of the IVF period resulted in a significant reduction in 
the subsequent morula and blastocyst development rates (Ali et al. 2003). 
Inclusion of β-mercaptoethanol in porcine IVF medium following a transient co-
culture without, increased blastocyst cell number, while inclusion for the entire co-
culture period decreased cleavage and blastocyst development rates (Funahashi 
2005). Together these findings indicate that there may be temporal effects of 
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adding antioxidants during IVF, and differential effects due to the types of 
antioxidants used. Further studies should focus on the impact of L-carnitine on 
ROS-induced oocyte damage and ATP production throughout fertilisation, to 
determine the optimum time of addition during IVF. 
 
When lipid metabolism was upregulated during embryo culture, cleavage rates 
were improved relative to the control. In in vivo derived cattle blastocysts, 
expression of CTP-1 was not detected, while transcripts of fatty acid synthesis 
genes were increased at this stage (Algriany et al. 2007). When added to media 
without any carbohydrate substrates, 1.5-12mM L-carnitine increased cleavage 
rates, although not blastocyst development rates. This implies a temporal role for 
lipid metabolism, with lipid usage greater during the early cleavage divisions than 
later in development. Given that embryo nutrient requirements change with the 
stage of development, it was hypothesised that the addition of L-carnitine during 
the early cleavage stages only would further improve development. While this 
targeted L-carnitine exposure did not improve the blastocyst development rate, 
blastocyst cell numbers were increased, indicating better quality embryos. Several 
studies have shown the beneficial effects of altering the carbohydrate composition 
of media on porcine embryo development (Kikuchi et al. 2002b; Karja et al. 2004; 
Beebe et al. 2007). The addition of L-carnitine to such a sequential media system 
for the first three days of culture did not improve developmental outcomes, 
indicating that carbohydrate substrates are preferentially utilised by porcine 
embryos in vitro. Conversely, temporal addition of L-carnitine to a single medium 
system (containing pyruvate and lactate, but no glucose) for the first 3 d only 
improved blastocyst cell numbers to the same extent as a sequential media 
system (containing glucose only at Day 3-7) without L-carnitine. This again shows 
that the changing requirements for energy substrates can be fulfilled in a number 
of ways to produce higher quality embryos. Assessment of ATP content and β-
oxidation rate at critical developmental stages throughout culture may further 
reveal links between the timing of lipid utilisation and improved developmental 
outcomes. 
 
Supplementation of medium at specific times during IVP was shown to improve 
the cryotolerance of the resulting embryos. Post-thaw survival was increased by 
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incubation in the presence of L-carnitine prior to co-incubation with sperm, and 
when embryo culture medium was supplemented with L-carnitine. Although not 
confirmed in this study, the increased cryosurvival following L-carnitine treatment 
is most likely attributable to a decrease in lipid content, as cryotolerance is 
associated with lipid content (Nagashima et al. 1995; Abe et al. 2002). Further, 
studies using other lipolytic stimulants have shown positive results regarding the 
cryosurvival of porcine embryos (Men et al. 2006; Gajda et al. 2011; Gomis et al. 
2013). This result is also consistent with those of previous studies in cattle, 
whereby L-carnitine was shown to reduce intracellular lipid and improve embryo 
cryosurvival (Sutton-McDowall et al. 2012; Ruiz et al. 2013; Takahashi et al. 
2013). Although there was no associated increase in ATP content of oocytes 
incubated in L-carnitine prior to insemination, blastocyst cell numbers were also 
similar to those not exposed to L-carnitine, indicating the embryos were of 
equivalent quality. This is an important finding as the ability to successfully 
cryopreserve embryos promotes the long-term storage and global movement of 
valuable genetic lines. Frozen genetic material is an important factor in the 
application of herd genetic improvement programs in the cattle and sheep 
industries, but is yet to be realised in the pig industry. Further improvements to the 
cryostorage of porcine embryos are essential for embryo transfer to become an 
integral component of advanced breeding programs. 
 
There was a consistent pattern of increased embryo cleavage rates found when L-
carnitine was added during IVF and IVC. This suggests that lipid stores were 
primarily utilised during the early cleavage divisions. This is interesting given that 
NCSU-23 medium, a culture medium commonly used for porcine embryos, only 
provides 5.55 mM glucose as the sole carbohydrate substrate (Petters and Reed 
1991; Petters and Wells 1993). However, exposure to glucose during the early 
cleavage stages was found to reduce embryo quality in the medium used in the 
present study, PZM-3, consistent with poor development of embryos seen when 
they were cultured in unmodified NCSU-23 medium (Kikuchi et al. 1999). 
Blastocyst development rates and embryo quality were improved by replacing 
glucose with pyruvate and lactate for the first two days of culture in NCSU-37, and 
NCSU-37 medium conditioned with oviduct cells supported the production of 
piglets following transfer (Kikuchi et al. 2002b). The PZM media formulations were 
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developed based on substrate concentrations of oviductal fluid (Yoshioka et al. 
2002). Both PZM-3 and PZM-4 (with PVA replacing BSA for a fully defined 
medium) produced embryos with higher ICM and total cell numbers than those 
cultured in NCSU-23 medium (Yoshioka et al. 2002). Further, embryos cultured in 
vitro in PZM-3 and PZM-4 had similar ICM to total cell ratios as that of in vivo 
produced blastocysts, and the transfer of PZM-4 cultured embryos to recipient 
females resulted in farrowing and live birth rates similar to those achieved 
following the transfer of in vivo produced embryos (Yoshioka et al. 2002). Higher 
blastocyst development rates and embryo cell numbers were obtained for both 
parthenotes and reconstructed nuclear transfer embryos when cultured in PZM-3 
compared with NCSU-23 medium (Im et al. 2004).  
 
The studies presented here utilised POM as the IVM medium because it was 
developed as a completely defined medium capable of supporting oocyte 
maturation (Yoshioka et al. 2008). Although BSA was used in place of PVA for 
these studies, this still provides for a more reliable medium compared to the use 
of undefined factors, such as follicular fluid. When used for IVM, NCSU-23 and -
37 media are commonly supplemented with follicular fluid (Petters and Wells 
1993), which leads to high variability of media batches due to the addition of 
undefined factors, and potentially exposes the oocytes to pathogens. The use of 
POM supplemented with PVA during IVM resulted in higher rates of normal 
fertilisation compared to POM with follicular fluid, and NCSU-37 medium with 
either PVA or follicular fluid, while the use of PVA in NCSU-37 medium resulted in 
lower rates of maturation to the MII stage compared with all other treatments 
(Yoshioka et al. 2002). Further differences between the two media are in amino 
acid concentration and composition, with POM containing a total of 22 amino 
acids and the NCSU media containing a limited number, including glutamine, 
taurine and hypotaurine. Amino acids act as osmolytes, contribute to intracellular 
buffering, and can contribute to energy generation. Excess amino acids can be 
stored, with the carbon skeleton converted to pyruvate, acetyl-CoA and various 
other intermediaries of the TCA cycle and used for energy production. In the case 
of ketogenic amino acids, this can also be converted to triglycerides for storage or 
metabolic use. When non-essential and essential amino acids were added to 
NCSU-23 supplemented with PVA during porcine oocyte IVM, maturation rates, 
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sperm penetration and blastocyst formation were similar to that of NCSU-23 
medium supplemented with follicular fluid (Hong et al. 2004), highlighting the 
importance of amino acids in a maturation system. Differences in media 
compositions all contribute to variable outcomes between studies, and make 
comparisons of results difficult. Future research should focus on how these other 
medium components affect oocyte and embryo metabolism, and aim towards 
standardising the use of a defined medium for scientific research. 
 
In muscle tissue, high glucose availability reduces the mobilisation of fat reserves 
and favours carbohydrate oxidation (Spriet and Watt 2003). It is proposed that a 
similar effect is seen within the in vitro oocyte and embryo models presented in 
these studies. Glucose oxidation produces citrate, which is converted into 
malonyl-CoA by acetyl-CoA carboxylase, with malonyl-CoA inhibiting entry of fatty 
acids into the mitochondria at CPT1. Therefore, when glucose oxidation is 
favoured, high concentrations of malonyl-CoA reduce the rate of fatty acid 
oxidation. When carbohydrates were present at sufficient concentrations during 
IVM and IVC, L-carnitine had little to no effect on the rates of nuclear maturation 
and embryo development. It is likely that with sufficient exogenous energy 
substrates available, there is a preference to utilise these substrates first while 
maintaining endogenous energy reserves. In situations where carbohydrates were 
limiting, there was a greater positive effect of upregulating lipid metabolism, and 
an increased detrimental effect of inhibiting this pathway. Without the necessary 
concentrations of exogenous substrates, there is higher mobilisation of 
endogenous lipid reserves for oxidation, and therefore alteration of the lipid 
metabolism pathway has greater effects under these circumstances. This is also 
consistent with a greater effect of L-carnitine shown during IVM with the inclusion 
of follicular fluid (Somfai et al. 2011), which is rich in exogenous free fatty acids. 
Increased free fatty acid availability increased muscle acetyl-CoA and citrate, 
which causes a downregulation of PDH and PFK activities leading to reduced 
glycolytic rate (Spriet and Watt 2003). Perhaps the key to enhancing lipid 
metabolism in porcine oocytes and embryos is to increase the rate of 
hydrolysation of triglycerides, thereby increasing the levels of available free fatty 
acids for metabolic use. 
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Future investigations are required to better understand the differences in 
metabolic processes between IVP and in vivo conditions in more detail. 
Transcriptomic (Ouandaogo et al. 2012), proteomic ((Kim et al. 2011), 
metabolomics (Bertoldo et al. 2013; Gu et al. 2015) and lipidomic (Ferreira et al. 
2010; Silva-Santos et al. 2014) assessments, and analysis of individual follicles, 
COCs and embryos using recently developed tools such as novel imaging 
techniques (Watanabe et al. 2010; Jasensky and Swain 2013), would reveal 
valuable insights into the development of porcine oocytes and embryos and key 
differences between good and poor quality cells. Such analyses could also 
contribute to our understanding of the effects of different environments and media 
formulations on oocytes and embryos. Continued annotation and analysis of the 
porcine genome will contribute to studies examining genes involved in 
metabolism. Advancements in our knowledge of the follicular, oviductal and 
uterine environments continue to contribute to our understanding of the available 
substrates during in vivo development. For example, recent characterisation of the 
metabolomic signatures of porcine follicular fluid showed differences in the 
concentrations of metabolites, including glucose, lactate and five different amino 
acids, between good and poor follicular environments (Bertoldo et al. 2013). It is 
evident that metabolic processes in oocytes and embryos differ between species, 
making extrapolation from research in other species difficult. Modifications of 
media should therefore be specific to individual species. 
 
To conclude, the metabolic processes of oocytes and embryos throughout 
maturation and culture are complex and dynamic. Attempts to examine these 
processes in vitro are confounded by the ability of oocytes and embryos to utilise 
different medium substrates, while comparisons between studies are made 
difficult owing to the different base media formulations used, often leading to 
contradictory results. This thesis has contributed to further understanding how 
porcine oocytes and embryos use endogenous lipid substrates throughout in vitro 
development, and the interaction with carbohydrate substrates. The majority of 
earlier research focussed solely on the metabolism of carbohydrates, with only 
recent studies focussing more intently on lipid utilisation. The results of the 
present study suggest that while lipid metabolism does occur during oocyte 
maturation and embryo culture, it is at low levels with preferential use of 
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carbohydrate substrates, namely pyruvate and glucose. However, when these 
carbohydrates are deficient, lipid metabolism can compensate to some extent to 
support development. Upregulation of the β-oxidation cycle during embryo culture 
also enhanced embryo cryosurvival, with porcine embryos being notoriously 
difficult to cryopreserve due to their high lipid content. Further investigations are 
required to better understand the complex interactions of the metabolic processes 
throughout each stage of IVP and thus improve overall IVP efficiency as well as 
the quality of the resulting embryos. In particular, understanding why porcine 
oocytes and embryos have such a large intracellular store of lipid and what the 
fundamental role of this lipid is in embryo formation and development will lead to 
improved support of these cells in vitro. 
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